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PREFACE 
The research into thyroid function has a long history. The recognition of 
goiter as pathology of the thyroid gland dates back to the ancient world of Rome 
and Greece and possibly even to the early history of chinese medicine. In an 
excellent review of the historical aspects of the discovery of thyroid hormones 
and their biological action (1) Pitt-Rivers describes the growing awareness of 
the significance of iodine for thyroid function early in the 19th century. 
The actual presence of organic iodine in the thyroid gland was demonstrated 
for the first time in 1896 1:y Ba1.llTBnn who called his concentrate of a thyroid 
extract "Iodothyrin". In 1914 Kendall isolated a crystalline material from thy-
roid hydrolysates and named it "Thyroxin" after thyroxindole, since he believed 
this sUbstance to be an indole derivative. The compound proved to have biologi-
cal activity in hypothyroid man and aninals. The actual structure fonnula of 
the thyroxine rrolecule was disclosed by Harington in 1926. Only in 1952 the ex-
istence of 3,3' ,5-triiodothyronine was simultaneously demonstrated in beef thy-
roid and human serum by Gross and Pitt-Rivers and in rat thyroid by RoChe et al. 
At the same time it appeared that this triiodothyronine was about three times as 
potent as thyroxine in the goiter prevention assay in rats. The original postu-
late by Gross and Pitt-Rivers (1953) that triiodothyronine originates by degra-
dation of thyroxine in peripheral tissues and constitutes the principal active 
thyroid hormone was established by Sterling and Braverman in as late as 1970. 
Since this time thyroid research has explosively expanded in many fields, 
such as thyroidal synthesis and secretion of iodothyronines, feedback regula-
tions of the hypothalamic-pituitary-thyroid axis, goiter etiology and autoimmune 
rrechanisrns with associated hyper- and hyp::>thyroidism, thyroid cancer, vascular 
transport proteins, nuclear thyroid hormone receptors with post-receptor biolog-
ical effects and the br03.d field of peripheral thyroid honnone rnetal.:::olism. This 
last sUbject in its turn can be subdivided into smaller areas, suCh as kinetic 
studies with isotope labeled thyroid hormones ,the processes involved in mem-
brane transport, as well as the subcellular distribution of either locally pro-
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duced or plasma-bome iodothyronines. But also, and this represents an impor-
tant section in this tllesis, the intracellular metabolism of the m.lltiple thy-
roxine-derived metaJ:.:olites. It is obvious that the above list is far from com-
plete, but it gives an irrpression of the wide scope of current thyroid research. 
This thesis is a compilation of various investigations in the field of peri-
pheral thyroid horrrone metabolism. The rrain objective of the presented work has 
been to obtain rrore kno.vledge about the physiology of the various metalx>lic 
pathways of iodothyronines. This objective was chosen in the hope to contribute 
to a better understanding of the complex metabolic adaptations in iodothyronine 
:metabolism, known to be induced by several drugs, dietary changes or diseases. 
At first sight the rather diverse subjects of investigation in Section II of 
this thesis bear no apparent relation. Ha.vever, in the next chapters a tenta-
tive linkage of the various results will be discussed. 
Essentially three different lines of researCh have been followed. The first 
line consists of the investigation of dietary influences on peripheral thyroid 
horrrone rnetab:Jlism. Since the observation of Spaulding et al ( 2) that 800 kCal 
of dietary carbohydrates nullified the changes of hurran serum 
3,3' ,5-triiodothyronine {T3) and 3,3' ,5'-triiodothyronine (reverse T3) normally 
seen with hypocaloric nutrition, multiple reports mentioned similar effects with 
a variety of different dietary compositions, all paying special attention to the 
effect of carbohydrates. The lack of detailed information about the influences 
of the other two major corrponents of focd i.e. proteins and fat, prompted us to 
design the study described in Section II:l. It was found that dietary fat pla-
yed an active role, opposite to carbohydrates and proteins, in altering the 
serum levels of both T3 and reverse T3 . 
The second line of research represents the in vitro experiments with monola-
yers of isolated rat hepatocytes. Kinetic studies with labeled iodothyronines 
in human beings and animals give information about the respective production and 
metabolic clearance rates. MJreover, with these techniques in the 1:ody, apart 
from plasma, two different pools for iodothyronines can be distinguished Which 
vary in equilibration and disposal characteristics. However, the individual 
contribution of the various tissues to overall metabolism remains obscure, and 
rapid successive intracellular reactions cannot be detected. On the other hand 
in vitro studies with tissue hamogenates or subcellular fractions laCk the in-
tegrated function of the intact cell. We, therefore, felt that monolayers of 
isolated rat hepatocytes would be a suitable model for studying iodothyronine 
metabolism at the tissue level. The more so, since the liver is regarded to be 
very active and play a central role in thyroid hormone metabolism. Indeed, this 
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in vitro model, WhiCh is ever more widely used for all kinds of different stu-
dies, proved to be a useful tool in thyroid horm::me research as well. The rele-
vance and complementary function of studies with intact cells is well illustrat-
ed by the striking difference of 3,3'--diicxlothyronine (3,3'-T2) metaOOlism with 
either rat liver microsorres or isolated rat hepatocytes. It was found that with 
the former, 3,3'-T2 is only very slowly deiodinated in the outer ring, Whereas 
in intact cells the reaction had a much higher velocity (Section II:3). In 
fact, the recognition of this discrepancy led to the discovery that hepatic de-
iodination of iodothyronines is preceded, and in effect accelerated, by conjuga-
tion with sulfate. Detailed information about the discovery and the charac-
teristics of this hitherto unknown metabolic paL1way for 3,3'-T2 and T3 is pre-
sented Section II:3-6. 
A general problem in studying peripheral thyroid hormone metabolism is the 
ITillltiplicity of degradative routes. The corrrron metab:Jlic pathways for icxlothy-
ronines are deiodination, conjugation with either glucuronic acid or sulfuric 
acid, oxidative deamination of the alanine side chain and finally the possibili-
ty of cleavage of the ether linkage. Theoretically all icxiothyronines can be 
subjected to all of these reactions, but preferential pathways have been found 
in the different tissues. Another complicating factor is the rapid intracellu-
lar succession of some of these reactions, prohibiting the estimation of their 
exact rate. Moreover, the observations described in this thesis make it clear 
that close interactions "between the different degradative pathways exist. Taken 
together, we are confronted with a vast arrount of p:Jssible pathways and metatol-
ites with quite different characteristics. 
The early experiments described in Section II:2, Where thyroxine and reverse 
T3 were incubated with rat hepatocytes, already brought these comlexities to our 
attention. For this reason we decided first to study the metal::olic fate of the 
less iodinated iodothyronine 3,3'-T2, since it could be expected that from this 
substrate fewer metabolites would originate. The results of these experiments 
are presented in Section II:4. 
The outcane of this in vitro v.ork, enhanced by the recent data atout diiod.o-
thyronine metal::olism in humans ( 3) , has brought ab:Jut the realization that tho-
rough knc:wledge of the pathways of these "lower" iod.othyronines considerably fa-
cilitates the interpretation of thyroxine, T3 and reverse T3 metabolism. 
Exemplary to this notion is the elucidation of the actual metabolism of T3 in 
rat hepatocytes. In Section II:6 it is shown that deiod.ination of T3 is accom-
plished by three sequential intracellular reactions i.e. sulfation, deiodina-
tion of the inner ring and finally outer ring deiodination of the 3,3'-T2 sul-
fate generated. Similarly the significance of sulfation as initial and rate 
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lbmiting reaction for the metabolic clearance of T3 and 3,3'-T2 is indicated. 
Finally, the third line of researCh investigated the hydrolytic potential of 
rat gut bacteria tONards iodothyronine sulfates. Thyroid horm:mes preferential-
ly appear in bile as conjugates with either glucuronic acid or sulfuric acid. 
Since the unconjugated form is more rapidly reabsorbed from the digestive tract, 
bacterial hydrolysis of the conjugates may well enhance an enterohepatic circu-
lation. Whereas the fJ -glucuronidase activity of the intestinal :microflora is 
well established, rruch less is kna.vn about its sulfatase potentiaL In Section 
II:7 we provide evidence for the existence of hydrolytic activity towards iodo-
thyronine sulfates in 2 anaerobic strains of rat cecal bacteria. 
Section I of this thesis attempts to integrate the current knowledge of per-
ipheral thyroid hormone metabolism with the most relevant observations from our 
own 'NOrk. In this respect special attention is given to the recent and irrpor-
tant reccgnition of two tissue-specific pai:h.v'ays for iodothyronine deiodination. 
By this distinction the body tissues can be devided in having deiodinase activi-
ty which is either inhibited or nnaffected cy propylthiouracil (PTU). W'hereas 
e.g. liver and kidney are considered to be PTU-sensitive, pituitary and cere-
bral cortex belong to the latter category. This tissue-specific deicdination in 
ooffibination with our awn observations, has inspired us to propose a tentative 
mcdel, postulating a close metabolic interaction of the two tissue types in the 
modulation of iodothyronine serum levels. It is conceived that the serum levels 
of a number of iodothyronines are determined cy production in the one type of 
tissue and, after "crossing" the plasma. corrpartment, degradation in the other 
type of tissue. '!he basis for this rrodel will be 3,3'-T2 rnetatolisrn, since the 
rapid turnover of this metaOOlite enables the measurement of arterial and venous 
plasma gradients. Support for the above hypothesis was found in our prel~nary 
observation that human brains seem to be an important site of 3,3'-T2 produc-
tion, whereas the liver very efficiently extracts this corrpound from the blcx:d. 
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SECTION I 
ASPECTS OF PERIPHERAL 
THYROID HORMONE METABOLISM 
What makes science so fascinating is the 
task of pushing ever closer to the 
unattainable goal of complete knowledge. 
Owen Gingerich 

CHAPTER 1 
MECHANISMS OF PERIPHERAL THYROID HORMONE METABOLISM 
After the secretion from the thyroid of rrainly thyroxine (T4 ) with small 
quantities of 3,3' ,5-triiodothyronine (T3) these principal representatives of 
the iodothyronine family enter the 1:ody circulation. In contrast to the larger 
protein and peptide hormones as thyroid stimulating hormone (TSH) or adrenocor-
ticotrophin (ACTH) Which are soluble in aqueous solutions, thyroid hormones are 
rather small W'1d hydrophobic rrolecules. '!hey share this property with the mul-
tiple steroids in the l:ody. To transport these corrpcunds in sufficient amounts 
through the blood vessels, non-covalent binding to the plasma proteins is manda-
tory (1,2}. The transp:Jrt proteins for iodothyronines are thyroxine-binding 
globulin (TBG), prealbumin and albumin. Very recently a fourth T4-binding pro-
tein has been identified in our laboratory: thyroxine-binding albtmrin (TBA) 
(2A). Whereas the bulk of the iodothyronines are bound to these proteins it has 
been well established that it is the small fraction of unbound molecules that is 
available for uptake and subsequent metabolism or biological activity in the 
various tissues (2). Since 99.96% of thyroxine and 99.6% of T3 is bound to the 
plasrre proteins it may be envisaged that during a single transit of blood 
through the tissue capillaries only a small fraction of the total plasma T4 and 
T3 content can ''cross'' to the tissue ccmpartment. Ho.vever, since the tissue 
cells possess binding sites for these hormones not only within the plasma memr 
brane but also on their surface, binding to the tissue compartment is not equi-
valent with cellular uptake. The transfer of iodothyronines fran the rroving 
plasma to the static tissue compartments should be regarded as the dynamic re-
sultant of many and rapid equilibrium reactions between iodothyronines and the 
different binding proteins (3). In fact, it has recently been calculated both 
in rat and man that of both total T4 and T3 plasma-to-tissue-flux in slo.-.rly ex-
changing tissues 12% and in fast exchanging tissues only about 3% is further 
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processed. 'Ihe remaining 88 and 97% retum unaltered to the plasma corrpartment 
{ 4-6) . The fraction of this plasma-tissue shuttle that actually does cross the 
cellular membrane can not be discriminated by the tracer injection technique. 
Recently the interest in cellular uptake of thyroid hormones has been great-
ly revived by the demonstration of an ATP-dependent carrier system for iodothy-
ronines in rat hepatocytes ( 7) . Since diffusion is characterized as a passive 
transfX)rt process directed to the lo.vest free horrrone concentration, the energy 
dependence of the hepatocyte uptake system suggests the reverse i.e. 
transp:::lrtation in the direction of a higher intracellular free hormone concen-
tration. At present the exact intracellular free hormone concentration is unk-
nown and may fluctuate in different (sub-)cellular compartments. Furthermore, 
the intriguing question arises why the cell would require a high concentration 
of unbound hormone where the principal cellular target, the nucleus, has the hi-
ghest affinity for T3 of all subcellular elements (8). A possible advantage of 
functioning at a higher intracellular free hormone concentration is that by 
means of an active and controlled trans!X'rt system the cell would be able to 
auto-regulate the desired intracellular hormone concentration. It may also be 
speculated that only those subcellular compartments that require a higher con-
centration are connected to the energy dependent uptake system. The possible 
' ' HOOoO~ 
3,3'·T2 
---------------
~ ~ 
------ -------~oOoO• 
Fig.l. Thyroxine (T4 ) and the cascade of other icdothyronines originated by either inner ring ( .....--) 
or outer ring (--...) deiodination. The outer or phenolic ring is characterized by the hydroxyl grrup 
in the 4' position. R represents the alanine side chain; in between is the inner- or tyrosyl ring. 
After reroval of all iodine rrolecules the thyronine (T0 ) skeleton rerains. Fran ref. 15. 
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existence of different intracellular transport pathways and compartments is dis-
cussed in Chapter 4C. 
Metabolism of iodothyronines in the peripheral tissues is characterized 
by 1) deiodination, 
ther glucuronic acid 
2) esterification of the phenolic hydroxyl 
(glucuronidation) or sulfuric acid 
group with ei-
(sulfation), 
3) de~nation and decarboxylation of the alanine side chain (oxidative deamina-
tion) and 4) ether link cleavage. 
Although in theory all eight iodothyronines can be subjected to all these five 
processes, to the tranquility of the researcher in this field, this does not 
happen. It has became increasingly clear that different tissues have preferred 
metaOOlic pathways for the distinct iodothyronines. This notion has brought a 
new dimension to the understanding of thyroid hormone homeostasis. Fonner ki-
netic investigations were lirrUted to plasma production rates and metabolic 
clearance rates of the various icx'lothyronines. There is nON a gro.Y'ing interest 
in the contribution of the individual organ tissues to these processes. 
A. Deiodination~ a Tissue-Specific Pathway 
Before thyroxine (3,3' ,5,5'-tetraiodothyronine, T4 ) can exert its biological 
activity this main secretory product of the thyroid follicles has to be convert-
ed to 3,3' ,5-triiodothyronine (T3) (8-10). The sUbstitution of an iodine atau 
in the 5'-position with a hydrogen ion is essentially a reductive, enzymatic 
process called deiodination. Not only the iodine atom in the 5'-position of the 
outer ring is susceptible to deiodination but all four iodine atoms of thyroxine 
can sUbsaJUently be removed in a non-random fashion, giving rise to a total of 7 
iodinated thyroxine metabolites (Fig.l). Several publications have reviewed the 
multiple aspects of these processes both in vivo and in vitro (11-19). 
The in vivo conversion of T4 to T3 , already suggested in 1953 by Gross and 
Pitt-Rivers (20), could definitely be established by Sterling (21) and Braverman 
(22) in 1970. Soon after the discovery of T3 in human serum (23), invitrogen-
eration of this hormone from T4 was found to occur in rat kidney slices by Al-
bright et al. (24). Later, this conversion was also demonstrated in other tis-
sues of the rat as heart, liver, muscle, pituitary, brain and the thyroid itself 
(25-30). Similar activity was found in tissues of human origin as kidney, 
liver, heart, rruscle, fibroblasts, poljlffiorphonuclear leucocytes, lymphocytes, 
placenta and thyroid (31-37) as well as in tissues of other vertebrates (17). 
It was readily understood that these tissues showed considerable differences in 
deiodinative activity. In the rat, the liver and the kidney were found to have 
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the highest in vitro activity Whereas e.g. muscle, spleen, lung and intestine 
have little deiodinating potential (27,38). 
since the first demonstration of predominant deiodinase activity in the mi-
crosomal fraction of rat liver homogenates (39,40) substantial effort was initi-
ated to elucidate the mechanism and characteristics of these enzymatic reactions 
throughout the 1.xxly. D.:te to their high activity, the liver and kidney deiodi-
nases were the first to be scrutinized. Important advances have been the dis-
closure of the essential role of thiol groups as cofactor for outer ring deiodi-
nation (40) and the elucidation of the "ping-pong" kinetics of this reaction 
with rat kidney and liver microsomes in the presence of dithiotreitol 
(41,4lA,42). They provided insight in the mechanisms of deiodination and the 
·.vell-kna.vn inhibition by P'IU (41A,43,44). The strong thiol dependency of deiod-
ination suggested the existence of a SH-group containing endogenous cofactor 
( 16,40 A5-47). The advocated potential role of glutathione as principal endoge-
nous cofactor, however, has been disputed (47-52A). Interestingly, a recent re-
port suggests that not the total amount of glutathione in rat hepatocytes influ-
ences deiodination of iodothyronines (51) but that the ratio of oxidized (GSSG) 
versus reduced glutathione (GSH) is of importance (51A..). 
Similarly, considerable controversy has existed as to whether inner ring and 
outer ring deiodination were catalysed by one single or two distinct enzymes. 
It is now generally accepted that in liver both the phenolic and tyrosyl ring 
are deiodinated by the same enzyme (53,54). This deiodinase is a basic, integ-
ral membrane protein of the endoplasmic reticulum with a molecular weight of ap-
proximately 60.000 D (55,56). Further characterisation is retarded by the dif-
ficult solubilization of this tightly membrane bound enzyme (17,57,58), although 
very recently a 400-fold purification has been reported (59). 
The discovery of thiol-dependent but PTU-insensitive T4 to T3 conversion in 
rat pituitary (60-63) in 1978 heralded the existence of an entirely different 
de1odinating enzyme system. MeanWhile, the characteristics (64-71) and the tis-
sue occurrence (72-76) of these deiodinases, now commonly referred to as type II 
deiodination, have been extensively documented. M:>st data are derived fran ex-
periments with rat cerebral cortex or pituitary tissue but extracranial type II 
deiodinase activity has also been found in brown adipose tissue of the rat (76), 
both hurran and rat placenta (77, 78) and possibly in cultured monkey hepatocarci-
norra cells (79,80). 
Several prominent differences between type I (D I) conventionally found in 
liver and kidney, and type II deiodinase (D II) can be indicated. 
First, it is important to realize that, in contrast to the type I deiodinase 
in liver and kidney that catalyses l:xJth outer and inner ring deicdination, there 
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are t\'1.0 separate enzymes in the type II category required for these reactions. 
Both subtypes are present in brain cortical tissue (66,67,69,70,73,74) but outer 
ring type II deiodinase (ORO II) prevails in the pituitary (60,62,64,68,71). 
The latter plays an important role in maintaining thyroid hormone homeostasis 
through intra-pituitary T4 to T3 conversion (81). 
Second, type I and II deiodinases follow different reaction mechanisms. In 
type I deiodination an essential thiol group of the enzyme is involved, that al-
ternates (ping-pong) between the reduced state (-SH) and the oxidized state 
(-SI) (Fig.2) (69). PTU, as uncompetitive inhibitor, irreversibly inactivates 
the enzyme by fanning a mixed disulfide with this reactive sulfur ( 43-44) . 
Contrary to D I, type D II is not inhibited by preincubation with lo.v concentra-
tions io::loacetate (41A,69). Icdoacetate inhibits liver deiodination in a 
non-competitive manner (82) probably through inactivation of an essential 
SH-group in the enzyme (13,16,17,40). Therefore, enzymic thiol groups apparent-
ly are not obligatory to type II deicxlination. This also explains the lack of 
PTU inhibition on this reaction as no enzyme inactivation via fonration of mixed 
disulfides ca!'l. occur. At present the exact reaction mechanism of type II deio::1-
ination has not yet been elucidated. The reaction kinetics derived from incuba-
tions with different Sllbstrate and DTr concentrations, are suggestive for a se-
quential-type reaction (69,83). This implies sequential formation of a reactive 
ternary corrplex of substcate (iodothyronines), cosubstrate (DTT) and the enzyme 
(Fig.2). 
The third distinction between the two classes of deiodinases is their dif-
ferent susceptibility to inhibitors. Ap:lrt from PTU, t:ype D I inhibitors as so-
dium salicylate, dicoumarol and amiodarone appear to leaveD II unaffected (70), 
although iopa.noic acid inhibits both enzymes (65,69,70,84). 
rT3 3,3'·T2 
H E,~-SI 
DTT, DTT "' 
+HI 
Fig.2. Pathways of outer. ring deicdination. On the left the l?l'U-sensitive (type I, ORO I) deicd.i-
nation of rr3 which depends on the presence of an essential, reduced thiol group in the enzyme 
(E1-SH). On the right the prop::Jsed PI'U-insensitive (type II, ORO II) outer ring deicxlination of T4 . 
The latter reaction does not rEqUire enzymic SH-groups and may be accauplished through a ternary 
ccrrplex of substrate (T4 ), enzyme (E2 l and reduced cofactor, dithiotreitol (DI'l'). From ref. 69. 
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N Table 1. DEIODINATION CHARACTERISTICS OF IODOTHYRONINES IN RAT LIVER AND CEREBRAL CORTEX N 
Reaction T a K Vmax v max 1Km DTTb PTUa Ref. X m 
{min-l.mg mM 
prot-1) 
CEREBRAL CORTEX 
T4 + rT 3 + 37 nM 144 fmol 3.9 50 70 
2 T4 + T3 t 14 nM 1. 5 fmol 0. 1 100 -- 74 
hypo 1.1 nM 11 fmol 10 20 66,69 
3 T3 + 3,3'-T 2 + 5. 5 nM 134 fmol 24 50 66, 70,73 
4 3,3'-T 2 -+ 3'-T l + 74 
SA rT 3 + 3,3'-T 2 29 nM 37 fmol 1.3 20 + 67 
SB rT 3 + 3,3'-T 2 hypo 2. 8 nM 6 fmol 2. 1 20 69 
LIVER 
6 T4 + T3 + 2. 3 MM 30 pmol 1 3 3 + 266 
7 T4 + rT 3 + 1.9 MM 18 pmol 9 3 + 266 
8 rT 3 + 3,3'-T 2 + 0. 06 MM 560 pmol 8730 3 + 266 
11 T 3s + 3,3'-T 2S ? 4.6 MM 1050 pmol 228 5 + 268 
12 3,3'-T2S-+ 3-T 1s ? 0. 3 MM 350 pmol 1170 5 + 267 
a The arrows indicate an increase (t) or decrease(~) of the reaction rate after thyroidectomy {Tx) or 
PTU. Hypo: condition in hypothyroid tissue. 
b Concentration of dithiotreitol in the experimental incubate. 
The reaction numbers correspond with the numbers in fig. 12 A and B. 
(fold-out in the back of the manuscript). 
A fourth difference is found in the generally much higher substrate affinity 
for type D II, as reflected in the l<:J.\Ier ~ values for these reactions. On the 
other hand, the reaction rates, with corrparable DTI' concentrations, are much 
lower. A survey of the available deiodination characteristics with both types 
of deiodinases is given in Table I . 'lbe reactions are numbered in order to 
match with the reaction numbers of the fold-out diagram in the back of the man-
uscript. 
The fifth interesting but intricate discrimination is found in the enzymes' 
adaptation to hypothyroidism (Table I). After thyroidectomy typeD I activity 
in rat l.iver and kidney rapidly declines {85-87). In contrast, hyp:Jthyroidism 
has a divergent influence on the two PTU-insensitive deiodinase sUbtypes i.e. 
inner ring deiodinase (IRD II) and ORO II. In the euthyroid adult rat cerebral 
cortex IRD II activity, responsible for T4 to rT3 and T3 to 3,3'-T2 conversion, 
prevails. After thyroidectomy this activity decreases, conversely an increase 
in ORD II, converting T4 to T3 and rT3 to 3,3'-T2, is found (66,67,69,73). It 
is of interest to note that, While thyroid har.mone homeostasis generally is a 
slow and static process, increased ORO II activity regresses within 4 hours 
after T3 substitution to hypothyroid rats (88). It has been suggested that in 
the pituitary these changes in enzyme activity are mediated through effects on 
deiodinase synthesis (89), though this notion was refuted by others {89A). It 
can be speculated that the hyp:Jthyroid adaptations, causing increased T3 genera-
tion and diminished T3 degradation, may serve to prevent cerebral T3 depletion 
under this condition. However, this explanation probably is far too simple 
since the enzymatic changes after thyroidectomy also differ greatly with age, 
brain region {73,74) and during starvation (68,90). 
B. Conjugation of lodothyronines 
M:>st of the 10 major conjugation reactions in man and anirra.ls were disco-
vered in the nineteenth century {91), long before Kendall in 1914 isolated "thy-
roxin'' fran the thyroid gland. Five years later, in 1919, Kendall ref.X)rted the 
biliary excretion within 50 hours of 43% of iodine from 200 pg thyroxine inject-
ed in a dog (92) . This observation demonstrated for the first time that biliary 
secretion contributes to the disposal of thyroid hormone. 
In the following years several investigators attempted to elucidate the na-
ture of the iodine secreted in the bile. Hcwever, their methods lacked suffi-
cient specificity to discriminate thyroxine from closely related but different 
compounds. The availability of radioactive isotopes and the development of 
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paper chrorratography in the early 1940's pennitted a rrore precise analysis of 
secreted products in bile. After the injection of small doses labeled thyroxine 
in rats, Taurog et al. in 1951 were the first to identify thyroxine glucuronide 
(T4G), initially narred "carpound U", as major biliary secretion product (93,94). 
The quantitative irrportance of this disposal pathway was demonstrated in 
[ 131rJT4-substituted, thyroidectomized rats {95}. In equilibrium conditions the 
radioactivity excreted was equally distributed over feces and urine, the latter 
containing mainly iodide {Fig.3). In bile, however, the majority of the radi-
oactivity is excreted as iOO.othyronines ccnjugated mainly with glucuronic acid 
(67%} or to a lesser extent with sulfate (6%) {111}. These observations desig-
nate conjugation as an important route in thyroid hormone metabolism. 
Nevertheless, its contribution may vary per species since lower excretions have 
been reported in nan ( 96) and dog ( 9 7) . 
Most data on iodothyronine conjugation are obtained from in vitro studies 
with isolated, perfused rat livers or from animal experiments, mainly with rats 
and dogs. The obligatory collection of bile limits these studies in humans to 
rare occasions (98). 
100f-FE_C_E-,---
80J 
:l 60 
i 
P-J 
URINE 
Days on 11' 1 labeled l-lhyrox1ne 
Fig.3. Excretion of radioactivity in feces and urine of thyroidectomized, 1 pg/day 
[131I]T4-substituted rats with or without treatrrent of 15 rrg PTU/rat/day. In parentheses the number 
of an:ina1s per group. Fran ref. 95. 
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1. Glucuronidation 
Glucuronidation, for the first time recognized in 1855, is the most widespr-
ead form of "conjugation" in rrammalian metal::olism (99). The reaction, coupling 
D-glucuronic acid with a variety of corrpounds, is catalysed. by the enzyme 
UDP-glucuronyltransferase (EC 2.4.1.17). The enzyme, which appears in rrany het-
erogenous foDmS, is predominantly located in the endoplasmic reticulum of the 
liver cell. Extrahepatic glucuronidation, ho,.;ever, has been derronstrated in 
lTBnY tissues throughout the body. The reaction is highly dependent on the con-
centration of the "activated" form of glucuronic acid, uridine diphosphate 
D-glucuronic acid or UDP-glucuronic acid. The synthesis of this corrpound from 
D-glucose and uridine triphosphate is an energy-requiring process (99). 
The preferential secretion of T4 glucuronide in rat bile after tracer doses 
of labeled T4 as originally observed by Taurog et al (93,94), has repeatedly 
been confi.rm:::d by others (100-103). Similarly it was found that when increasing 
amounts of unlabeled T4 wer2 added to the injected l3lT4, a greater proportion 
of thyroxine was secreted in bile in the unconjugated or free form. At very 
higl1 concentrations, e.g. 0.1 to 20 mg, virtually all radioactivity appeared in 
the free T4 fraction (99A,l00-105). These experiments show that the liver can 
clear unphysiological amounts of thyroxine very efficiently by rapid biliary 
disposal of the unprocessed hormone. It has been suggested that this biliary 
clearance is mediated through active secretion (113). This mechanism may, quite 
feasibly~ be operative in hyperthyroidism. 
Conjugation with glucuronic acid has also been reported with T3 and reverse 
T3 (100,106-110) but only in minute amounts with the lesser iodinated iodothy-
ronines as 3,3'-T2 (110). In vitro glucuronidation of 3,3'-T2 has been reported 
in rat hepatoma cells (162), but not in m:mkey hepatocarcinana cells (193). 
This may be due to defective sulfation or a different glucuronyltransferase in 
the former cell line. At present no information exists al::out the characteris-
tics of these compounds as substrates for UDP-glucuronyltransferase. In this 
respect it is of interest to note that halogen, and notably iodine, substitution 
in either the ortho-- or para-position of a phenol rrolecule considerably enhances 
the affinity of the aglycon for UDP-glucuronyltransferase (126--128). It may, 
therefore, be anticipated that icdothyronines are pc>tentially good substrates 
for glucuronidation and that the number and location of iodine molecules will 
ha~e ~n important influence on the rate of conjugation. Since gluruconidation 
appears to play a significant contribution to thyroid hormone disposal, and pos-
sibly may even have a honrone conserving role in hyp:Jthyroidisrn (Chapter 3), 
more detailed knowledge about the characteristics of this reaction with the var-
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ious iodothyronines may help to understand the complex shifts in serum concen-
trations induced by dietary modifications, drugs or diseases. 
The significance of glucuronidation for thyroid hormone turnover is well il-
lustrated by the effects of UDP-glucuronyltransferase inductors as phenobarbi-
tal, methylcholanthrene, polychlorinated biphenyls, benzpyrene and rifampicine 
(112-119,130,131). After at least 2 days administration to man or animals these 
compounds invariably induced increases in T4 metabolic clearance rate, biliary 
secretion of T4G, as well as raised fecal excretion and turnover of T4 • In hu-
mans (118,119) and intact rats (ll2,ll2A,ll6) T4 levels were unchanged or only 
slightly depressed. Increased thyroid activity and T4 production compensated 
for the au:JIUented T4 clearance (112,131). On the other hand the norrral basal 
and TRH-stimulated TSH levels (118,119) suggest an adapted pituitary feedback. 
In T4-substituted, thyroidectanized rats, however, the increased metabolic 
clearance caused a profound lowering of serum T4 levels (112,116). In contrast, 
T3 serum levels tended to "be less affected by these corrpounds (116) and sane-
times were even raised (117) in spite of a documented increased T3 clearance 
rate (119). Moreover, a prolonged half life and raised thyroxine serum levels 
have been found in untreated Gunn rats, a species with genetically deficient 
UDP-glucuronyltransferase activity (125,129-132). These observations support 
the concept that glucuronidation contributes significantly to thyroid hormone 
disposal. 
Extrahepatic glucuronidation has also been demonstrated for iodotlwronines 
in hepatectomized dogs (102,110,111,120) and eviscerated rats (121). In spite 
of B1is extrahepatic production of glucuronides, surprisingly low (110,122) or 
laCking (100,107) serum levels of these conjugates are found, unless the bile 
duct is ligated {100,107). This phencmenon is explained by an extremely 
rapid hepatic clearance and biliary secretion of T4 glucuronide (123-125). The 
estimated half life of this CDmfXJund in the rat is a.b:Jut 13 minutes. Of partic-
ular interest is the glucuronidation of orally ingested thyroxine during tran-
sportation through the intestinal wall after its absorption from the gut lumen 
(134). The generated T4G is rapidly and almost completely eliminated by the 
liver from the :portal blo::xl and secreted in the bile ducts (135). The shunting 
of absorbed thyroxine back into the intestinal lumen by this short circuit, at 
least in part, may explain why substitution of hypothyroid patients generally 
requires higher doses of thyroxine than endogenously prcduced in euthyroid per-
sons. The existence of an enterohepatic circulation for icdothyronines and 
their conjugates has been advocated and disputed. This subject is arrply dis-
cussed in the literature (92,111,136-139) and will be shortly mentioned in 
Chapter 3. 
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2. Sulfation 
Sulfation, initially discovered in 1875, is a widely distributed conjugation 
form of inorganic sulfate with xenobiotics or endogenous corrpounds (91). The 
reaction occurs in most, if not all, animals and plants, is catalyzed by a group 
of heterogenous sulfotransferases and in higher mammals requires next to a suit-
able acceptor, the sulfate-donating cosubstrate PAPS or adenosine 3'-phosphate 
5'-sulfatophosphate (140). The generation of this "activated sulfate" is an en-
ergy-requiring process and its concentration an important factor in the reaction 
rate (141). 
Sulfotransferase activity seems to be present in most mammalian tissues, 
though considerable tissue and species variations with regard to substrate af-
finity and reaction rate exist (141). Many different forms of sulfate conjuga-
tion, e.g. c.oso3-, N.oso3- or C.NH.so3-, have been recognized. Since iodo-
thyronines principally are sulfated in the phenolic hydroxyl group, our atten-
tion is focused on the family of phenol or aryl sulfotransferases (EC 2.8.2.1.) 
(142-147). Fran rat liver alone 3 forms have been purified to hanogeneity. The 
enzymes appear in the 140.000 x g supernatant of rat liver homogenates and have 
a molecular weight of about 65 kD (142). The cytosolic origin makes these en-
zymes quite distinct from the membrane-bound glucuronyltransferases. Ha.....ever, 
as is exenplified by icxlothyronine metaOOlisrn, their substrate specificities 
have a considerable overlap. 
Sulfation of iodothyronines in vivo, though sunnised for long {106), 1Na.S de-
monstrated for the first time by Roche and COvJOrkers in 1957 {148,153). After 
sllnultaneous injections of 35so~- and 0.7 p.g [3'-131r] T3 they identified in 
rat bile a conpound bearing toth lal:::els and having the same chroma.tographic pro-
perties -'iS synthetic T3 sulfate (T3S). Scon hereafter, the same corrpound was 
found in the plasrra of similarly treated rats ( 149, 154) and human beings ( 158) . 
The isolated material was j3 -glucuronidase resistant but after incubation in lN 
HCl at lOOC for 10 min yielded 35so~- and [3'-131r] T3 as hydrolysates. 
Later, the existence of iodothyronine sulfate esters was substantiated by enzy-
matic hydrolysis with a rather crude preparation called Mylase P (157) and par-
tially purified commercial sulfatases (161,163, Section II:3,4). 
Roche and ca.....orkers also carpared the metaOOlic fate of T3s and [3'-1311] T3 
after intravenous administration in rats. Quite contrary to the glucuronide of 
T4 which has an extremely rapid hepatic and biliary clearance (123-125), the 
sulfate of T3 was found to have a much slower plasma disappearance rate than T3 
itself (150,151) (Fig.4). Furthermore, a rrarked difference in tissue-distribu-
tion was noted: T3 accumulated faster in liver and kidney than T3S. At the 
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Fig.4. Plasma disappearance curves of radioactivity after the intravenous administration of 0.8 
nrrol labeled T3 or T3 sulfate (ST3 ) in the rat. R indicates the percentage of the total radioactiv-
ity injected. From ref. 155. 
same time, the fecal, biliary and urinary excretion of T3 exceeded that of T3S 
( 151) . The urinary radioactivity was invariably excreted as icdide, irrespec-
tive whe~1er T3 or T3s was injected. This suggested deicdination of T3S in rat 
tissues, although preceding deconjugation was not excluded. Interestingly, in 
spite of its polar nature, virtually no T3S was detected in the urine. This is 
in keeping with the low urinary excretion of icx:lothyronines and their ronjugates 
in euthyroid subjects observed by Faber et al (l52A). Kidney clearance of sul-
fates is largely unexplained. It ar:pears that for sulfated aglycons with a mo-
lecular weight below 350 D urinary excretion, and for compounds over 450 D bili-
ary excretion prevails. Only molecules between 350 and 450 can be excreted via 
both ways (152). Correspondingly, T3 {651 D) as a sulfoconjugate predaninantly 
appears in bile. 'Ihe lo.Y urinary concentration of T3S is partly explained by 
the observation of Roche et al that in rat plasma this OOif!tX>Und is largely bound 
to albumin. The free fraction or the association constant of T3s with albumin 
was not determined, but would be of interest in the light of the slow plasma di-
sappearance of this conjugate (151) . 
Clearly, the group of Roche has made a major contribution to the knowledge 
about icrlothyronine sulfation. This work was explicitly oompiled in a mon03raph 
by Clason in 1964 (155). However, it should be emphasized that most of their ir 
vivo experiments have been carried out, for technical reasons, with hypothyroiC 
rats, i.e. 3 weeks after thyroidectat¥. Since this condition has profound im-
plications for thyroid hormone metatolism in general and deio:iination in partie· 
ular, no attempt should be made to draw quantitative conclusions from their st~ 
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dies with respect to the physiological role of conjugation in intact animals. 
This is illustrated by a minimal presence of iodothyronine sulfates in bile of 
euthyroid, [ 125r] T4 injected rats, using HPLC analysis (103). 
After the initial identific"'t-.i..on of T3s by. Roche in 1957, sulfation of other 
iodothyronines and in other species as dog (156,157), rabbit, fetal rat (155) 
and rran (158) has been derronstrated. Though in the various species considerable 
and incomparable differences exist in the conjugation properties of iodothyron-
ines, a unanimous observation seems to be the lacking of thyroxine sulfation in 
vivo in man (152A), rat (103,111,159) and dog (109), but also in vitro in per-
fus~i rat livers {160), monkey and rat hepatoma cells (161,162) and with prepar-
ations of rat liver aryl sulfotransferases I and IV (145). The only exception 
to this rule is the equal rate of glucuronidation and sulfation of T4 in 2 days 
cultured rat liver cells (163). This proportionally high sulfation rate has 
tentatively been explained by a loss of glucuronyltransferase activi..ty due to 
dedifferentiation of the cultured cells (Section II:6). At the same time it is 
equally clear that the lesser iodinated compounds as 3'-T1, 3,3'-T2 and T3 are 
good substrates for in vivo (109,110,129,149,154,156,157) and in vitro 
(145,160,Section II:4,5,6) sulfation. 
It is interesting to note that iodothyronines with 2 iodine molecules in the 
outer ring (i.e. T4 and reverse T3 ) are mainly substrates for glucuronidation, 
whereas iodothyronines with only 1 iodine molecule in the outer ring (3'-T1 and 
3,3'-T2) are the best substrates for sulfation. T3 is the only iodothyronine 
representative that appears to be equally well conjugated by both enzymes (Sec-
tion II:6). It should be rom in mind, ho.vever I that the icx'lothyronine sulfa-
tion rate estimated by biliary appearance, inevitably is underestimated since 
sulfated iodothyronines are rapidly deiodinated prior to excretion in the bile 
(this thesis). 
C. Oxidative Deamination 
Oxidative deamination is the denomination for a series of enzymatic reac-
tions converting the alanine side Chain of iodothyronines to the acetic acid 
form. Though this activity has been demonstrated in multiple tissues in the 
rat, it appears to prevail in liver and kidney (164). Tcmita and Lardy eluci-
dated the reaction sequence of oxidative deamination of various iodinated thy-
ronines with sonicated rat kidney 
alanine side chain (R.CH2.HCNH2.000H} 
(R.CH2.co.COOH) and subsequently 
mitOOl.ondria (165). They shewed that the 
first is deaminated to the pyruvic acid 
converted via the acetealdehyde fonu 
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(R.CH2.HCO) to the acetic acid (R.CH2 .000H) derivative. The first mention of 
iodothyronine acetic acid derivatives came from Harington and Pitt-Rivers who in 
1952 chemically synthesized the acetic acid analogue of thyroxine, 
3,3' ,5,5'-tetraiodothyroacetic acid or tetrac (166). Soon hereafter it was de-
monstrated that tetrac and 3,3' ,5-triiodothyroacetic acid (triac) possessed one 
tenth of the biological potency of T3 in the rat goiter prevention test (167). 
The observation of the immediate increase in oxygen consumption in rat kidney 
slices induced by triac and its rapid clinical effect in hypothyroid patients 
led Thibault and Pitt-Rivers to speculate that triac might be the biological ac-
tive form of thyroid hormone (168). This notion instigated a lot of investiga-
tion in search of the biological relevance of oxidative deamination. 
In 1954 deaminat~, pyruvic acid analogues of T4 and T3 were identified by 
the group of Roche in rat bile and urine ( 169) . Later the in vivo occurrence of 
tetrac, triac and 3,3'-diiodothyroacetic acid {3,3'-diac) was demonstrated as 
well as their generation after the parenteral administration of the labeled par-
ent compound in the rat (103,170,171), the mouse (172), the dog (109) and final-
ly human beings (98,22,164,173-175). It also appeared from in vitro experiments 
that essentially all iodothyronines can be subjected to oxidative deamination 
(165,168,176-179). In Section II:4 it is shown that most likely 3,3'-diac and 
probably some intermediate products are formed in isolated rat hepatocytes. 
Ha.vever, these metabolites are only detected in the presence of thiouracil or 
very high substrate concentrations. This accords with the observation that tet-
rac only appears in rat bile when 8.3 pg carrier T4 was added to the injected 
[ 125r] T4 tracer (103). 
The acetic acid derivatives are conjugated with glucuronic acid and sulfuric 
acid in rruch the same way as their parent iodothyronines. That is, te·trac and 
reverse triac are mainly glucuronidated, whereas the lesser iodinated compounds 
(e.g. 3,3'-Tz) are sulfated. Consonantly, triac is conjugated with both cornr 
pounds (180-182). In spite of a high affinity of triac for cellular nuclei 
(183), its biological potency is negligible (1,164,185). The biological signi-
ficance of oxidative deamination is further reduced by its minor contribution to 
overall thyroid hormone metabolism (164,186). The kinetics of tetrac and triac, 
rather s~lar to those of T4 and T3 , have very recently been reviewed {19). 
Finally it should be mentioned that in man, dog and rat tetrac and triac again 
"analogous" to T4 and T3 are prirrarily deicxlinated and to a lesser extent, are 
excreted as conjugates in the bile, subsequently appearing in the feces 
(182,187,188). 
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D. Ether Link Cleavage 
Ether link cleavage is the fourth and probably smallest metabolic pathway of 
thyroid honnones. The reaction is oxidative in nature, probably 
peroxidase-catalysed and results in cleavage of the ether link between the two 
ring structures in the thyronine skeleton. The multiple processes involved have 
lately been discussed by Engler and Burger (19). They demonstrated that ether 
link clea:vage is the rrajor meta:bolic pathway for icdothyronines in hurran leuco-
cytes in vitro, but also occurs in the rat in vivo (189). The presence of diio-
dotyrosine in serum of athyreotic, T4-substituted patients suggest t11at ether 
link cleavage also takes place in human peripheral tissues (190). Hc:».~ever, as 
stated before, the actual contribution to overall iodothyronine metabolism is 
small (186,190-192) but its significance may increase in diseases accompanied by 
severe leucocytosis (189). 
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CHAPTER 2 
FACILITATED DEIODINATION AFTER SULFATION 
OF IODOTHYRONINES: 
The Concerted Action of Two Metabolic Pathways 
Until very recently deiodination and conjugation of iodothyronines were con-
sidered to be functionally distinct metabolic processes in peripheral thyroid 
horm::)ne metal:xJlism. The rrejor function ascribed to deiodination seemed to 
be l) the biological activation of the prohormone T4 by its conversion to the 
T4 to the biologically inactive ca~und active hormone ~3 
reverse T3 and 
2) the shunting of 
3) the conservation of iodine through f11rther deiodination of 
partly iOO.inated metabolites. Conjugation of icxlothyronines, on the other hand, 
has invariably been associated with excretion of iodothyronines from the body, 
ma.inly by the fecal route and to a small degree in the urine. The studies pre-
sented in Section II cast a new light on this classical concept. 
As outlined in the Preface we have chosen to study 3,3'-T2 instead of T3 or 
T4 metal:::olism in rat hepatocytes since fev.rer metal:Dlites of 3,3' -T2 could be ex-
pected, enabling a closer loOk at the subsequent or simultaneous metabolic 
steps. It appeared that 3,[3'-125r]-T2 was far more rapidly degraded by the 
cells than its precursors T3 , reverse T3 or T4 . The generation of mainly la-
beled iodide suggested very active outer ring deiodination. In the presence of 
the deiodinase inhibitor thiouracil, 3,3'-T2 clearance remained unchanged and 
instead of iodide, the sulfooonjugate of 3,3'-T2 accumulated in the medium. 
This suggested that sulfation acted as metatolic "escape" route in case the ap-
parent preferential pathway, deiodination, was blocked. HCMever, the velocity 
of 3,3'-T2 deiodination in isolated hepatocytes was difficult to reconcile with 
the very lCM rate of deiodination of this co:rrpound with the deiodinase contain-
ing rrUcrosomal fraction of these cells. This apparent inconsistency led us to 
postulate an intermediate molecular conversion of 3,3'-T2 which might induce fa-
cilitated deiodination. The identical rate of 3,3'-T2 deiodination and sulfa-
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tion in the presence of thiouracil, designated 3,3'-T2S as a potential interme-
diate. To test this hypothesis biosynthesized 3,3'-T2S was incubated with rat 
liver microsomes and proved to be very rapidly deiodinated in the outer ring. 
The enhanced reactivity of 3,3'-T2s for this reaction in comparison with 3,3'-T2 
was explained by a 30 fold lCMer l)u (0.3 vs 9 flM) and a double Vmax (188 vs 353 
pmol.min-l.mg prot-1). The hypothesis of sulfation preceding deiodination of 
3,3'-T2 was corroborated by the finding that during sulfotransferase inhibition, 
3,3'-Tz deiodination and 3,3'-T2 sulfation in the presence of thiouracil were 
affected to the same degree (Section !!:3,4). From this point it required lit-
tle imagination to postulate a sirnrrlar mechamism for deiodination of other iodo-
thyronines. The biological significa..11ce of T3 made this horrrone an attractive 
candidate for further study. The obligatory synthesis of T3S, however, posed 
sorre problems as the biosynthetic Il."lE!thod used for 3, 3 '-T2s was not suitable. We 
adopted with some modifications, the method for chemical synthesis of T3s origi-
nally described by Roche and coworkers (148,154). In essence, appropriate am-
ounts solid T3 and [3'-125r]T3 were incubated with 100 pl concentrated H2so4 at 
-lOC for one hour. The incubate was diluted with 900 pl chilled H2o and irmedi-
ately chromatographed on small Sephadex LH-20 columns (Section II:S). 
After isolation of the appropriate fractions, the deiodination characteris-
tics of [3•-125r]T3s with diluted rat liver microsomes were determined. As out-
lined in Section II:5, Visser et al showed by the subsequent appearance of 
3,3'-T2S and 
125r- in the incubate, that T3s is first deiodinated in the inner 
ring followed by rapid outer ring deiodination of the 3,3'-T2S generated 
(Fig.S). Analogous to 3,3'-T2, inner ring deiodination of T3 was considerably 
en..~anced in the sulfated rrDlecule as evidenced by the two fold lo.ver ~ (11 vs 5 
pM) and 30 fold higher Vmax (30 vs 1050 pmol.min-1 .mg prot.-1 ). Interestingly, 
accelerated deiodination for sulfated T3 is accomplished by a raised Vmax• wher-
eas for 3,3'-T2 this is caused predominantly by an increased substrate affinity. 
In Section II:6 we present evidence for sulfation facilitated deiodination of T3 
in isolated rat hepatocytes. Although some sulfation-independent deiodination 
of T3 can not entirely be excluded, it is assumed that T3 degradation in the 
liver is TIB.inly acconplished through preceding conjugation with sulfate. The 
sulfation induced accelerated degradation is not a phenomenon confined to iodo-
thyronine metabolism. Rehfeld recently reported enhanced degradation of gastrin 
in rat cerebral tissues after sulfation of the tyrosine residues in this 34 ami-
noacid peptide (194). 
In retrospect, our interest in the deiodinative properties of sulfated iodo-
thyronines appeared not to be originaL The _p:Jssibility of enhanced inner ring 
deiodination of T3s was seriously considered by Flock et al in 1960. They 
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Fig.S. Prcduction of 3,3'-TzS {o) or radioactive r- (o) during incubations of Q.S pM "unlabeled" or 
[3•-125r]T3s, respectively, for 5-60 min with 42 pg microsomal protein per ml {left), or for 15 min 
with 16.8-168 pg protein per ml (right), 3,3'-T2S and r-are expressed as percentages of added T3s. 
The time sequence of 3,3 '-T2S and I- prcrluction suggests that T3S is first deiodinated in the inner 
ring. From ref. 268. 
founded their suggestion on the higher amounts of 3,3'-T2S in comparison with 
T3S in bile, ~:asma or urine of T3 injected dogs (202) . On the other hand Cla-
son, working with Roche, and studying in vitro T3s metabolism noted only 20% 
iodide projuction after 40 hours incubation of 1 pM [3'-131I]T3s with rat liver 
or kidney hanogenates (155}. In fact these investigators were forced to con-
clude that sulfation of T3 protected against deiodinase activity. The discre-
pancy with our observation may in part be explained by the lack of sufficient 
thiol groups in their incubates, an essential condition for this type of deiodi-
nation. Sato and Robbins have also studied the influence of sulfate depletion 
on iodothyronine metab:Jlism in 2 days cultured rat hepatocytes (51). Due to the 
presence of methionine and cysteine in the culture medium and the sulfate noo-
genesis through the cysteine-oxidizing pathway {195} in hepatocytes they were 
unable to detect the reduced deiodination in sulfate-depleted hepatocytes ob-
served by us. 
The significance of L~e sulfation-induced accelerated deiodination is still 
speculative. In general, as outlined in Section II:6, it may be assl..liTed that 
sulfation of iodothyronines predisposes to a very rapid and irreversible degra-
dation of the molecule. On the other hand conjugation with glucuronic acid ap-
pears at least not to enhance the rather poor deiodinative properties of T3 , and 
may in effect protect against irreversible degradation. Furthenrore, it may be 
envisaged that no longer a strict separation between deiodination and 
non-deicrlinati ve pa:t.1Mays can be maintained. Iodide production in in vivo ex-
35 
periments is likely to be accorrplished partly through prior sulfation of iodo-
thyronines. The enhanced excretion of biliary or fecal radioactivity in 
[131I]T4-equilibrated, PTU-treated rats (95,196) (Fig.3) is compatible with an 
increased excretion of sulfated iodothyron.ines in the bile, analogous to our 
findings with isolated hepatocytes. In fact, an increased biliary excretion of 
3, .3' -T2s and T3s was found by Flock a"fld Bollrran in long-term t.."'rliouracil-treated 
[l3li]T4 injected rats (197) and in Gunn rats fed butyl-hydroxydiiodobenzoate 
(BHDB), another substance knONn to interfere with deiOOination (129). A similar 
observation was made by De Herder and Otten in rats injected with a tracer dose 
of [3'-l25r]T3 30 minutes after the administration of 4 mg(kg PTU (Fig.6). Of 
academic interest is Whether the products of oxidative deamination as tetrac and 
triac are also sUbjecteQ to sulfation-preceded deiodination. The T4 and T3 re-
sembling metabolic properties of these compounds (Chapter lC) and the slaw rate 
of triac deiodination (252} are suggestive for this notion. 
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Fig.6. Distribution of radioactivity in rat bile. Rats were injected with a bolus of 25 1-lCi 
[3'-125I]T3 , 30 min after the admQnistration of either 1 ml 0.9% saline or the same solution con-
taining 4 rrg/kg PTU. HPLC analysis of bile sarrples at 30, 90 and 180 min revealed the depicted dis-
tribution of radioactivity in the iodide (I), 3,3'-T2S (T2s), T3s and T3G fractions. In rats pre-
treated with PTU a proportionally strong increase in biliary 3,3'-T2s and, to a lesser extent, T3S 
was observed. Iolide appearance was atolished by PI'U. 'I'ne total arrount of radioactivity is not in-
dicated on the y-axis since the specific activity in the bile samples decreased with that of plasma 
T3" (De Herder and Otten, unpublished). 
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In the light of the tissue-specific type of deiodination mentioned in 
Chapter lA the intriguing question arises whether sulfation also enhances type 
II deiodination of iodothyronines. At present this question is still open but 
should be relatively simple to answer by incubations of T3s or 3,3'-T2S with 
twe II deiodinase containing tissues under the appropriate conditions . 
Indirect evidence from experiments with rronkey hepatorra cells v.'Ould suggest the 
answer to be negative. These cells appear to have a PIU-insensitive, but very 
active inner ring deiodinase, with type II-resembling characteristics (199,200) 
and only a low activity of PTU-sensitive, type I outer ring deiodination 
(199,200,201). The presence of 100 pM PTU during one hour incubation of these 
cells with T3 or 3,3'-T2 did not affect their clearance or the generation of 
3,3'-T2 , 3'-T1 and their sulfates (201). 
Finally, a quite different but interesting observation linking sulfate and 
thyroid hormone metabolism was described by Tallgren in 1980 (203). In a large 
series of hypo-, eu- and hyperthyroid subjects serum sulfate levels were deter-
mined. There appeared to be a linear correlation between serum sulfate and T4 
(r=O.BB) or the free thyroxine index (r=O. 75). Several hypothetical but incon-
clusive explanations for this phenomenon were presented, including thyroidal in-
fluence of sulfate neogenisis 
as TSH mediated transmembrane 
or its tubular reabsorption in the kidneys as well 
2-
transport of so4 Unfortunately 
were not determined. It can be anticipated, hcwever, that the 
serum T3 levels 
correlation of 
senn sulfate with T3 would be fac less pronounced. This is expected eSJ?ecially 
in the hypothyroid range since T3 levels tend to remain normal in the early 
phases of developing hypothyroidism {81). On the other hand, the lew serum sul-
fate levels (many were below 0.1 rrM) under hypothyroid conditions might reduce 
sulfation of T3 {Section II:6) and thus protect this vital hormone from rapid 
and irreversible degradation. 
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CHAPTER 3 
SULFATION OR GLUCURONIDATION OF T3: 
The Significance of Dual Metabolism 
In Section II:6 it is demonstrated that in rat hepatocytes T3 initially is 
metabolized by conjugation with either sulfuric or glucuronic acid. As judged 
by our in vitro experiments the rate of T3 sulfation and glucuronidation in the 
cells is aOOut equal. Ho.vever, this rray not 1:Je the case in vivo, since glucuro-
nidation of T3 in our hepatocytes was found to be more susceptible to variations 
in cell viability than sulfation. As the cell isolation procedure is a rather 
rude way of tissue treatment, i·t is feasible that in spite of the 4 hrs preincu-
lJation, total cellular glucuronidaticn is belcw its physiolcgic level. 
Comparison of enzyme activities in the intact cell is hampered by many pit-
falls. A major problem is the lack of information about the actual free sub-
strate concentration(s?) in the subcellular comparbment(s?). This especially 
goes for UDP-glucuronyltransferase and phenol-sulfotransferase since the former 
is membrane associated whereas the latter is cytosolic in nature. furtherrrore, 
we do not k.nCJN exactly haw iodothyronines are transported in the cell to the 
different enzyme sites or via which mechanism they are excreted after metabolic 
conversion. All these steps may have a profound irrpact on the net metabolic 
rate. This problem has lately been approached by Koster and Mulder. These in-
vestigators developed a theoretical kinetic model for cellular metabolism of in-
creasing substrate amounts via two separate intracellular pathways assuming 
identical uptake and back-transport of the corrpounds involved (204). It was 
concluded that the intracellular sUbstrate concentration increases more d1an 
proportionally with the extra-cellular concentration when the reaction with the 
high affinity becomes saturated. This causes the conversion via the unsaturated 
route (with the lo.v affinity conversion) to increase also more than proportion-
ally. 
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Fig.7. Influence of substrate concentration on T3 metabolism in isolated rat hepatocytes. 
Monolayers of rat hepatocytes were incubated for 3 h at 37C with increasing amounts of T3 , 
[3•-125r]T3 and 10 pM Pru. 'Ihe distribution of icdide (I), T3s and TP is depicted on the left ha.rrl 
scale. 'Ihe right hand s·cale indicates the percentage of metal:x:llized T3 • Fran Section II :6. 
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Fig. B. Influence of substrate concentration on 3,3'-T2 metabolism in isolated rat hepatocytes. 
!1onolayers were incubated, for 30 min at 37C with increasing concentrations of 3,3'-T2 and 
3,[3•-125rJ-T2 . 'Ihe distribution of the metal::olites in the culture mediun, icdide (o---e) and 
3,3'-T2s {o--o), is depicted on the left hand scale. The proportional clearance of 3,3'-T2 ( v) is 
given on the right hand scale. From Section !!:4. 
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We observed a comparable situation for T3 metabolism in rat hepatocytes. 
Fig. 7 shc:Ms that with increasing medium T3 concentrations in the presence of 
PTU, the fractional clearance of this sUbstrate and the production of T3s and 
T3G remains constant upto 10-
6 M T3 . At 10-
5 M, however, the production of T3G 
declines Whereas T3s generation increases. This suggests saturation of T3 glu-
curonidation and a proportional increase of T3 sulfation. According to t~e pro-
posed kinetic model for this type of metabolism a lower ~ of T3 for 
UDP-glucuronyltransferase than for phenol-sulfotransferase should be expected. 
This TMY seem somewhat controversial since usually common substrates tend to 
have a lower ~ for sulfation than for glucuronidation. It is pointed out in 
Chapter lB that the presence of an iodine atom in the phenolic ring may explain 
the enhanced avidity of T3 for conjugation with glucuronic acid, as halogen sUb-
stitution in phenol lowers its~ for glucuronidation 30-fold (126-128). 
In a similar way, the metabolism of 3,3'-T2 and T3 in rat hepatocytes can be 
compared. Fig.S shows that the sulfation capacity of the cells for 3,3'-T2 is 
saturated at approximately 10-5 M Whereas T3 sulfation at the same concentration 
is not. According to the al:Dve theoretical kinetic model this wculd irrplicate a 
lower~ for sulfation of 3,3'-T2 than for T3 . It may, therefore, be speculated 
that the better substrate properties of 3,3'-T2 for sulfotransferase activity 
(145) at least in part are explained by a higher affinity for the enzymatic re-
action. Confirmation of this hypothesis awaits determination of the exact reac-
tion Characteristics of 3,3'-T2 and T3 with purified enzyme preparations. 
Closely associated with the interest in the quantitative aspects of hepatic 
T3 sulfation and glucuronidation is the question with respect to the physiologic 
significance of this dual conjugation mechanism. As p.Jinted out before, conju-
gation of xenobiotic or endogenous compounds, and T3 is no exception, has mostly 
been associated with detoxification or biliary and urinary secretion of hydro-
phobic aglycons (152). It has however become increasingly clear that this simr 
ple notion in no longer tenable. Several steroids retain their biological ac-
tivity after sulfation, also sulfated compounds sometimes are more actively me-
tabolized than their unconjugated precursors {152), and even the formation of 
reactive carcinogenic intermediates after sulfation of xenobiotic compounds has 
been described {205). Although these alternative functions are mainly associat-
ed with sulfation, similar properties have been attributed to glucuronidation 
(99). 
The recent discovery of sulfation-facilitated deiodination of iodothyronines 
endorses the view that conjugation with sulfate can induce enhanced metabolism 
of drugs or endogenous carpounds. In spite of this adapted insight in metabolic 
functions, the classical concept of "detoxification" still holds true for sulfa-
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tion of T3 . There are two ways by which sulfation can inactivate the biological 
potency of T3 . First, T3s probably lacks any biological activity since, using 
the method described by Docter et al ( 206) , we were unable to detect any specif-
ic binding of T3S to purified rat liver nuclei (Otten, Qnpublished). Second, 
irreversible inactivation of the T3 rrolecule due to accelerated deicxiination re-
sults from the conjugation with sulfate. So sulfation appears to be the way by 
which the liver can very effectively eliminate T3 frcm the body circulation 
without being dependent on urinary or fecal excretion. 
Quite distinct seems to be the role of glucuronidation of T3 . Conjugation 
with glucuronic acid probably disables direct biological activity of T3 in a 
sDnilar way as sulfation, i.e. by prohibiting binding to the specific T3 nu-
clear receptor. However, contrary to sulfation, glucuronidation does not seem 
to change rruch of the ratJ1er p:JOr deiodinative properties of T3 . Evidence for 
this conception is presented in Section II:6. In essence: 1) accumulation of 
T3G is not enhanced during incubation of T3 with hep:~.tocytes in the presence of 
PTU 2) inhibition of glucuronidation by cellular depletion of the essential 
UDP-glucuronic acid with galactosamine does not alter the rate of T3 deiodina-
tion by the cells and finally 3) T3G proved to be a very poor substrate for rat 
liver microsorral deiodinase (Otten, unpublished}. For the latter experiment la-
bele<.'l T3G was prepared biosynthetically by incubation of isolated rat hepato-
cytes for 16 hat 37C with 10 pM T3 in the presence Df [3'-125I]T3 without PI'U. 
After the incubation T3G was purified by the same chranatographic procedure as 
described in Section II: 6. '!his rraterial was incubated for 60 min at 37C at a 
concentration of 0.05 pM with 165 pg/ml rat liver microsomal protein. After the 
incubation only 2% of free iodide as a result of outer ring deiodination of T3G 
was generated. Furthermore, o.S pM T3G did not inhibit ~crosomal deiodination 
of 0.01 ~~ rr3 . The possibility of exclusive inner ring deiodination of T3G, 
also seens unlikely since no substantial amount of the glucuronides of 3,3'-T2 
or 3'-T1 were detected in the bile of T4 or T3 injected dogs (110,111,157} and 
rats (103,106). 
Since both T4 and T3 are excreted in bile mainly as glucuronides, we may 
look at glucuronidation as a means of the liver to dispose of these hormones. 
In this respect it is noteworthy that UDP-glucuronyltransferase activity in rat 
liver cells can be enhanced directly by cyclic adenosine 3' ,5'-monophosphate 
(cAMP) and indirectly by glucagon st.i.mulation of this second messenger (207). 
Induction of glucuronidation by compounds as phenobarbital or polyChlorinated 
biphenyls has been 
T4 (Chapter lB). 
associated with increased metabolic clearance and turnover of 
In contrast to these compounds the induction of 
UDP-glucuronyltransferase activity by cAMP, in agreement with its nature, is 
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rapid and reaches its rraximum within 2 hrs (207). This property of cAMP may ex-
plain in part the cAMP-induced changes in iodothyronine metaOOlism in 
isolated-perfused rat livers observed by the group of Hesch (208). Using T4 as 
a substrate they noted a reduction of T3 production in cAMP-treated perfused 
livers. Also a cAMP-enhanced metaOOlic clearance was found for T3 or rT3 as 
prinnry substrates, whereas 3,3'-T2 clearance remained unchanged. These effects 
were ascribed to a stDTiulated uptake and degradation of T3 via the 
non-deiodinative pathways. In the light of the unchanged clearance of 3,3'-T2, 
which is accomplished through sulfation, and the known effects of cAMP on glucu-
ronidation this phenomenon rray now tentatively be ascribed to enhanced glucuro-
nidation of T3 and rT3 . Even the slightly reduced T4/T3 conversion rate rray be 
envisaged through T4 shunting via enhanced conjugation with glucuronic acid. 
The esse~tial difference between iodothyronine conjugation with either glu-
curonic or sulfuric acid is that after biliary secretion the glucuronidated ag-
lycons, notably T4 and T3, have kept their original structure. This provides 
the possibility of an enterohepatic circulation for these hormones. Both T4G 
and T3G are poorly absorbed from the digestive tract (134,209), Whereas for T4 
40-68% (210,211,212,215) and for T3 100% absorption (214,215,217) has been re-
ported. Hence, hydrolysis of these glucuronides by bacterial (3 -glucuronidase 
activity in the intestinal contents is likely to promote reabsorption of T4 and 
T3 {Fig.9). Although we have no intention of dealing extensively with the rath-
er controversial enterohepatic circulation of iodothyronines (136,137,139), the 
potentially important function of T3 glucuronidation will be discussed. 
Glucuronidation of T4 and T3 results in biliary excretion of these hormones. 
Putting aside the above-mentioned possible enteral reabsorption after bacterial 
hydrolysis, biliary excretion will ultimately result in fecal elimination. 
Under norrral conditions this natural loss of active horrrones is balanced by the 
daily thyroidal production. Under conditions of documenta1 increased fecal loss 
of thyroid honuones e.g. in steatorrhea in man (96) or during ingestion of 
highly absorbing dietary components as soyflour or fibre in rats (216,217) a 
compensating increase in thyroidal function was found, in extreme situations 
even producing goiter in rats (216). Conversely, with low residue diets only 
half of the normal amount of thyroxine sUbstitution was needed in the rat goiter 
prevention assay {217). These data are suggestive of fecal mass and camposition 
dependent thyroid hormone disposal. At the same time biliary and subsequent 
fecal excretion of glucuronides may also function as a rapid drainage system for 
superfluous honnones in hyperthyroidism {218). 
In contrast to this disposal function of glucuronidation a hormone conserv-
ing task rnay be postulated in hypothyroid patients. Glucuronidation of T3 es-
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Fig.9. Diagram of the postulated enterohepatic circulation of iodothyronines. An unkna.m. propor-
tion of the conjugated iOOothyronines is hydrolysed by the gut mi.croflora. This hydrolysis prorotes 
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s2ntially protects the molecule against sulfation-induced deiodination and, 
therefore, against irreversible loss of biological activity. In spite of T3 de-
pletion in hypothyroidism its meta1:olism via hepatic glucuronidation, sulfation 
and biliary excretion will continue, though possibly at a different rate. Due 
to the bacterial {.$-glucuronidase activity in the intestinal tract T3G but also 
T4G will be hydrolysed and by reabsorption (92,151,154) saved for the depleted 
body. Several conditions present in hypothyroidism will prolong the exposition 
of D1ese glucuronides to the enteral bacteria and thus contribute to their hy-
drolysis and subsequent recovery. For instance, the lew gut motility in hY.fO-
thyroidism (l39,2l9A) will a) increase the intestinal transit time 
and b) cause bacterial overgrowth in the ileum (219). Consonant with the above 
hypothesis is the reduced fecal excretion of l3lr in hypothyroid (218,218A,218B) 
and iodine deficient rats (220). In conclusion, glucurodination may have the 
paradoxical function of either disposal or salvage of thyroid hormones. 
A simila:- mechanism rray be postulated for iodothyronine sulfates in hypothy-
roidi.sn. Roche et al have observed a strong increase in biliary T3s excretion 
in T3 injected hypothyroid rats (106,154). This is probably caused by the re-
duced deiodinase activity in hypothyroid rat liver (45) prohibiting complete de-
iOOination of T3s. Sulfatase activity in gut flora tcwards iodothyronine sul-
fates has been demonstrated by Clason and Roche as early as 1959 (221). The hy-
drolytic activity was caused by an exo-enzyme of an nnidentified bacterial stra-
in (155). Recently De Herder et al isolated two anaerobic, grarnrnegative rods 
from rat cecal contents Which showed sulfatase activity towards 3,3'-T2S and T3s 
(222,Section 11:7). Since in hypothyroid rats increased a.rrounts of T3S are ex-
creted in the bile these sulfatase producing strains may in a similar way con-
tribute to the vital recovery of T3 . 'Ihis postulate is supported by the 28% ab-
sorption of 4 pg labeled T3s infused in the duodenum of hypothyroid rats (223). 
T3S hydrolysis seemed plausible since part of the radioactivity was recovered in 
bile as T3G (Fig.lO). Whether this mechanism is also operative in human sub-
jects is uncertain since it is unknown Whether in hypothyroid man the liver de-
iodinase activity is reduced. Also, as discussed in Chapter 2, the lOW sulfate 
serum levels in hypothyroid patients ( 203) will reduce sulfation of iodothyron-
ines in man and in this fashion prevent loss of scarce T3 . 
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CHAPTER 4 
THE INTERACTION OF DIFFERENT TISSUES 
IN THYROID HORMONE METABOLISM: 
The Proposal of a Hypothetical Model 
As with any complex mechanism, knowledge advances 
by the gradual refinement of oversimplifications. 
Panksepp 
As outlined in Chapter 1 serum levels, as well as production and rretabolic 
clearance rates of iodothyronines give no information about the site of their 
generation or degradation. Since considerable tissue differences in iodothyron-
ine metabolism have been demonstrated, the interest in the contribution of the 
various organs to peripheral thyroid hormone metabolism is rapidly increasing. 
The rrore so, since the rorrplex changes in iodothyronine serum levels induced by 
fasting, altered dietary composition, diseases or drugs are incompletely under-
stood. A major contribution to the growing interest in tissue-specific thyroid 
hormone metabolism has been the realization that plasma T3 is not totally ex-
changeable with tissue T3 (225) and the discovery of a PTU-insensitive (type II) 
deicxlinase in rat cerebral tissues by the group of Larsen. This enzyme proved 
to have quite distinct physicochemical characteristics in comparison with the 
"classical" liver and kidney dei<Xl.inases (Chapter lA). Despite the fact that 
same PTa-sensitive outer ring deicxlinase is present in rat cerebral tissues, the 
predaninance of type II deiodination caused these tissues to be referred to as 
PTU-insensitive. This tissue-specific deiodination in combination with several 
incompletely understood phenomena has brought about a growing dissatisfaction 
with the concept that hepatic outer ring or 5'-deiodinase is the sole regulator 
of fluctuating T3 and reverse T3 serum levels in what erroneously is called "The 
lo.< T3 Syndrane". 
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Fig .ll. 'Ihe original concept of the regulation of icdothyronine serun levels. T4 is degraded in 
rrainly the liver to either T3 or reverse r 3 . 3,3'-T2 originates frcm both these prc:xiucts. 
According to this rrodel inhibition of outer ring deiodination (----), e.g. by fasting, illness or 
drugs, would cause a decrease of T3 and increase of reverse T3 serum levels. 
In this model the liver is the central organ in controling iodothyronine 
serum levels. Total Cody production of T3 depends for alx:mt 80% on outer ring 
deiodination of T4 in extrathyroidal tissues. Since the metabolic clearance 
rate of T3 shows little changes in fasting or diseased individuals, reduction of 
outer ring deiodination conceivably is responsible for the lowered T3 serum lev-
els under these conditions. Also the usually increased serum reverse T3 levels 
are explained by the same reduction of outer ring deiodination and an essential-
ly unaltered pra1uction rate (Fig.ll). However, several observations both in 
vivo and in vitro are hard to reconcile with this simple theory and suggest far 
more complex regulatory meChanisms. To illustrate this point some examples are 
given. 
1) According to the a'bove concept the liver (and/ or the kidneys) INOuld be 
both the supply and clearance organ of reverse T3 . Several studies, however, 
show that in spite of documented hepatic inner ring deiodination of T4 
(163,227), no rr3 is released from perfused rat livers (160,208,226), rat liver 
slices (227) or cultured hepatocytes (163). This is probably best explained by 
rapid intracellular outer ring deiodination of all reverse T3 generated. 
2) During the initial period of caloric restriction in man serum T3 lowers 
and reverse T3 shows a reciprocal rise (228). After 4 weeks, however, reverse 
T3 norrralises, whereas T3 remains low. Also, the dietary study in Section II:l 
demonstrated separate influences on T3 and rr3 serum levels by dietary constitu-
ents. Moreover, serum 3,3'-T2 levels remained remarkably constant in spite of 
considerable fluctuations of the common precursors T3 and rr3 . All these obser-
vations are hard to explain merely by fluctuations of hepatic outer ring deiodi-
nase activity. 
3) The theory does not account for the rrultiple alternative rnetatolic path-
ways for iodothyronines. Especially conjugation with glucuronic acid and sulfa-
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tion-facilitated deiodination contribute significantly to thyroid hormone meta-
bolism and are believed to be the principal processes in hepatic T3 handling 
(Section II :6). 
4) Despite the fact that hepatic outer ring deiodination is entirely blocked 
by pha.rrracological concentrations PTU (Section II:4), T3 generation in 
L-thyDOxine-substituted, PTU-treated hypothyroid patients is not completely in-
hibited (229). 
5) The theory further depends on the existence of 2 separate enzymes for 
outer and inner ring deiodination. However, recent investigations favour the 
opinion that OOth processes are catalysed by the same hepatic enzyme {17). 
6) Also other factors as incomplete plasma-tissue T3 exchange (225), active 
transport of iodothyronines into rat hepatocytes ( 7) and the documented deiodi-
nase activity in rat kidney plasma membranes (230) suggest far more intricate 
regulatory systems. 
The gradual realization of these inconsistencies and the different deiodi-
nase properties in PTU-insensitive tissues has instigated in our laboratory a 
new conception about iodothyronine metabolic pathways. This notion will be pre-
sented here as a hypothetical rncxiel. A scherratic diagram is given on a fold-out 
page in the bad( of the rranuscript (Fig.l2 A, B). 
In spite of the rather complex drawing, the model clearly is an oversimplif-
ication of the actual situation. The rrajor presupposition is the subdivision of 
the l::ody in three corrpartments : the PI'U-insensitive {type II) and the 
Pl'U-sensitive (type I} tissues, connected by the plasma compartment. The type I 
tissues are represented by the liver in order to include biliary excretion of 
thyroid hormones. The concept is essentially based on the production of 3,3'-Tz 
and reverse T3 in type II tissues and their sUbsequent degradation in the liver 
after "crossing" via the plasma corrpartment. For T4 and T3 a nore corrplex situ-
ation exists. The model will be intvoduced by successive discussion of the 
pathways of 3,3'-T2, reverse T3 , T3 and T4 in the presence or absence of PTU. 
We would like to mention that the OPPJrtunity of reading a preprint of the 
excellent review about iodothyronine deiodination by Engler and Burger (19) as 
well as the foreknowledge of their work on the generation of the various diiodo-
thyronines (231) have had an irrportant corrplementary function in the support of 
our contention. 
A. Metabolism of 3,3'-T2 
As outlined in Section II:4 a significant proportion of iodothyronine degra-
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dation is channelled via the generation of 3,3'-T2. Serum levels of this meta-
bolite are rather low (ranging in the literature from 23 to 137 pmol/1) despite 
the relatively high production rate (38 to 76 nmol/day). This is caused by a 
very rapid metabolic clearance rate, with 621 to 1116 !/day the highest of all 
iodothyronines (19). Since 3,3'-T2 has no metabolic activity, this compound has 
received rather Limited attention. However, it is the rapid turnover that makes 
3,3'-T2 an interesting metabolite. Due to this property it is one of the few 
iodothyronines for which an anterio-venous gradient in certain tissues can be 
estimated. Faber et al. (232) as well as Bauer and co.vorkers in our lab::Jratory 
(233) found the 3,3'-T2 concentrations in the hepatic vein to be only 60% of ar-
terial values. Faber et al. calculated a hepatic clearance of 14 nmol/day ac-
coun-ting for alllDst half of the total 3,3'-T2 clearance (34 Ill1K)l/day). 
M:.Jroover, they also shewed that the proportional liver clearance of 40% was in-
dependent of the plasma 3,3'-T2 concentration (234). This latter phenomenon has 
been disc,ussed. in Section II :4 and reflects the high sulfation capacity of the 
liver Which is not saturated. at in vivo serum concentrations. 
The various observations corres];Ond well with our in vitro experiments, 
showing that 3,3'-T2 in hepatocytes is rapidly metabolized by sulfation before 
undergoing accelerated. outer ring deioclination. In the upper diagram (A) this 
rapid proces is indicated by a fat arrow directing 3,3'-T2 from the plasma~ 
partrnent into the liver cell with subsequent sulfation (Rg) and outer ring de-
iodination (R12). Plate B shows that hepatic clearance is not affected by PTU 
but outer ring deiodination (R12 ) is, resulting in a high output of 3,3'-T2s in 
the bile. Support for this mechanism has been provided by the strong increase 
in biliary 3,3'-T2s in PTU-pretreated., [3'-125I]T3-injected rats (Fig.6) (De 
Herder and Otten, unpUblished). The rapid clearance of 3,3'-T2 by the liver ra-
ises the question where this metabolite might 00 generated. Faber et al, by 
measuring 3,3'-Tz concentrations in renal arterial and venous blood of 20 normal 
subjects, calculated a net renal 3,3'-Tz production of 2,4 nmol/day, accounting 
for only 6% of the total 34 nmol generated daily. No significant 
arterial-venous gradient was measured in the femoral vessels, eliminating the 
extremities and therefore the muscles as important source of 3,3'-T2 production. 
It was found by I.aur"berg and Weeke that 3, 3' -T2 serum levels in P'IU or rrethima-
zole-treated hyperthyroid patients did not differ significantly ( 235) . Since 
hepatic 3,3'-T2 clearance is not affected by PTU or methimazole (Section 1!:4), 
this observation suggests mainly PTU-independent production of 3,3'-T2 . In 
another study 3,3'-T2 serun levels decreased 18% in T4-substituted, hypJthyroid 
patients treated. with PTU (254). This seems to be in close agreement with the 
16% of plasma 3,3'-T2 being derived from reverse T3 (231), Which according to 
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our model in euthyroid conditions, is exclusively mediated via PTU-sensitive de-
iodinase. '!he kidneys probably contribute to this part of 3,3'-T2 production 
(232). These observations point at PTU-insensitive tissues as potential source 
of plasma 3,3'-T2. 
Fig.l2 shows the possibility of 3,3'-T2 generation via two pathways in these 
tissues. The thiCkness of the arrows in indicative for the expected conversion 
rate based on the Vmax/~ ratio's of the various reactions from the literature 
{Table I). Especially conversion of T3 to 3,3'-T2 (R3) is reported to proceed 
very rapidly {66,70), Whereas further inner ring deiodination {R4 ) of 3,3'-T2 to 
3'-Tl is much slower. It is hypothesized that 3,3'-T2 is mainly generated in 
PTU-insensitive tissues from either locally produced (via ~) or plasma-borne 
T3 . Since both Rj and R3 are PTU-insensitive, 3,3'-T2 production will not be 
affected by this corrpound. The contribution of pathway RsA {PTU-sensitive outer 
ring deiodination of rT) will be rrodest coopared with pathway R3 and absent in 
the presence of PTU (diagram B). Reaction SB is only significant in hypothyroid 
tissues { 69) . '!his concept is corroborated by the study of Engler et al. who 
showed that 84% of plasma 3,3'-T2 is derived from T3 {19,231). If indeed 
PTU-insensitive tissues are the main source of plasma 3,3'-T2 then an uphill ar-
terio-venous gr~dient of this metabolite in the cerebral circulation should be 
expected. To verify this concept we have compared in anesthesized humans the 
3,3'-T2 serum concentrations in arterial blood, and in blood from the internal 
jugular vein, the predominant efferent vessel of the brain. In two subjects 
studied so far the 3,3'-T2 content in the jugular vein was raised by 29 and 36% 
{Otten, Avezaat , Visser and Hennemann, unpublished). This observation firmly 
supports the postulate that plasma 3,3'-T2 is generated frcrn in 
PTU-insensitive (e.g. cerebral) tissues and further indicates that the brain 
may contribute significantly to peripheral thyroid hormone metabolism. 
B. Metabolism of Reverse T3 
Similar to 3,3'-T2, reverse T3 also has a rather rapid turnover. If the 
lower reported RIA values for serum rr3 {average 0.3 nmol/1) are considered to 
be true (236), the total daily production is calculated at approximately 30 to 
45 nrrol with a metab:>lic clearance rate between 82 and 108 1/day {15,19). 
Despite these figures and contrary to 3,3'-T2 this clearance rate appears to be 
too lCM and the blcod flON too high to allow the measurement of arterio-venoos 
plasma gradients in the various tissues {232). Therefore, the actual proof for 
generation or clearance of rr3 in a specific organ is hard to obtain. It has 
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been pointed out in the introduction of this chapter, that the liver probably 
does not contribute to plasma rr3 . On the other hand perfused livers 
(160,208,226) and hepatocytes (163, Section II:2) rapidly metabolize rr3 giving 
rise rminly to iodide a'ld small arrounts of 3, 3 '-T2 as well as sore unidentified 
glucuronides aTJ.('l. sulfates (160). 'Ihe production of 3,3'-T2 is u..r1expected in the 
light of its rapid hepatic clearance but may be due to the artificial in vitro 
conditions. With T4 no 3,3'-Tz production was noted in perfused livers (208). 
On the basis of these observations, we are at present inclined to consider the 
liver ~san important clearance organ for rT3 . 
In Section II:2 it is suggested that hepatic clearance of this metabolite is 
acconplished rrainly through direct outer ring deiodination. This is concluded 
fron the fact that inhibition of deiodination by PTU, again contrary to 3,3'-T2, 
drastically reduces rr3 degradation in rat hepatocytes. This conception is re-
presented in the diagram by pathway Rs· The likely, but m:xlest formation of 
rT3G has 
(237-240)' 
'oeen left out for ease of survey. Diagram B nc::MI' rrakes clear Why PTU 
but not methimazole (237), causes an increase in serum rT3: the 
major pathway of rT3 degradation (Rg) is blocked. 
At this p:Jint we would also like to point out that the total 1Jojy production 
rate of rr3 probably exceeds the production rate generally indicated in the li-
terature (see above). Reverse T3 generated from T4 (R7 ) in the liver is not se-
creted into the vascular compartment, but rapidly degraded by outer ring deiodi-
nation (Rg). Therefore, rr3 produced via this pathway will not contribute to 
plasma rT3 and the production rate {defined as: Serum rT3 x Metabolic Clearance 
Rate) will be underestimated. This phencrnenon may exist for all other iodothy-
ronli1es as well. Thyroxine is the only exception since this hormone has only 
one source: the thyroid gland. The higher the intracellular catabolism of a 
generated metabolite, the greater the underestimation of its production rate. 
This may also apply to the 3,3'-T2 originated fran rr3 in the liver (RgL since 
the high rate of subsequent sulfation (Rg) results in only small amounts of ex-
tracellular 3,3'-T2 {Section II:2, 208,226). To indicate that the tracer injec-
tion technique neglects this hidden production the terms "extrinsic" or "plasrm" 
production rate seem rrore appropriate. 
Considering the facts mentioned and analogous to 3,3'-T2, we postulate that 
a major portion of plasma rT3 is formed in type II tissues whereas the clearance 
takes place in the liver. The theoretical basis for this thesis is, that R1 
{PTU-insensitive) proceeds very rapidly L~ euthyDDid rat cerebral cortex 
(66,70), whereas the much slower RsA (67) will cause accumulation of rr3 which 
is then shunted to the vascular corrpartment. As stated l:>efore, this hy:[:xJthesis 
is difficult to substantiate since at present RIA's are not sensitive enough to 
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detect the expected small arterio-venous concentration gradient in the high flow 
vessels of the cerebral circulation. The only indirect indication for this 
PTU-insensitive production in vivo is the equivalent rr3 production rate in PTU 
or methimazole-treated hyperthyroid patients {235). In this study the differ-
ence in peripheral activity of both drugs towards type I tissues is reflected by 
a 50% lower metabolic clearance rate in the PTU-group causing significantly ele-
vated rr3 levels. Interestingly, extra-hepatic production of rr3 has, on quite 
different grounds, been suggested before {11). 
C. Metabolism of T3 
For obvious reasons T3 metabolism has attracted a lot of investigation. 
Several review articles have dealt with this sUbject {11-13, 241). It is gener-
ally accepted, that in healthy individuals and animals same 20% of the 34-52 
nmol T3 produced. daily, is directly secreted by the thyroid gland (15,19). The 
ralnining 80% originates from T4 by outer ring deiodination in peripheral tis-
sues. Ho,.,rever, for the same reasons as with rr3 the exact production site can 
not be discriminated by arterio-venous plasma gradients. On the other hand, in 
vitro experiments strongly suggest that the liver contributes significantly to 
plasna T3 production. Many studies describe the production of T3 fran T4 in 
perfused rat livers (208,226,242), rat liver slices (227,243) and in human and 
Fat hepatocytes (250, Section II:l). This hepatic production of T3 fran T4 is 
mediated by a PTU-sensitive deiodinase {%). In thyroidectanized, T4-replaced 
rats inhibition of this reaction by PTU causes only 50-70% decrease of serum T3 
generation {244-247). This contrasts with the almost complete inhibition of T4 
to T3 conversion in kidney or liver homogenates of PTU-treated rats (41,248), 
and suggests an altemative, PTU-insensitive production of T3 . 
When these data are taken into consideration the following conclusions may 
be made: a) in the euthyroid 
type I (PTU-sensitive) tissues, 
state the major part of serum T3 is 
b) the liver and quite possibly 
generated in 
the kidneys 
(251-253) have an important contribution to this T3 production, c) a smaller but 
significant arrount of serum T3 is produced in type II tissues. At present it 
can not be discriminated whether this T3 originates from cerebral tissues or 
fran the extracranial bra.vn adipose tissue ( 76) . The irrq:ortance of this pathway 
is illustrated by the recent report that the contribution of type II tissues to 
plasma T3 production may increase to 100% in hypothyroid rats {249). 
According to the present concept T3 metabolism takes place in both tJTeS of 
tissues. In the liver it was demonstrated (Section II:6) that T3 initially is 
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conjugated witJ1 TJDP--glucuronate or sulfate (R10 ). Of the respective prcx'lucts 
T3G is predominantly secreted in the bile, whereas T3S is successively deicxli-
nate1 in the inner ring (R11 ) and the outer ring (Rl2). In the presence of PTU, 
ho,.,revec, T3s accumulates and should be increased in the bile. This expectancy 
was confirmed by De Herder and Otten (Fig.6). From this figure also a second 
feature becomes apparent. The other sulfate conjugate, 3,3'-T2S, found to in-
crease in bile of PTU treated-rats after [ 125r]T3, appears later but in rrore 
massive amounts than T3s. This 3,3'-T2S cannot be fanned from T3S in the liver 
sinc(:e R11 is corrpletely inhibited (Section II:5,6). The observation, therefore, 
is fu~other indication for extra-hepatic PTU-insensitive production of 3,3'-T2 
and subsequent sulfation in the liver (Section !!:4) or other, extra-hepatic 
tissues (202) . 
The second degradative pathway of T3 is, of course, inner ring deiodination 
in type II tissues (R3) yielding 3,3'-T2 and small amounts of 3'-T1 (R4 ) (66). 
The fact that short-term pretreatment of PTU does not affect the T3 clearance in 
rats (244,249) may "be envisaged since all T3 degradative pathways R3 , R10 and 
glucuronidation are not influenced by this agent. The d~nished production of 
T3 from T4 in the liver (~) will therefore cause reduced pl~sma T3 levels. 
However, in long-term PTU-treated animals this reasoning may not entirely be 
tenable since under these conditions a slightly reduced (14%) T3 clearance was 
found (2188). 
An interesting aspect aOOut T3 meta.J.ulism no.v emerges. If indeed the _tX)stu-
lated pathways exist, the liver seems to be playing a double role: on the one 
hand it is responsible for a ma.jor part of T3 plasma prcx'luction whereas on the 
other hand it is involved in the plasma clearance of T3 . This may seem sCl!Tie'W'hat 
controversial, but, in fact, it would provide a potentially flexible medhanism 
for metal:olic adaptation and regulation of plasma T3 • Van Doorn and Van der 
Heide came to a s~lar conclusion based on their observations with [l25I]T4 and 
[ 131IJT3-equilibrated rats (218B). The immediate question arises how the liver 
cell could accorrplish this dual task. 'IWo speculative theories may be put for-
ward. 
1) The existence of separate intracellular pathways and ccmpartments for io-
dothyronines and/or their metaOOlites. From recent studies it has becane incre-
asingly clear that iodothyronines do not exchange freely between the plasma and 
the various subcellular fractions of living cells (81,218A,B,225), Some tissues 
depend heavily on locally (i.e. in the cell itself) generated T3 , whereas in 
others plasma-borne T3 predominates. Furthe:rrrore, the ratio between the two 
sorts of T3 is 
provisionally 
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different in some subcellular fractions. In the diagram this is 
indicated for the nucleus of the two cell types: the he_patocyte 
nucleus obtains its T3 mainly from the plasma, whereas the nucleus in cerebral 
or pituitary cells is occupied by a larger proportion of locally generated T3 . 
This phenomenon has been mentioned to shaN that "corrpartmentation" in cells 
exist and that, therefore, the possibility of separate intracellular pathways is 
plausible. This seems to be an interesting field for future research. 
2) The liver is not an organ composed of functionally identical hepa.tocytes. 
The hepatocytes in each acinus of the liver are sub:1ivided into three zones de-
pendent on the exte11t to which their blcxrl supply is oxygenated (261). In zone 
1, where the portal and arterial blood perfuse first, the oxygen availability is 
highest, whereas zone 3 receives less well oxygenated blood. Marked differences 
in hepatocyte enzyme corrposition in the three zones have been detected (261). 
Therefore, it is quite feasible that the cells in the different zones accomplish 
different tasks with regard to icxiothyronine metabolism, e.g. the generation or 
the clearance of T3 . The hypoxia-induced reduction of T4 deiodination but in-
tact T3 generation in rat liver slices illustrates this possibility (262). The 
question may be addressed in the future with the use of fluorescent monoclonal 
antibodies directed against hepatic deiodinase or by studying iodothyronine me-
tabolism in isolated rat hepatocytes at different pa2 . 
D. Metabolism of Thyroxine 
In the r~t, after secretion from the thyroid gland, T4 is distributed over 
the plasrra corrpartment ( 26%) , a fast pool made up mainly by the liver and the 
kidneys (17%} and a slow pool, e.g. muscle tissue (57%) (5). As discussed in 
Chapter 1 these hormonal contents of the tissues should not be regarded as a 
static condition but as a continues entry and efflux of molecules. A small por-
tion of this shuttle (3% in fast pools and 12% in slow pools) is sUbjected to 
further metabolism. It was calculated that the arrount of T4 degraded in both 
pools is about the same i.e. 2 rurol/day (5). 
As sha.vn in the diagram, there are rrany ways by -which T 4 can be metal:olized. 
In general, a distinction can be made between deiodination in type I and type II 
tissues, Whereas also conjugation with glucuronate and oxidative deamination oc-
curs. Tnese pathways have all extensively been discussed in Chapter 1. It has 
been estimated that 80% of the total daily T4 production is metabolized by mono-
deicxiination, yielding approximately equal amormts of '1'3 and rr3 (19). Since 
the fast and slow pools mentioned above, are not equivalent to type I and II 
tissues, the proportion of T4 deiodinated in either PTU-sensitive or insensitive 
tissues is not exactly kncwn. HCJN"ever, the roughly 50% PI'U-induced reduction of 
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urinary iodide in T4 substituted thyroidectomized rats injected with T4 randomly 
labeled with l31I (257), suggests that both tissues have an equal contribution 
to deiodination of T4 . 
Interestingly, this inhibition of PTU-sensitive deiodination, which consti-
tutes some 40% of T4 degradation, has only a modest influence on T4 serum levels 
and metabolic clearance. In rrultiple studies with T4-substituted humans or 
rats, PTU caused either no change (229,239,246,255) or a small increase in plas-
ma T4 (196,238). It appeared that, identical to T3, the T4 metabolic clearance 
rate is either unChanged (244,257-259) or slightly reduced, mainly during pro-
longed PTU administration (l97,218B,245,256) and in hyperthyroid patients (196). 
Apparently the alternative pathways corrpensate for the loss of P'IU-sensiti ve de-
icxlination. 
On the basis of the presented metabolic m::xiel a tentative prediction of the 
short-term PTU-influenoe on the metabolite composition in bile of 
[ 125r]T4-injected rats can be made: T4G may be unaltered or slightly increased, 
T3G is expected to be lCJW"er due to the lCJW" plasma T3 levels, conversely rT3G 
will increase. The major proportional rise in radioactivity, however, is ex-
pected in the 3,3'-T2s and T3S fractions. These expectations are only partly 
confirmed by the study of Flock and lbllrran, who investigated the biliary meta-
bolite composition in thiouracil treated,[ 131I]T4-injected rats (197). In these 
animals a modest decrease in T4G and T3G was compensated by an increase of rT3G 
leaving the total arrount of glucuronides essentially intact. On the other hand 
only a small rise from 6 to 12% of iodothyronine sulfates was noted. 'Ihe dis-
crepancy may be explained by the prolonged duration of thiouracil administration 
( > 3 wks) which rrust have caused hypothyroidism (198). Experiments with T4 , an-
alogous to those described for T3 (Fig.6), are required for confirmation of the 
above supposition. 
E. Concluding Remarks 
The presented model for thyroid hormone metabolism contains many incerti-
tudes, gaps and speculations, and clearly is an oversimplification of the actual 
situation. It is errphasized that the model has not been designed in a atterrpt 
to answer all questions regarding fluctuations in icdothyronine serum levels. 
The main purpose behind this concept has been to present some evidence that mul-
tiple tissues may closely interact in rraintaining of what is called "the euthy-
roid state". By this notion also a better understanding of the intricate 
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Changes in iodothyronine serum levels induced by drugs, diseases or diets, might 
be obtained. 
In our model we have purposely only discussed PTJ as interfering agent. 
'Ihis corrp01.md selectively inhibits type I de iodination in the 1::ody, thus ena-
bling the estimation of the remaining type II deiodinase activity. Other condi-
tions known to affect deiodination as fasting or illness are far more difficult 
to interpret. 
A major contribution to the conception of our tentative rn:::x:'lel has been the 
elucidation of 3,3'-Tz metabolism in rat hepatocytes. Ever since, we have repe-
atedly experienced that thorough knowledge of the metabolism of this relative 
un~rtant metabolite is very helpful in underst~nding the sometimes enigmatic 
fluctuations of the rrore notorious icrlothyronines. It can be speculated that in 
the future elucidation of the metabolism of the lower iodothyronines will prove 
to be essential for understanding of the more complex conditions mentioned 
above. 
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CHAPTER 5 
FUTURE ASPECTS 
In the last two decades the research of peripheral thyroid hormone metabol-
ism has enjoyed considerable attention and progress. A lot of information em-
erged about the kinetic and metabolic properties of the various iodothyronines 
as well as their enzyme-inducing potency. Ha.vever, the corrplex changes induced 
by alterations in dietary composition, different diseases or drugs are largely 
unexplained, and require a lot of future investigation. 
As hypothesized in Chapter 4 the composition of thyroid hormone levels in 
the plasma seens to be determined by the concerted action of multiple tissues. 
By this notion it may be envisaged that different diseases can cause different 
changes in thyroid honrone homeostasis. This will depend on 1tany variables such 
as the extent of the disease, i.e. whiCh organs are affected by which noxious 
agent and to what degree, but also on changes in tissue perfusion, the presence 
of toxic or interfering metabolites and more general conditions as tissue oxyge-
nation, caloric supply and body temperature. A prerequisite for a proper under-
standing of the pa.thobiological changes is a full canprehension of euthyroid 
organ physiology. At present this is far from corrplete. 
Whereas the liver has been rather extensively investigated as perfused 
organ, very little information exists about similar experiments with other or-
gans kno,.m to be active in thyroid hormone metal:olim e.g. the kidneys and the 
brain. Perhaps also less obvious tissues as muscle and fat should be scrutin-
ized, since even if their metabolic rate is slow, they may, due to their larger 
mass, contribute significantly to overall production or degradation of iodothy-
ronines. 'Ihis will require further investigation of the subcellular deiOOinat-
ing and conjugating properties of the respective tissues in combination with the 
net production or clearance of iodothyronines in isolated (re-)perfused organs 
or limbs. 
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The use of PTU or thiouracil as selective type I deiodinase inhibitors, may 
prove to be very helpful in these tissue-directed investigations. It is in fact 
astonishing, that until now so little turnover studies of the lower iodothyron-
ines in PI'U-treated subjects have been published. In this context the discovery 
of a selective type II deiodinase inhibitor would be greatly welloomed. 
Simultaneously, the question arises if the common type I and II inhibitor iopa-
noic acid, is capable of abolishing all deiodinating activity in the body and 
whether still other thyroxine degrading systems exist (263-265). 
Furthermore, in vivo inhibition of glucuronidation with D-galactosamine or 
sulfation with pentachlorophenol (PCP) in the rat, rray contribute to a better 
estimate of the physiolc:gic relevance of these pathways. SUmming up of the 
above organ-directed investigations could provide a more integrated understand-
ing 8C thyroid hormone metabolism and eventually of the interfering action of 
dietary alterations, drugs and diseases. 
Lastly, the possible existence of separated intracellular pathways for iodo-
thyronines has already been mentioned. This prcblem is primarily associated 
with T3 production and 
partmentation ( 218B) 
degradation, since for this hormone intracellular corrr 
and distinct nuclear and cytoplasmic equilibration in the 
liver (8,260) has been demonstrated. The approach to this intriguing possibili-
ty is not yet clear. 
Despite the steady progress in understanding of peripheral thyroid hormone 
metabolism, it seems a long way before this knowledge will ultimately result in 
clinically applicable therapeutic measures. 
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PAPER 1 
THE ROLE OF DIETARY FAT 
IN PERIPHERAL THYROID HORMONE METABOLISM 
M.H. Otten, G. Hennemann, R. Docter, T.J. Visser 
Short term changes in serum 3,3',5-triiodothyronine 
(T3 ) and 3,3',5'-triiodothyronine (reverse T 3 • rT 3 ) 
were studied in four healthy nonobese male subjects 
under varylng but isocaloric and weight maintaining 
conditions. The four 1500 kcal diets tested during 72 
hr. consisted of: I, 100% fat: II. 50% fat. 50% protein; 
Ill, 50% fat. 50% carbohydrate (CHO). and IV. a 
mixed control diet. The decrease of T 3 (SO%) and 
increase of rT3 (123%) in the all-fat diet equalled 
changes noted in total starvation. In diet Ill (750 kcal 
fat. 750 kcal CHO) serum T 3 decreased 24% (NS) and 
serum rT3 rose significantly 34% (p < 0.011. This 
change occurred in spite of the 750 kcal CHO. This 
amount of CHO by itself does not introduce changes 
in thyroid hormone levels and completely restores in 
refeeding models the alterations of T 3 and rT 3 after 
total starvation. The conclusion is drawn that under 
isocaloric conditions in man fat in high concentration 
itself may play an active role in inducing changes in 
peripheral thyroid hormone metabolism. 
SINCE THE BEGINNING of the past decade a lot of attention has been paid to 
peripheral thyroid hormone economy. 1 Among 
the many stimuli and conditions in man and 
animals introducing a preferential decrease in 
5'-deiodinase activity resulting in a decrease of 
serum 3,3',5-triiodothyronine (T 3 ) and an 
increase of serum 3,3',5'-triiodothyronine (re-
verse T3, rT3), fasting is one of the most exten-
sively studied. 
A great number of dietary and kinetic models 
with a great variety of changes in calorie intake, 
dietary compositions, and body weights, have 
been used to further investigate the possible role 
played by each of the three basic elements of 
food: carbohydrates, proteins, and fat. 
An interesting phenomenon during experi-
mental dietary changes is the important contri-
bution of oral carbohydrates (CHO) in restoring 
or preventing these alterations in peripheral 
thyroid hormone metabolism. Under total fast-
ing conditions in man serum T 3 starts to decline 
within 24 hr to reach a plateau 50%-60% below 
control levels in about 4-6 days.2•3 rT3 shows a 
reciprocal rise of 58%-107%,4--7 while in most 
reiX>rtS of short term experiments thyroxine (T 4) 
shows little or no change.7 Refeeding after total 
starvation with as little as I 00 kcal of CHO 
causes a partial normalization of serum T 3 
concentrations.8 Moreover, refeeding with 800 
kcal CHO, in spite of the still subnormal total 
amount of calories, fully restores T 3 to control 
levels8 or 800 kcal CHO, per se, fails to induce 
T 3 or rT3 changes in nOnfasted normal subjects. 5 
On the other hand a normocaloric diet with a 
high CHO content mimicked the rise in T 3 and 
decrease in rT3 normally seen in overfeeding. 9 
While in the recent literature much data and 
speculation appeared about intracellular mecha-
nisms influencing these presumed enzymatic 
deiodinations in relation to glucose metabo-
lism,10'11 far less detailed and quantitative docu-
mentation exists about the influences of oral 
proteins and fat on peripheral thyroxine metabo-
lism in man. As most studies use ( 1) the refeed-
ing model of the fasted state4·8·12- 14 or (2) hypoca-
loric diets5.1 5·16 we were interested in the direct 
influence in nonobese subjects of approximately 
weight maintaining diets strictly composed of 
maximally 2 constituents on a 50%-50% basis. 
One isocaloric diet of mixed composition would 
serve as a control for the influence of the small 
caloric reduction. The rather arbitrary amount 
of 1500 kcal was chosen for comparison with 
other studies using amounts of approximately 
1400 or 800 kcal.4·5·8•13 
MATERIALS AND METHODS 
Studies were performed in four healthy nonobese male 
volunteers aged 27-31 yr, on 4 different occasions with at 
least I mo interspace. In all studies after obtaining two 
baseline blood samples a 1500 kcal (6276 kJoule) mixed diet 
regimen was kept during 24 hr in order to rule out the 
possible influences of substantial individual variations. In the 
next 72 hr a 1500 kcal regimen with free water intake was 
maintained as well, but the fat (F), protein (P), and carbohy-
drate (CHO) content in the 4 studies differed as follows: I, 
100% fat (F, 164 g; P, 5 g; CHO, 3 g); II, 50% fat with 50% 
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protein (F. 82 g; P, 168 g: CHO. 7 g): Ill. SO'fn fat with 50% 
CHO (F, 73 g; P, 6 g; CHO, 167 g): IV, mixed diet (F, 70 g: 
P, 76 g; CHO, 137 g). 
Blood samples were taken twice daily during the 72-hr diet 
period. After this period usual caloric intake was resumed 
and 3 more blood samples were taken up to 72 hr after 
termination of the dietary regimen. During the whole experi-
ment normal daily activities in the hospital or laboratory 
were allowed. The following measurements were done: serum 
T4 17 , T1 ' 8• rT1 1", 3,3'-diiodothyronine (T2),l-0 thyrotropin)_' as 
duplicates in the same radioimmunoassay, Trresin uptake 
(Triosorb, Abbott Laboratories, Chicago Ill.) as well as 
routine hematologic and chemical laboratory analyses. Every 
subject served as his own control and statistical analyses 
were performed using the Student's paired t lest. 
RESULTS 
The diets were well tolerated. The serum 
concentrations of sodium, potassium, calcium, 
magnesium, phosphate, SGOT, SGPT, and 
alkaline phosphatase as we!! as total protein, 
cholesterol, phospholipids, triglycerides, and 
hematologic values did not change during any of 
the diet periods. The important changes in crea-
tinine, uric acid, and bilirubin are listed in Table 
I, Only 0 and 72 hr values are depicted. Serum 
creatinine rose significantly in diets I (40%), II 
(19%), and IV (9%) but not in the fat/CHO 
diet. Serum uric acid showed significant rises in 
all four periods (1, 59%; II, 30%; Ill, 30%; IV, 
II%). Serum bilirubin only increased, though in 
a considerable amount, in diet periods I (112%) 
and III (46%). On the other hand, serum glucose 
showed a fall predominantly in periods I and II 
(not shown). A rise in serum urea (66%, 
p < 0.001) only occurred in the protein/fat diet. 
Serum T4 , TSH, T 2, and T 3-resin uptake did 
not change significantly during any of the exper-
iments. Important changes, however, were noted 
in T 3 and rT3 levels especially during periods I 
and II. These changes, as depicted in Table 2, 
equalled in diet period I (I 00% fat) the changes 
observed during total starvation in man. Serum 
T 3 fell significantly 50% and 41% in the first two 
periods, respectively. There was a nonsignificant 
decrease of 24% in period III and 16% in the 
1500 kcal mixed diet. Serum rT3 rose as much as 
123% in diet I, higher than most data about total 
fasting in man. The rise in rT3 in the fat/protein 
and fat/CHO diet was about the same (maxi-
mally 29% and 34%, respectively) but with a 
higher significance during the diet containing 
750 kcal CHO and 750 kcal fat. The increase of 
rT3 in the 1500 kcal mixed control diet was 23% 
and only significant on one occasion. 
Serum creatinine correlated inversely with 
serum T3 (r = -0.75, p < 0.001) and positively 
with serum rT3 (r = 0.67, p < 0.001) only in the 
fat diet. Serum uric acid was significantly corre-
lated with changes in rT3 (I: r = 0.73,p < 0.001: 
II: r ~ 0.61, p < 0.005; III: r ~ 0.55, p < 0.005) 
except in the mixed diet. Only in diet I there was 
also an inverse correlation with serum T 3 
(r = -0.84, p < 0.001). There was no important 
correlation of serum glucose with serum T 3 or 
rT 3 during any of the diet periods. 
DISCUSSION 
The present study confirms the finding of 
Danforth et aL,9 that under isocaloric conditions 
variations of diet composition can drastically 
alter peripheral thyroid hormone metabolism. 
The constant T4 and minimal change of TSH 
levels suggest that, as in fasting, 3 the hypothala-
mo-hypophyseal control is not responsible for 
Table 1. Alterations in Serum Creatinine, Uric Acid and Bilirubin During 41socaloric Dietst with Different Composition" 
Creatonine Uric Acid Bilirubin 
Increase Increase Increase 
Hours ><mole/1 1%) mmole/1 1%1 ><mole/1 1%1 
0 90 ± 18 40 0.39 ± 0.08 59 7.8 ± 2.4 112 Diet I 
p < 0.05 0.62 :!: 0.04 p < 0.001 16.5 ± 4.9 p < 0.01 72 126 ± 3 
0 86 ± 7 19 0.37 ± 0.07 30 11.5 ± 3.1 4 Diet II 
p < 0.005 0.48 ± 0.05 12.0 ± 2.9 NS 72 102 ± 6 p < 0.01 
Diet Ill 
0 96 :!: 4 5 0.37 ± 0.06 30 11.3 ± 1.9 46 
72 101 
' 
11 NS 0.48 ± 0.02 p < 0.02 16.5 ± 2.6 p < 0.05 
0 97 ± 8 9 0.37 ± 0.05 11 11.0±2.0 25 Diet IV 
72 106 ± 7 p < 0.01 0.41 ± 0.06 p < 0.005 14.0:!: 3.0 NS 
--Values are mean ±SO and percentage increase of basal value. 
tAll diets contained 6.276 kJ 11.500 kcal) divided as follows: Diet I, 100% fat; Diet II. 50% fat and 50% protein; Diet Ill, 50% fat and 
50% CHO; Diet IV, 40% fat. 20% protein. and 40% CHO 
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these changes. However. in the !500 kcal all-fat 
diet the decrease of T 3 and the increase of rT3 
were far more pronounced than in the 80% fat 
20% protein isocaloric diet used by Danforth et 
al..~ (T3 decrease 50% versus 33% and rT3 
increase l23% versus 30%, respectively). These 
changes, as depicted in Table 2, equalled in diet 
period ! ( 100% fat), in spite of adequate caloric 
intake, the changes observed during total starva-
tion in man. A logical explanation for the 
dramatic alteration in peripheral thyroid hor-
mone metabolism in diet I would. of course, be 
the total deprivation of oral carbohydrates and 
proteins. In tha1. case, the conclusion could be 
that energy supply' in the form of 1500 kcal oral 
fat is totally inert in the complex process of 
chaTJ.ging peripheral thyroid hormone metabo-
lism. Or. the other hand. it also cannot be 
excluded on basi~ of this observation, that the 
consumed amount of fat in diet ~does play more 
than a mere pass1ve role in these regulating 
processes. 
Another interesting and quite unexpected 
observation is the significant increase of rT3 up 
to 34% (p < 0.01) and, though not significant, 
the decrease of serum T 3 by up to 24% in diet IlL 
This diet contained 750 kcal of CHO and 750 
kcal of fat. The essential role of CHO in main-
taining normal serum T 3 and rT3 levels is well 
established. Spaulding et al.5 noted in a 800 kcal 
all-CHO diet no significant changes in serum T 3 
and rT~. Moreover, Azizi 8 found a complete 
recovery of both values after refeeding starved 
subjects with the same amount of CHO. 
One might argue that in our study an increase 
in rT3 was also present in the 1500 kcal mixed 
control diet. However, this increase was less 
pronounced, only significant on one occasion and 
did differ (p < 0.02) at 56 hr from diet Ill. We 
are inclined to contribute the changes in diet IV 
to the slight caloric reduction. 
The discrepancy that serum rT3 remains 
normal on a 800 kcal aii-CHO diet5·H while there 
is a significant increase in rT3 (34%, p < 0.01) in 
our diet period I! I (F jCHO) can only be 
explained by an effect of the added quantity of 
750 kcal fat in the latter. in spite of the relatively 
small number of persons investigated in all 
published studies, including ours. it is tempting 
to speculate that fat in large amounts could have 
an influence on peripheral thyroid hormone 
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metabolism. This presumed influence then 
apparently would interfere with the well known 
stabilizing potency of carbohydrates on periph-
eral deiodination. On the other hand, the also 
well documented higher potential of oral CH08 
to maintain normal peripheral deiodination in 
comparison with oral protein is still demon-
strated in the significant difference (p < 0.05) in 
serum T 3 decrease between diet II (F jP) and 
diet Ill (F /CHO). The "protective" effect of 
protein against the postulated influence of fat is 
apparently stronger for rT3 than T 3 levels. This is 
compatible with the findings of Azizi,8 who 
in his starvation-refeeding model noticed no 
changes in the low T 3 levels and a partial recov-
ery of rT3 levels on 800 kcal protein. Similarly, 
Spaulding et a!. 5 noted a decrease in serum T 3 
only and no change in serum rT3 concentrations 
on a 800 kcal diet composed of 80% fat and 20% 
protein. Of further interest to the possible 
influence of fat on peripheral thyroid hormone 
metabolism in man are the in vitro observations 
of Harris et alY in fresh rat liver homogenates. 
They found a decreased T 4 to T 3 conversion in 
the liver homogenates of 2-day starved rats. This 
decrease was fully restored by oral CHO, 
partially restored by oral protein, but not by oral 
lipid. These data are compatible with the find-
ings in our study. 
The mechanism by which fat can induce these 
changes in peripheral iodothyronine conversion 
remains purely speculative. The possible role of a 
gastroenterohepatic regulatory mechanism has 
been advocated. 13·22 The different secretions of 
various gastrointestinal hormones induced by 
oral ingestion of fat, amino acids, glucose, or 
fasting have been documented on several occa-
sions.24.25 A possible influence of one of these 
gastrointestinal hormones on peripheral thyroid 
hormone metabolism, however. has not yet been 
established. 
This study clearly demonstrates further that 
the metabolic influences, merely by changing the 
composition of an isocaloric diet. are far more 
complex than just an alteration in peripheral 
thyroid hormone metabolism. Many mecha-
nisms during fasting are directed towards fuel 
economy. 26 ·27 The demonstrated correlations of 
serum T 3 and rT3 with the various metabolic 
parameters indicate that changes induced by 
dietary manipulation might be very complex. 
The significant correlation in changes of rT3 and 
T, with uric acid and creatinine, respectively, in 
long-term hypocaloric diets has been observed 
and discussed by us before. 16 The present data 
provide evidence that the close association 
between rT3 degradation and uric acid metabo-
lism also exists in short term isocaloric changes 
of dietary composition. 
In conclusion, we are inclined to believe that 
dietary fat plays a more active role in changes in 
peripheral thyroid hormone metabolism than has 
been assumed until now. The mechanism by 
which fat could induce these changes are yet to 
be elucidated but could be mediated by gastroin-
testinal hormones. Protein seems to have more 
stabilizing potency for changes in rT3 than T 3 
levels induced by fasting or an isocaloric fat diet, 
while carbohydrates especially maintain a 
normal serum T 3 level when consumed in combi-
nation with the same amount of fat. 
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Abstract 
PAPER 2 
IODOTHYRONINE METABOLISM 
IN ISOLATED RAT HEPATOCYTES 
Initial results 
M.H. Otten, H. Bernard, J. Blom, R. Docter, G. Hennemann 
Freshly isolated rat hepatocytes have been used to study iodothyronine meta-
bolism at the tissue level. Approximately 2 x 106 cells were incubated at 37C 
with different 2 .. -u::::mnts of thyroxine (T4 ), 3,3' ,5'-triiodothyronine (rT3 ) and 
3,3'-diiodothyronine (3,3'-T2). The culture media were sUbsequently assayed for 
3,3' ,5-triiodothyronine (T3), rr3 and 3,3'-Tz content. T4 metabolism was Char-
acterized by a very lCY.Y prcxluction of T3 • Within 60 min at a concentration of 
10-B M both rr3 and 3,3'-Tz were rapidly cleared from the medium for 35 and 80%, 
respectively. An irrportant observation was the influence of thiouracil, an in-
hibitor of deiodination, on these clearance rates. Whereas 3,3'-Tz disappear-
ance was hardly affected, rr3 clearance was reduced from 35 to 8%, indicating 
that hepatic deiodination of rr3 constitutes a major degradative pathway for 
this rretabolite with little metal::olic alternatives. This observation tentative-
ly explaines Why the metalx:>lic clearance of rr3 is reduced in conditions with 
associated reduced hepatic deiodinase activity and raised rr3 serum levels, as 
e.g. starvation, illness or deiodination-inhibiting drugs. The unimpeded 
clearance of 3,3'-T2 is explained by rapid conjugation with sulfate preceding 
deiodination. 
Introduction 
This paper describes the initial experiments with freshly isolated rat hepa-
tocytes in the study of thyroid honrone metaOOlisrn. At the tirre these experi-
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ments were initiated, in 1978, the importance of the extra-thyroidal conversion 
of the proho:rrrone (T4 ) to the biologically active hormone 
3,3' ,5-triiodothyronine and the inactive rretaOOlite 
3,3' ,5'-triiodothyronine (reverse T3 , rr3 ) was already fully appreciated. 
fureover, the liver and kidneys were believed to be the principal tissues in 
which these processes take place. Furthermore, in addition to the determination 
of iOOothyronine serum levels under varying conditions, the interest in produc-
tion and clearance rates of these compoWldS was grc:wing rapidly. Thyroid hor-
mone kinetics in vivo, be it in man or in rat, are studied with injections of 
labeled ioCI.othyronines ( L 2) . Since this technique depends on sequential col-
lection of plasma samples, the individual contribution of the different tissues 
to the production or clearance of the numerous iodothyronines remains obscure. 
Moreover, rapid successive intracellular reactions can not be detected ly this 
methc:x'i. Therefor-e, it was decided to study iodothyronine metabolism at the tis-
sue level with the use of monolayers of isolated rat hepatocytes. It was hoped 
that with this rrcdel a more detailed impression of thyroid honrone handling by 
liver cells could be obtained. 
Methods 
Monolayers of freshly isolated rat hepatocytes were prepared by the :rrethoCI. 
of Berry and Friend with minor mcd.ifications ( 3). The technical details are 
given in Section II:4. The overall cellular vitality after isolation, as esti-
rrated by trypan blue exclusion, was over 85%. The incubation period was started 
4 hours after the cell isolation. The cells (2 x 106/dish) were incubated at 
37C under atmospheric condition with 4 ml complete Hams' F10 culture medium, 
which contained 10% fetal calf serum (FCS) and varying amounts of L-thyroxine 
(T4 ), 3,3' ,5'-triiodo-L-thyronine (rT3 ), or 3,3'-diiodo-L-thyronine (3,3'-T2 ) 
(Henning Berlin GmbH). Every experiment was performed in 8-fold. In later ex-
periments the culture dishes were placed on a slightly angled, slowly rotating 
dish to irrprove cellular interaction with the culture rred.ium. This methcd con-
siderably enhanced the rnetat:olic rate of the incuba.ted ic:x'iothyronines. After 
incubation, the culture media were stored at -20C until further duplicate ana-
lysis by specific radioimmunoassays for either T3 (4), rT3 (5) or 3,3'-T2 {6) 
content. In parallel incubations with rT 3 or 3, 3 ' -T 2 varying concentrations of 
2-thiouracil (TU) (Sigma), an inhibitor of deicdination, were added. '!'he 
non-protein-l:x:mnd fraction of rr3 and 3,3'-T2 in the culture medium was estimat-
ed by equilibrium dialysis. '!'he influence of culture med.iurn protein content on 
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hepatic icxiothyronine metabolism was investigated by measuring the 3, 3' -T 2 pro-
duction in 10-7M rr3 incUbates with or without 10% FCS. 
Results 
T4 metabolism 
In the first experiments the cells were incubated with 10-6 M T4 for 2,4 and 
16 h, and the media analysed for T3 and 3,3'-T2 content. Fig.l shews the pro-
duction curves. The appearance of T3 in the culture medium was, even at 16 h, 
very lo,..r i.e. 8 nrrol/1 which is less than 1% of the added am::mnt of T4 . For 
3,3'-T2 the production was even lower and amounted to only 10% of T3 . 
Therefore, further experiments were conducted with rr3 and 3,3'-T2 which showed 
a faster metabolic rate. 
Reverse T3 metabolism 
The metabolic clearance rate of rr3 was estimated in incubations containing 
5 x 10-9 , 10-B or 10-7 M of this corrpound. Fig.2 shows the rrolar and propor-
tional disappearance of rr3 fran the culture medilEL1 with or without 100 pM TU. 
At the lower 
ture medium. 
10-7 M rr3 
concentrations rr3 showed an almost linear clearance from the cul-
At 60 min approximately 35 to 40 percent had disappeared. With 
a lcJ.Ver 60 min clearance of 19% was noted. In the presence of TU, 
however, irrespective of the rr3 concentration, only a circa 10% decrease was 
observed.. 
Production of 3,3 '-T2 from rT3 
The appearance of 3 , 3 ' -T 2 
which contained 10-B, 10-7 
in the culture medium was assessed 
or 10-6 M rr3 with or without TU. 
fran incubates 
The respective 
prcxiuction curves of 3,3'-T2 are depicted in Fig.3. In spite of the exponential 
concentration increase only a very moderate rise in 3,3'-T2 production was 
noted. The data are corrected for rT3 cross-reactivity. In the presence of 100 
pM TU and irrespective of the rr3 concentration, the generation of 3, 3' -T2 was 
reduced to 10% of the highest production rate. The rather constant 3,3'-T2 pro-
duction at higher rT3 concentrations was also damonstrated in the incubations of 
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Fig.2. Influence of thiouracil on rr3 clearance 
by hepatocytes. Hepatocyte monolayers were incu-
bated at 37C upto 60 min with 5 x 10-9, 10-8 and 
10-7 M rT3 in culture medium containing 10% FCS. 
At 2, 4 and 16 h sanples of the culture medium Parallel incubations were performed with 100 pl 
·were analysed in duplicate by RIA for T3 and TU (o).The culture media were analysed by RIA for 
3,3' -T2 content. Values are given in nrrol as rT3 content at the given times. The values are 
means + SD1. expressed in nmol/1 and represent means ~ SEM of 
at least 4 different experiments. 'Ihe points 
without SEM represent means of 3 exper.iments or 
less. 
10-7 M rr3 with or without 10% FCS. Fig.4 shoos the rerrarkable small differ-
ences in the respective 3,3'-Tz production curves. Since the non-protein-bound 
fraction of rT31 for all concentrations used, amounted to 6.0 ~ 1.4%, the medium 
substrate concentration, available for cellular uptake, ~ght have been as much 
as 16-times higher in the protein-free 
relation to the clearance rate of 
incubates. 
w-8, w-7 
The production of 3,3'-Tz 
and lo-6 M rr3 is depicted 
in 
in 
Fig.S. At the lowest concentration tested only a minor part (22%) of the rr3 
cleared, reappeared in the medium as 3,3'-T2. This discrepancy became even ITDre 
pronounced at higher rr3 concentrations when only 9% (10-7M) and 1.3% {10-6 M) 
was recovered as 3,3'-T2 . 
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Fig.3. Production of 3,3'-T2 fran rT3 by nonola- Fig.4. Production of 3,3'-T2 fran rr3 by hepato-
yers of isolated rat liver cells. Cells were in-
cubated at 37C upto 60 min with w-8 , 10-7 or 
10-6 M rr3 . In parallel experiments 100 pM TU 
cytes in incubations with (o) or without (e) 10% 
fetal calf serum. 1-bnolayers of riit hepatocytes 
were incubated at 37C for 3 h with 10-7 M rr3 . 
was added. The culture media frcm 8 parallel in- The prcduction of 3,3'-T2 was measured by RIA. 
cubations in every experiment were analysed for Values are expressed as pmol/1 and represent the 
3,3'-T2 content by RIA. Values are expressed in mean.:!:. SEM of 8 parallel incubations. 
nmol/1 and represent means + SEM of at least 3 
different experiments. 
Table 1. Disappearance of 3,3'-T2 from the culture medium. Influence of 
thiouracil. 
Thiouracil 3, 3'-T 2 DECREASE (% ± SD) 
~M n 30 min n 60 min 
0 
10 
100 
Difference from control: 
18 
7 
11 
* p<0.05 
+ p<O.Ol 
60 ± 7 
51 ± 8* 
51 ± 8+ 
1 5 80 ± 7 
5 72 ± 11 * 
8 73 ± 5* 
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Fig.S. Production of 3,3'-T2 in relation to the 
clearance rat of rr3 by isolated hepatocytes. 
Monolayer rat hepatocytes were incubated at 37C 
for 60 min with 10-B, 10-? and 10-6 M rr3 in cul-
ture medium with 10% FCS. The media of 8 paral-
lel incubations per experiment were analysed for 
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Fig.6 Thiouracil influence on 3,3'-T2 metabolism 
bf rat. liver cells. funolayers of hepatocytes 
were incubated at 37C for 1 h in the presence of 
10-7 M 3,3'-T2 with (o) or without (•) 100 pM TU. 
Media in 8 fold were analysed by RIA for 3,3'-T2 
content. The values are expressed as nrrol/1 and 
rT3 and 3,3'-Tz content by RIA. Values are ex- represent the means of at least 4 different ex-
pressed as tllll::ll/1 and represent the means + SEM perimsnts. 
of at least 3 different experi.rrents. When no SEM 
is indicated the value is derived fran rreans of 
one or tv.o experiments. 
3,3 '- T2 metabolism 
The metaOOlic rate of 3,3' -T2 proved to be rruch faster than that of rr3 . At 
an initial medium concentration of lo-B M, 3,3'-T2 decreased by 60 and 80% after 
30 and 60 ~n, respectively (Fig.6). In the presence of 10 or 100 pM TU, dif-
ferent from rT3 again, only a small reduction of this fractional clearance was 
observed (Table I). The non-protein-bound fraction of 3,3'-T2 was estimated to 
be 12.9 + 2-2%. 
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Discussion 
These initial experments shCMed that rat hepatocyte monolayers can be used 
as a rocdel to study iodothyronine metabolisn at the tissue level. We have fo-
cused our attention in this study on rr3 and 3,3'-Tz metabolism. The higher me-
tabolic rate of these compounds allCMed shorter incubation times than with T4 • 
Apart from this practical aspect, incertitudes about cellular changes during 
culture were thus avoided. 
Both rr3 and 3,3' -T2 are rapidly cleared from the culture medium. Their 
rate of disappearance, however, was not identical. At a substrate concentration 
of 10-8M, 35% of rr3 and 80% of 3,3'-Tz disappeared within only 60 ~nutes of 
incubation. This difference nay, at least in part, be explained 
non-protein-bound fraction of rr3 (6%) in comparison with 3,3'-Tz 
by the 
(13%). 
lower 
The 
relevance of the free substrate concentration in this model was demonstrated in 
later experiments where a close correlation with the metabolic clearance rate 
was observed (Section II:4). Of further interest is the influence of the pres-
ence of thiouracil on the medium clearance of rr3 and 3,3'-T2 . At 10-
8 M the 
disappearance 
clearance fell 
of 3,3'-Tz was 
from 35 to 8%. 
only mildly affected by thiouracil, 
These results have puzzled us for a 
whereas rr3 
long time, 
especially When sUbsequent exper~ents showed that thiouracil actually did inhi-
bit outer ring deiodination of 3,[3•-125rJ-T2 . The phenomenon could later be 
explained by the discovery that 3,3'-T2 is first conjugated with sulfate l:::>efore 
it is subjected to accelerated outer ring deiodination. Inhibition of the 
latter process, therefore, will result in the accumulation of 3,3'-Tz sulfate 
(3,3'-T2s) and this compound is not detected by the 3,3'-Tz radioimmunoassay 
{Section II:S). 
Simultaneously, the notable reduction of rr3 clearance by thiouracil sug-
gests that for this metabolite no such intermediate metabolic step occurs and 
that deiodination is a direct and quantitatively important degradative pathway. 
This notion has later been sufPOrted by experiments with outer ring lal::eled re-
verse T3 • Olrana.tography of the medil.m on Sephadex LH-20 revealed no accumula-
tion of rr3 conjugates in the presence of PI'U. Also no reduction of rr3 outer 
ring deiodination was noted in sulfate depleted hepatocytes (Otten, unpub-
lished). Interestingly, the decreasing fractional clearance of rr3 from the 
culture medium with increasing sUbstrate concentrations (Fig.2) suggests satura-
tion of the hepatic rr3 deiOOinating capacity. The concentration range in ques-
tion (10-100 nM) corresp:mds rerrarkably well with the apparent KID value for in 
vitro outer ring deiOOination of rr3 with rat liver ~crosones, i.e. 0.06 pM 
(14). 
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In Chapter 4 (Section I) it is postulated that rT3 is predominantly generat-
ed in extra-hepatic tissues and cleared by the liver. Since apparently hepatic 
rr3 metabolism largly depends on direct outer ring deiodination with little al-
ternative, degradative pathways, inhibition of deiodinase activity will inevit-
ably result in a reduction of the metatolic clearance rate of rr3• This accords 
wi~1 the reduced rr3 clearance rate during starvation (7) or systemic illness 
(B-10), both conditions being associated with diminished liver deiodinase activ-
ity (11,12). The demonstrated lack of important alternative degradation of rr3 
in the liver corroborates the concept that the raised serum rT3 levels in the 
atove situations are explained by reduced outer ring deiodinase activity and un-
impeded rT 3 production. 
If indeed hepatic outer ring deiodination of rT3 is a direct major clearance 
pathway, an equivalent production of 3,3'-T2 would be expected, since 3,3'-T2 is 
a poor substrate for rat liver microsomal deic:dinase. Ho.vever, only a very mod-
est 3,3'-T2 production from rT3 was noted. This "meta1:olic gap" is explained by 
the excellent substrate properties of 3,3'-T2 for rat liver sulfotransferase ac-
tivity {13) and the large sulfation capacity of the hepatocytes. Most of the 
3,3'-T2 generated from rr3 will be conjugated immediately with sulfate and de-
iodinated in the outer ring prior to cellular secretion. The rather constant 
3,3'-T2 production at higher rr3 concentrations can be explained by the high ca-
pacity of the hepatic phenol sulfotransferases which is far from 'being saturated 
at the 3,3'-T2 concentrations measured (Section II:4). 
More detailed information about the contribution of glucuronidation and sul-
fation to overall hepatic rr3 metabolism and deiodination can be expected fran 
further incubations of labeled rr3 with hepatocyte rronolayers and subsequent 
chromato::Jraphic analysis of the culture media. 
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PAPER 3 
SULFATION PRECEDING DEIODINATION OF IODOTHYRONINES 
IN RAT HEPATOCYTES 
M.H. Otten, J.A. Mol, T.J. Visser 
Abstract. In man and animals iodothvronines are metabolized by ddodination and 
conjugation with glucuronic acid or sulfate. Unril now rhese processes have been 
regarded as independent reacrions. However. in the present studv u close interaction 
of these pathways was observed in rhe hepatic merabolism of 3 .3' -diiodothvronine 
and 3,3'.5-triiodothyronine. Studies with rat hepatocytes and /il'er micro.wmes 
indicated that sulfation of the phenolic hydroxyl {;rOup faciliwtes rhe d;•iodination of 
these compounds. 
layers. The medium \'/as analyzed b:o 
chromatography on Sephadex LH-20. A 
good separation was obtained between 
mr produced by outer ring deiodina-
tion, and 3.3'-T:: sulfate {T2SJ and un-
processed 3.3'-T2• At substrate coneen~ 
trations of lO nM 3.3'-T:: or less. iodide 
was the principal ;:noduct observed 
(> 90 percent). At higher 3J'-T2 con-
centrations or during coincubation with 
6-propyl-2-thiouracil (PTU ). an inhibitot· 
of deiodination. increasing amounts of 
T 25 accumulated in the medium at the 
expense of I- formatiun (2). The rate of 
outer ring deiodination of 3,3'-T2 in rat 
liver cells i' similar to that of rT, (3) 
Thi~ is a surprising observation because 
3.3'-T2• in compari~on to rTJ. is a poor 
substrate for outer ring deiodination by 
micro~omal deiudin<Jse activity (41. \Ve. 
therefore. suspected that in intact hepa-
tocytes deiodination of 3.3 '-T:: is preced-
ed. and in effect accelerated. by -;ulfate 
conjugation. If indeed sulfation precedes 
deiodination of 3.3'-T2• inhibition of the 
The thyroid gland secretes mainly thy-
roxine (3.3' ,5.5' -tetraiodothyronine. T 4). 
which is the precursor of the active form 
of thyroid hormone, 3.3' .5-triiodothyro-
nine (T3). Some 80 percent of the total T-' 
production originates from outer ring 
deiodination of T4 in peripheral tissues. 
especially the liver. Inner ring deiodina-
tion of T 4 yields 3.3' ,5" -triiodothyronine 
(reverse TJ. rT1J. a biologically inactive 
compound. Both T, and rT, are further 
deiodinated to 3.3 '-diiodothyronine 
(3.3'-T2J. A second imponant metabolic 
pathway for iodothyronines is conjuga-
tion with either glucuronic acid or sul-
fate. These principal pathways. deiodi-
nation and conjugation. have usually 
been regarded as functionally distinct 
processes. Here we present evidence for 
a close association of these processes in 
the hepatic metabolism of iodothyro-
mnes. 
The metabolism of 3.3 -T 2 and T; was 
studied with monolayers of rat hepato-
cytes. prepared as described previously 
(1). Whereas hepatic T1 metabolism is 
rather complex. 3.3'-T:: metabolism is 
easier to follow as it is subject only to 
outer ring deiodination and ~ulfation (2). 
Initially. therefore. we focused on the 
metabolism of 3.3'-T2 by incubating 
3.[3'- 12 'I]T:: with hepatocytes in mono~ 
Ts 
Sulfe.te concentration {mM) 
Fig. !. Sulfate dependence of OL!ler ring deiodin<~tion of 3.3" -T, and T, 
by monolaycrs of isolat~d rat hepatocyt~'i. Appmximately 2 x 10'' 
hepatocytes were incubated for 60 minutes wtth sulfate- and protein-
free Dulbecco"s balanced salt •;elution to reduce the cellular sulfate 
content (13). Hereafter. incubations v.-ere performed with 4 ml of 
Du!becco·s medium containing 10 nM unlabeled plu-; 2 ~Ci of "'J. 
labeled 3 .3' -T, or T, and incre<~sing sulfate concentr~tions. Identical 
incubations were conducted in the presence of 100 ~M PTU (lower 
panels) to inhibit deiodination. The 3.3"-T: incubation> cont;~ined 0.5 
percent bovine serum albumin. After 30 minutes for 3.3"-T, and ll\0 
minutes for T,. 100-~1 samples were taken from the medium. After 
protein precipitation with ethanol. the supernatants were ev<~powted 
The residues were dissolved in O.IN HCI and chromatographed by 
subsequent O.ll•,' HCl and O.IN NaOH elution on small tO.i5 mil 
Sephadex LH-20 columns. By this method a good separation was 
obtained between iodide and the conjugated <1nd free iodothyronines. 
respectively. From the radioactivity in the various fractions. before 
and after incubation. the respective production and clearance r;~tes 
were calculated. The result<; arc expressed as picomolcs produced or 
metabolized by 10' cells. The conjugates of 3.3'-T, and T, were 
identified by hydrolysis with sulfatase or ~·glucuronidase (Sigma). 
Whereas 3.3' · T, was exclusively sulfated. T, was aloo glucuronidated. 
In the absence of PTU. T, glucuronide '-'"<~S the major conjugate. In 
the presence of PTL:. the sulfate-dependent increment ofT, conju-
gates represents accumulation ofT ,S Symbols: 8. iodide: V, 3 .3' -T 2 ; 
0, T,S; &, T1 : 0, T, conjugates. 
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form~r proc~ss will inevitably result in n 
r<;;duction of deiodination. 
Sulfati,m in hepottocyte-, may he influ-
~:nced by til reduction of the so/- con-
c~:ntration in the medium and tiil inhibi-
tion by compound' such a' salicylamide, 
2.6-dichloro-4-nitrophenol (0CNP), or 
pentachlorophenol (PCP) (5). We tested 
both pos~ibilities. Figut-e l shows that]-
production in the absence of PTC and 
TcS fot·mation in the presence of this 
inhibitor are remarkably similar func-
tions of the SO.," conc~ntration in the 
m~dium. The disappeanmce of 3.3'-T2, 
with or without PTL. also depend~ on 
medium SO/·. Addition of 10 f.l..-\1 sali-
cylamid~. 100 f'.M DCNP. or 100 f.l.M 
PCP reduced out~r t·ing deiodination by 
50. 48. and 70 percent. n~speetively. In 
the pn~senee of PTL. T2S formation was 
inhibited by the~e compounds to similar 
extents. that is. 60, 57. and 80 percent. 
respectively. These rductions were 
identical to the decrease oi"3.3'-T2 clear-
ance. 
After incubation of hepatocyte~ with 
r:r_t.~-'!]T;. mewholite~ were separated 
on Sephadc;; LH-20 into three peab. 
that is. l . T, conjugates. and unrcaeted 
T1 !Fig. 1). The conjugate peak con-
tained both T, sulfate Cf_,Sl and T, glucu-
ronide as r~vcaled by enzymatic hydrol-
ysi.~. Glucuronidation was not a!fected 
by PTU or S04> At lov ... · S0-1:-- levels 
'" 
little T,S formation was observed. The 
increase of the conjugate peak with in-
creasing so/-. especially in the pres-
ence of PTU, reflects the accumulation 
of TJS. A ~imilar S0 4:- dependence of 
T, deiodination wa:> observed in the ab-
sence of PTU. 
Deicx!ination ofT, without PTU and 
T,S formation with PTU were inhibited 
to similar extents by 25 f.J.i\.1 salicylamide, 
10 fLM DCNP. and I f.!.i\1 PCP. that is, 80. 
S5, and 75 percent. respectively. The 
greater en·ectiveness of DCNP and PCP 
in this case is explained by the use of 
albumin-free medium. No effect of these 
compounds on glucuronidation was not-
ed. 
The second part of this study consist-
ed of the determination of the enzymatic 
charact~:ristics of QUter ring de iodination 
of 3.3'-T;o, T0S. and rT1 by r<lt liver 
microsome~. This oubcellular fraction is 
the principal site of deiodinase activity in 
r~'' liver (4). Outer ring deiodination of 
the three t::<r-labeled substrates was esti-
mated from the iodide production in in-
cubations with microsomes. Figure 2 
shows the rate of deiodination as a func-
tion of the substrate concentration. In 
accordance with earlier work (4) rT,, 
with a Michaelis constant (K~1 J of 0.1 
fJ./\.1. is the best substrate for outer ring 
deiodination. The K'"'~ ofTo.S (0.3 f.J.M) is 
close to that or rT1, making it a much 
'''I/ ,,~ 
0 1/s 10 
0.5 1.0 
T2S (u.M) 
;oo 
Fig. 2. Linear and double reciprocal (in>d) plots of the rate of outer ring detodination of 3.3 '-T,. 
T 1S. and rT, by r,ttli~er microsomes as a function of sub>trmc concentration. Deiodination wa~ 
estimated according to the method of Leonard and Rosenberg ( /4) by measuring the pro<.iuction 
of 12 '1 in 200-111 reaction mixtures. The mixtures contained diluted rat liver micro~omes <ln<.i 
adequate concentration> ofolller ring " 51-labele<.i 3.3'-"L. T,S. or rT 1 m hutfer(O.t5M so<.iium 
phosphate ipH 7.2). 3 mM EDTA. and 5 m.-\1 dithioth~eitO!. the cofactor for deiodination) 
Microsomal protein concentratiDn-; wer~ 8.4 )J..giml for rT, and T2S and 336 llgiml t"or 3.3'-T1 . 
After incubation for 10 minutes (rT, and T-5) or 30 minutes (3.3'-T,) at 37T the reaction wa; 
~topped with 50 11l of human serum con"iaining 5 mM PTU. PrOwn-bounU sub~trate was 
precipitated by 350 )J..l of 10 percent trichloroacetic acid. Jodi<.ie w>ls separateU from other 
products in th~ supernatant by ion-exchange chromatography (Oowex 50W-X2J. Deiodination 
rates were calculated from the increase ofra<.iioactivi\y in the iodide fr,lctions and expressed a' 
picomoles per minute per milligram of protein IL"I. The K" and 1/m"' values are given as mean 
::: standard deviation: J.J'-T2• K,.., 8.9 ± 3.9 11M. \/"'·" IH8 ::':: 94 U 1.-V = 4); T,S, KM 
0.34 ± 0.07 11M. \/"'·" 353::: 137 U (}·,' "-' 31: rT.1 • KM 0.10 ± 0.02 11M. 1/m" 445 :':: 88 U 
IN"' 41. T~S was prepared by bioo)-'nthesis: lf1 . V 3.3'-T,. tO 11Ci of3.13'-"'I]T,. and tOO 11M 
PTU were incubated in 4 ml of culture medium with rat hepatocvtes at 37"C. After 2 hour> 
approximately 80 percent of both labeled and unlabeled 3.3'-T, wa~ sulfated. T,S was purified 
by Sephadex LH-20 chromatography. and its yield was calculated from the recovery of added 
radioactivity 
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better substrate for microsomal deio-
dinase than 3.3'-T~ (KM 9 ~J-Ml. Several 
compounds were tested as. potentia! in-
hibitor<; of the deiodination of 0.0! f.l.M 
rT, or T,S. A close correlation (r = .99, 
P < .01) was observed between the de-
grees of inhibition of both reactions by 
these compounds at I 11M (6). This ob-
servation is compatible with deiodina-
tion of rT, and T,S by a single enzyme. 
Our observations demonstrate that al-
though 3,3'-T2 and T, are poor ~ub· 
strates for deiodination by the micro-
somal fraction of rat liver. this process 
readily takes place in rat hepatocytes. 
Three lines of evidence support the view 
that sulfation of3.3'-T2 and T, in hepato-
cytes yields conjugates which are highly 
prone to deiodination. First. significant 
amounts of the sulfate conjugates accu-
mulate only if deiodination is blocked 
with PTU. Second. deiodination varies 
with the sulfotransferase activity of the 
cells. either by restriction of SO/- in the 
medium or by the addition of inhibitors. 
Of these. salicylamide is the most specif-
ic competitive inhibitor of pheno!sulfo-
transferases (7). The metabolic inhibitors 
PCP and DCNP may. in addition, inter-
fere with the synthesis of adenosine 3'-
phosphate-5'-phosphosu!fate (7), while 
PCP may also inhibit deiodination direct-
ly (6). The similar influence of the above 
conditions on l- production and on sul-
fate conjugation in the presence of PTU 
strongly suggests that sulfation is the 
rate-limiting step preceding deiodina-
tion. Third. T:cS and T3S are preferred 
substrates for microsomal deiodinase ac-
tivity. This is illustrated by the low K'"'~ 
ofT2S (0.3 f.J.M) in comparison with 3.3'-
T2 (9 fJ..Ml. For T,S we obs~:rved an 
enhanced inner ring deiodination by rat 
liver microsomes [KM 4.6 fl."\.!. maximum 
velocity (Vm:c,l 1050 pmole per minute 
per milligr<1m of protein] compared with 
TJ (KM IO.i ~,J.M. Vm"' 33 pmolelmin-mg 
protein). The T,S generated is then rap-
idly deiodinated in the outer ring (8). 
It is not surprising that 3.3'-T2 and T 1 
are sulfated in rat hepatocytes. They 
both are substrates for rat liver cytosolic 
sulfotransferases (9). However, the pref-
erential deiodination of iodothyronine 
sulfates casts a new light on the process-
es involved with the peripheral metabo-
lism of thyroid hormone. It is interesting 
that monkey hepatoma cells showed no 
reduction of T1 inner ring deiodination 
when sulfation was inhibited {10). The 
very different characteristics of inner 
ring deiodination in hepatoma homoge· 
nates (KM 0.034 IJ-M. Vm"' 223 fmole/ 
min-mg protein) and the Jack of inhibi-
tion by PTU (10) resemble the PTU-
insensitive deiodination ofT~ in rat cere-
bra! cortex (KM 0.021 ~J-M, Vm~' 320 
fmole/min-mg protein) (11). For this type 
of deiodinase sulfation does not appear 
to enhance deiodination. It remains to be 
established to what extent sulfation de· 
termines the hepatic deiodination and 
clearance of iodothyronines in vivo. Our 
results support the concept that ~ulfation 
is not merely a means to facilitate biliary 
and urinary excretion of hydrophobic 
aglycons (}21. 
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PAPER 4 
METABOLISM OF 3,3'-DJIODOTHYRONINE IN RAT HEPATOCYTES 
Interaction of sulfation with deiodination 
M.H. Otten, G. Hennemann, R. Docter, T.J. Visser 
Abstract 
Production cf 3, 3 I -diiodothyronine ( 3, 3 I -T 2} is an important step in the 
peripheral metab:Jlism of thyroid honrone in :rran. 'The rapid clearance of 3,3'-T2 
is accorrplished to a large extent in the liver. We have studied in detail the 
meChanisms of this process using rnonolayers of freshly isolated rat hepatocytes. 
After incUbation with 3,[3~-125r]-T2 , chromatographic analysis of the medium re-
vealed two major metabolic routes: outer ring deiodination and sulfation. We 
recently denonstrated that sulfate conjugation precedes and in effect acceler-
ates deiodination of 3,3 1 -T2. In media containing different serum concentra-
tions the cellular clearance rate was determined by the non-protein-b:Jund frac-
tion of 3,3 1 -T2. Below 10-
8 M substrate concentration [ 125r] iodide was the 
rrain product observed. At higher concentrations deiodination became saturated., 
while the sulfate ester of 3,3 1 -T2 (T2S) accumulated in the medium. Saturation 
of overall 3,3'-T2 metab:Jlism was found to occur only at very high ( ?-10-6 M) 
substrate concentrations. The sulfating capacity of the cells exceeded that of 
deiodination by at least 20-fold. Deiodination was completely inhibited by 10-4 
M PTU or thiouracil resulting in the accumulation of T2s whereas clearance of 
3,3'-T2 was 
from 72 h 
little affected. No effect was seen with methirrazole. Hepatocytes 
fasted rats showed a significant reduction of deiodination but unim-
paired sulfation. Other iodothyronines interfered with 3,3 1 -T2 metaOOlism. 
Deiodination was strongly inhibited by 2 pM T4 and rT3 (80%) but little by T3 
(15%), whereas overall clearance was reduced by 25% (T4 and rT3) and 12% (T3). 
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In the presence of PI'U or at high substrate concentrations ( > 10-7 M) a third 
metabolite was generated, most likely the acetic acid analogue of 3,3'-T2• It 
is concluded that the rapid hepatic clearance of 3,3'-T2 is deteDmined by the 
sulfate-transferring capacity of the liver cells. Subsequent outer ring deiodi-
nation of the intermediate T2s is inhibited by PTU and by fasting essentially 
without affecting overall 3,3'-T2 clearance. 
Introduction 
The study of the peripheral metabolism of thyroid hormone in vivo is compli-
cated by the large number of successive metabolic reactions, and by the differ-
ent tnetabolic properties of the tissues. Best documented are the conversion of 
the prohormone thyroxine (T4 ) to the biologically active 3,3' ,5-triiodothyronine 
(T3 ) and the biologically inactive 3,3' ,5'-triiodothyronine (rT3). A thorough 
kna.vledge of the metal.:Dlic degradation of these and other iodothyronines is 
likely to contribute to a bettet· understanding of the changes in their serum 
levels as induced by illness, drugs or fasting (1) . 
3,3'-Diiodothyronine (3,3'-T2) is a common deiodination product of T3 and 
rT3 . The production of 3,3'-T2 in euthyroid subjects has been estimated between 
38 and 76 nrrDl/day (2,3), corrpared with 115 nrrol/day for T4 (4). Production of 
3,3'-T2 is, therefore, an important step in the sequential deiodination of T4. 
Nevertheless, serum levels of 3,3'-T2 are low, between 34 and 114 pM (2,3,5,6). 
This is explained by its high metabolic clearance rate, with 560 to 1116 1/day 
the fastest of all iodothyronines {2, 7). About 50% of this clearance is attri-
buted to hepatic extraction of plasma 3,3'-T2 (6), underlining the important 
role of the liver in iodothyronine metal:Dlisrn. 
We have studied the mechanisms of 3, 3' -T 2 metabolism in monolayers of fresh-
ly isolated rat hepatocytes. The advantages of this model for the study of thy-
roid hormone metabolism have been outlined by Sato and Robbins (8). Apart from 
practical aspects, the i.rrportance of cellular integrity is illustrate::l by the 
striking differences in 3,3' -T2 rnetaOOlisrn observed with hepatocytes or with 
liver homogenates (9). 
In the early stages of this study it appeared that 3,3'-T2 is metabolized in 
liver cells mainly by outer ring or 3'-deiodination and by conjugation with sul-
fate (10). These pathways were believed to be independent and to have different 
metabolic functions. Hc:wever, we recently demonstrated that in rat hepatocytes 
sulfation is an essential step preceding and accelerating the deiodination of 
3,3'-T2 (9). Similarly, sulfation facilitates the inner ring deiodination of T3 
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(9,11}. Sulfation is, therefore, an important factor in the peripheral metabol-
ism of thyroid hormone. 
We now present in detail the quantitative aspects of hepatic 3,3'-T2 meta-
bolism and the crucial role of sulfate conjugation. In particular, conditions 
were tested that are known to inhibit deiodinase activity, i.e. in vivo fasting 
and in vitro addition of iodothyronine analogues or thiouracil derivatives. 
Materials and methods 
3,3'-Diiodo-L-thyronine (3,3'-T2), 3,3' ,5'-triiodo-L-thyronine (rT3), 
3,3' ,5-triiodo-L-thyronine (T3) and L-thyroxine (T4 ) were purchased fran Henning 
Berlin GmbH, FRG. 3,[3'-125I]-diiodothyronine with a specific activity of 3300 
Ci/g was prepared as described earlier (5). Before every experiment the tracer 
was purified on Sephadex LH-20. Contamination with l2SI- was less than 1.0%. 
Sephadex lli-20 was obtained from Pharrracia Fine Chemicals, Uppsala, Sweden. The 
follo.ving materials were from Sigma Chemical Co., st. Louis, MO: 2-thiouracil, 
6-propyl-2-thiouracil, methimazole, D-saccharic acid-1,4-lactone, sulfatase type 
VIII, f3 -glucurcaidase t-ype IX, collagenase t-ype I, L-arninoacid oxidase, bc.wine 
pancreas insulin, Pipes, Hepes and Bes. Fetal calf serum, newborn calf serum 
{NBCS), penicillin and streptcmycine sulfate were obtained. fran FlCJW" LaJ:x:>rato-
ries, Irvine, UK. Ham's F10 nutrient mixture was purchased frcm Gibco Europe, 
Hoofddorp, The Netherlands. 
Isolation of rat hepatocytes and in incubation procedures 
Isolated rat hepatocytes were prepared essentially as previously described 
(12). After successive perfusion of the liver with ea2+ free Hanks' salt solu-
tion for 10 min and with the same medium containing 0.05% collagenase for 20 rrUn 
at p:I 7.4 under 5% co2 and 95% o2 , the liver was extirpated and minced. Cells 
were separated from tissue debris by repeated centrifugation (50 x g) and resus-
pending until a clear supernatant was obtained. Irrlrnediately after the isolation 
procedure cell viability, as estimated by trypan blue exclusion, was over 90%. 
Culture medium (4 ml) containing rv 2 x 106 suspended cells was slo.vly infused 
in sterile, plastic culture dishes, 5 em in diameter (Costan, Cambridge, MA., 
USA). The dishes were placed in a culture stove at 37C for 4 h under atmospher-
ic conditions. DJ.ring this period the culture medium was oomposed of unrncxlified 
Ham's F10, 10.6 rrM Pipes, 11.2 rrM Bes, 8.9 mM Hepes (pH 7.4), 2 rrM CaC12, 12 
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rrU/1 insulin, 10 U/ml penicillin, 10 rg/ml streptomycin sulfate and 10% fetal 
calf serun. After this preinrubation the viable cells { > 85%) were finnly at-
tached to the culture dish. Subsequently, incubations were perfonned at 37C 
under atmospheric conditions. The dishes were placed on a slightly angled, 
slowly rotating plate to ascertain optimal cell-fluid interaction. In these in-
cubations the general corrp:::>sition of the culture :rrediilltl VJas identical, except 
that 10% neWborn calf serum (NBCS) instead of fetal calf serum VJas used_, and no 
penicillin or strept.<:Jrr¥cin were added. This medium contains 0.6 nM Mgso4 which 
ensures optimal 3,3'-T2 sulfation (9). 
Analytical procedures 
Incubation media with unlabeled 3,3'-T2 were analysed by a specific RIA (5}. 
Incubation media with labeled 3,3'-T2 were assayed by column c~omatography. 
For this p.1rpose sa.rrples (100 p.l) of the culture medium were extracted with 1.0 
ml ethanol containing 10-4 M PTU, and evaporated at SOC under a stream of N2 . 
The residue v.Jas dissolved in 1 ml 0.1 N HCl and applied to small (0. 75 m1 bed 
volume) Sephadex LH-20 columns. Good separation of 3,3'-T2 and its metabolites 
was obtained by sUbsequent elution with 1 m1 fractions of 0.1 N HCl, 0.1 N NaDH 
and ethanol. The free fraction of the various iodothyronines in the culture 
medium was determined by equilibrium dialysis. In so:rre experiments, the free 
fraction was rrodified by changes of the NBCS content of the culture medium. The 
number of cells in every experiment was estimated from the average DNA content 
of 8 to 16 culture dishes and expressed as pg DNA. per dish. DNA content was de-
termined according to the methcd of Burton ( 13}. 
Analysis of 3,3'-T2 conjugates 
The chromatographic fractions, expected to contain 3,3'-T2 conjugates, were 
collected, neutralized and evap::>rated. The remaining :rra.terial was dissolved in 
the appropriate buffer for incubation with sulfatase or f3 -glucuronidase. 
Approximately 10 nmol of 3,3'-T2 conjugate was incubated at 37C overnight in 500 
pl b.Jffer with either enzyme at various concentrations (25 to 500 p.g/ml) with or 
without 5 nM D-saccharic acid-1,4-lactone, an inhibitor of f3 -glucuronidase. 'Ihe 
buffers used were 0.05 M sodium acetate {pH 5.0} for sulfatase and 0.05 M sodium 
phosphate {pH 6.8) for f3 -glucuronidase. 'Ihe mixtures, after extractiqn with 
ethanol, were again chromatographed on Sephadex LH-20. Since 250 p.g/1 sulfatase 
100 
yielded complete hydrolysis of T2s, this concentration was routinely used. 
3,3'-T2 metabolism by isolated rat hepatocytes 
During the initial stages of this study various concentrations (lo-10 to 
10-7 M) of unlabeld 3,3'-T2 were incubated with the cells. Samples of the cul-
ture medium in 8 parallel incubations were taken from 0 to 60 min and analysed 
for 3,3'-T2 content by 
of 10-5 and 10-4 M PTU. 
RIA. Similar experiments were performed in the presence 
In later experiments 0.5 pCi 3,[3'-125I]-T2 was added 
to enable chrorrat03raphic analysis on Sephadex LH-20. The 
concentration range was extended 
of the culture medium 
from lo-11 to 10-5 M unlal:::eled 
Initially, time curves were produced; later on, samples were taken at 
3,3'-T2• 
0 and 30 
or 60 min. The influence of thiouracil, PTU and methimazole was investigated by 
addition of 10-5 and 10-4 M of these substances to the incubations. Similarly, 
interference of other iod.othyronines with 3,3'-T2 metabolism was studied by co-
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Fig.l. O":traratographic patterns of ethanol extracted culture media. Culture medium (4 ml) con-
taining 10% NBC$, 10-8M 3,3'-T2 , 3,[3'-l25r]-T2 , and 0, 10-
5 or 10-4M thiouracil was incubated 
with m:molayers of isolated rat hepatocytes. Samples (100 pl) of the culture mediun at 0, 30 or 
60 min were extracted with ethanol and evaporated. 'The residue was dissolved in 1 ml 0.1 N HCl 
arrl applied to srrall- HCl equilibrated Sephadex IR-20 columns. Elutioo was perfonred by 1 ml 
fractions with 0.1 N HCl, 0.1 N NaDH and pure ethanol (E) respectively, as indicated by the hor-
izontal bar. 'The rmterial eluting between iolide (I) and 3,3' -T2 was identified as the sulfate 
ester of 3,3'-T2 (T2S) by hydrolysis with sulfatase. The elution profile after hydrolysis is 
depicted in the lo.ver right panel. A metal:clite that was tentatively identified as 
3,3'-diiodothyroacetic acid (diac, Ac) eluted in the ethanol fractions. 
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incubation with 0.1-2 p..."-1 T4 , T3 or rr3 after l h preincubation pericxl with these 
horrrones. To assess the influence of varying numbers of cells in the culture 
dishes, monolayers were prepared with 25, 50, 100 and 200% of the usual number 
of cells. Cell number was verified by measuring the DNA content of the various 
culture dishes (12,13). Other experiments were conducted with cells isolated 
from 72 h fasted rats. Cell isolation, plating and experimental procedures were 
otherwise un.rrodified. Conversion rates were corrected for DNA content when 
cells from fed and fasted rats were conpared. 
Determination of subsu·ate in the cellular companment 
The arrormt of 3, 3' -T2 in the cellular corrpartrnent during incubation was es-
timated by the decrease of total radioactivity in sequential 50 pl sanples of 
the culture medium. The decrease measured was corrected for changes in radioac-
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Fig.2. Elution profile of 3,3'--diiodothyroa.cetic acid (diac) on Sephadex LH-20. Diac was syn-
thetized by incubation of lo-6 M 3,3'-T2 and 3,[3'-
125rJ-T2 with L-aminoacid oxidase (C) and 
sonicated rat kidney mitochcndria (D) (for conditions see Materials and Methods}. The mixtures 
were extracted with ethanoL evaporated and dissolved in 1 ml 0.1 N HCl. '!his sanple was ap-
plied to HCl equilibrated Sephadex IR-20 columns and eluted with 1 ml fractions of 0.1 N HCl, 
Q.l N N<DH and ethanol (E) respectively, as indicated by the horizontal re.r. Profiles are shewn 
under C and D. Diac eluted in the same fractions as the unidentified material (U) fo.md after 
incubation of 10-6 M 3,3'-T2 with isolated rat hepatcx:ytes (B). The elution profile of 
3,[3'-125r]-T2 with a small iodide (I) peak is shown in panel A. 
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tivity in cell free culture dishes. The result, expressed as percentage of 
total radioactivity, was assumed to represent the arrount of 3,3' -T2 in the cel-
lular compartment. At the end of the incubation, cells were dissolved in 1 ml 
0.1 N NaDH and counted for radioactivity. 
Oxidative deaminarion of 3,3 '-T2 
In order to identify the elution pattern of 3,3'-diiodothyroacetic acid 
{diac) on Sephadex LH-20, this substance was synthetized ~ incubation of 
3,3'-T2 with both sonicated rat kidney mitochondria {14) or L-aminoacid oxidase 
{15). Preparation of rat kidney mitochondria was done according to the method 
of Nakano and Dano.vski (15). Sonicated mitochondria (1 :rrg protein/ml) were in-
cubated for 3 hat 37C with 10-6 M 3,3'-T2 , 0.02 JlCi 3,[3•-
125IJ-T2 , and 10-
4 M 
PrU in a 0.15 M sodium phosphate and 3 rrM EDI'A (J;H 7 .4) under 100% oxygen. 
Similarly, L-arninoacid oxidase (0.1 mg/ml) was incubated for 1 h at 37C with 
identical arrounts of 3,3'-T2 and PTU in 0.1 M sodium phosphate and 2 rrM EDTA (pH 
6. 5) . Both mixtures were extracted with ethanol and chromatographed on Sephadex 
LH-20. 
Results 
As shown before (9,10}, monolayers of freshly isolated rat hepatocytes are 
very active in metabolizing 3,3'-T2. Fig.l shows that radioiodide was the main 
product formed in incUbations with 10-8 M outer ring labeled 3,3'-T2 in the a~ 
sence of thiouracil. The second metal::oli te eluting in our chrorratographic pro-
cedure was observed especially When deiodination was inhibited with thiouracil. 
This metal10lite was identified as 3,3'-T2 sulfate (T2S) by the complete hydro-
lysis with 0.25 :rrg/ml sulfatase, independent of the presence of saccharic acid 
lactone. No substantial hydrolysis was observed with J3-glucuronidase. Next to 
iodide and T2s a third metabolite was generated in small amounts in the presence 
of thiouracil but also at high substrate concentrations (see belcw) . This com-
pound was tentatively identified as 3,3' -diiodothyroacetic acid {diac} by com-
parison with the elution profile in the two diac preparations obtained as des-
cribed under "Materials and Methcx:ls" (Fig. 2) . The greater adsorption of diac 
onto Sephadex LH-20 compared with 3,3'-T2 is in keeping with its reduced polari-
ty due to the loss of the NH2-group. Increased lipophilicity has also been ob--
served for the acetic acid analogues of T4 and T3 in reversed-phase liquid chro-
rratography (16). 
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Table 1. Effect of thiouracil on the metabolism of 3,3'-Tz as measured by RIA and Sephadex LH-20 
chromatography. Hepatocytes were incubated for 30 min with 10-8M 3,3'-Tza. 
Thiouracil 
(M) 
% 3, 3'-T 2 metabolizedb Proportion of products formed { %) b 
10- 5 
1 o- 4 
n 
15 
6 
3 
RIA 
58.0 ± 2.3 
55.6 ± 2. 7 
so. 7 ± 9.2 
n 
18 
7 
11 
LH-20 I 
60.3 ± 1.7 92 ± 2 
50. 9 ± 3. OC 32 ± 5 
50.6 ± 2.4d 5 ± 1 
a Per experimental point chromatography was done in duplicate and RIA in 8-fold; n 
experiments 
b Mean ± SE 
c Significant difference with controls by Student's t test, p<O. OS; 
d p<O. 01 
T2S "Diac 11 
8 ± 2 
66 ± 6 3 ± 
93 ± 1 3 ± 2 
number of 
Table 1 compares the rate of 3,3'-T2 metabolism as measured by RIA or by Se-
phadex chromatography. No significant difference between the two methods was 
observed. Since T2s is the main product in the presence of thiouracil, there is 
apparently no ~rtant crossreactivity of the conjugate in the 3,3'-T2 RIA. 
This agress with the observation that 3, 3' -T2 is undetectable by RIA in unhydro-
lyzed assay mixtures with T3 sulfate (T3s) or T2S (11). Furthermore, it is 
shown in Table 1 that deiodination of 3,3'-T2 is inhibited by thiouracil in a 
dose-dependent manner, being virtually undetectable at 10-4 M of the inhibitor. 
In contrast, overall clearance of 3,3'-T2 was only reduced by 10%. Identical 
results were obtained with PTU, but 10-4 M methimazole had no effect. 'Ihe reco-
very of radioa.ctivity in the chromatographic analysis was 95-97% for the ethanol 
extraction of the medium, and 99.7 + 2.3% (n=lOO) for the column Chromatography. 
Influence of substrate concentration on 3,3 '- T2 metabolism 
In a previous study (9} the metabolism of 3,3'-T2 was tested at a single 
substrate concentration (lo-8 M}. Fig.3 shows the production of medium iodide 
and T2S from varying concentrations of added 3,3'-T2. At lCJW" ( < lo-8 M) 3,3'-T2 
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Fig.3. Influence of substrate concentration on 3,3'-T2 metabolism by isolated rat hepatocytes. 
Culture medium (4 ml) containing 10-ll to w-5 M 3,3'-T2 , 3,[3·-125r]-T2 and 10% NBCS was incu-
bated for 30 min at 37C with the cells. After incubation analysis of the corrposition of the 
culture rrediun was made by Sephadex LH-20 column chrooatography. The radioactivity in the iod-
ide and T 2s fractions was expressed as p<2rcentage of tile =nverted arrount of 3, 3' -T 2 (left hand 
scale). The decrease of 3,3'-T2 in the culture medium is depicted as percentage of the original 
amrunt present before incuba-tion (right han:1 scale). 
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concentrations little T2s formation was detected. However, if deiodination was 
saturated at increasing 3,3'-T2 concentrations, accumulation of T2s was ob-
served. The results indicate a higher sulfating than deiodinating capacity of 
the cells. This is further illustrated in Fig.4 that gives the molar amounts of 
the metatolites produced during incubation of hepatocytes for 60 min with dif-
ferent substrate concentrations. Especially at high 3,3'-Tz concentrations sub-
stantial quantities of "diac" were produced. A fourth possible metatolite, 
3'-iodothyronine (3'-T1) whether free or in the conjugate form, was never de-
tected in the culture medium either by chromatography or by RIA (17). 
Another aspect of interest was the almost constant fractional clearance of 
3,3'-T2 from the culture medium over a wide range of concentrations (Fig.3). In 
spite of a 104-fold increase in concentrations, the fraction of 3,3'-T2 metabol-
ized only decreased from 69 ~ 5% (l0-11 M) to 59~ 3% (lo-7 M). At still higher 
concentrations this percentage more rapidly declined to 49 ~ 4% (lo-6 M) and 30 
~ 4% (10-S M) indicating saturation of the cellular 3,3'-T2 metabolizing capaci-
ty. These results are not biased by difference in the non-protein-bound sub-
strate fraction since this percentage, as assessed by equilibrium dialysis, was 
identical (12.9 ~ 2.2%) for all concentrations used. The relevance of this free 
fraction for hepatic 3,3'-T2 clearance was demonstrated in experiments where the 
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2 
Fig.4. Influence of substrate concentration on pro::iuction of icdide (I-), T:zS and a metabolite 
that was tentatively identified as 3, 3' -diiodothyroacetic acid (diac) l:y isolated rat hepato-
cytes. Culture medium containing 10-11 to 10-5M 3,3'-T2, 3,[3'-12
5r]-T2 a:ncJ. 10% NBCS was incu-
bated at 37C for 60 min with the cells. The molar producticn of the three rret.al:x:rlites, ex-
pressed as mrrol per 100 /19 DNA, was calculated fran the radioactivity in the respective frac-
tioos after column chrornatcgraphy of extracted rulture media. 
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protein content of the culture medium was varied. With increasing concentra-
tions of NBCS { 10, 20 and 30%) the non-protein-bound fraction decreased. from 
12.1 to 10.7 and 9. 7%, respectively, which correlated strongly with the dimin-
ishing 30 ~n fractional clearance of 3,3'-T2 : 74.9, 56.3 and 40.3% {r=0.99, 
p < Q.Ol}, Ho.o.rever, the decrease in 3,3' -T2 clearance is greater than that in 
the free fractions, indicating that in this rrodel the relation 'between the two 
parameters is not a simple one. 
Substrate content of the cellular compartment 
When correcte:l for non-specific binding to the culture dish, a maxirrum of 
4.4% of adde:l 3,3'-T2 {10-B M) was estimated to be in the cellular compartment 
{Fig.5). After 15 min this cell bound fraction declined as radioactivity gradu-
ally appeared in the iodide fraction. Apparently the storage capacity of hepa-
tocytes for 3,3' -T2 is rather low. The arrount of radioactivity recovered in the 
cells at the end of the incubation corresponded well with that disappeared fran 
the medium. 
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Fig.S. Total radioactivity in culture medium during incubation of 3,3'-T2 with 3,[3'-
125
rJ-T2 
in culture dishes with (...--.) and without (o-- -o) isolated rat hepatocytes. CUlture rredium 
(4 rnl) containing 10-8M 3,3'-T2 , 3,[3'-l25r]-T2 (rvO.S pCi/ml) and 10% NBCS was incubated for 
60 min in cu1 ture dishes containing either no or approximately 2 x 106 cells. Seq:uential 50 pl 
samples of the culture medium were taken at 0, 5, 10, 15, 30 and 60 min fran 6 different culture 
dishes. Radioactivity of these sanples is given as mean.:!:. SD. A significant difference 
(p< O.Ol) was noted for the 5 to 30 min sarrples as indicated by the asterisk. The right hand 
scale gives the percentage decrease from the original arrount of radioactivity in the culture 
medium. 
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concentr~tion c:oincubated iodothyronine 
Fig. 6. Influence of other iOOothyronines on 
3, 3' -T 2 metatolism by rat hepatocytes. Cells 
were preincubated at 37C for 60 min with the 
indicated concentrations of unlabeled T4 (o), 
T3 (A) or rT3 (e) in the presence of 10% 
NBCS. After this preincubation the culture 
medium contained, in addition to the same am-
ount of the respective iodothyronines, 10-8 M 
3,3'-T2, 3,[3'-l25r]-T2 and 10% NBCS. After 
30 min of lilcubation 100 p1 of the culture 
medium was extracted with ethanol and chrana-
tographed on Sephadex IB-20. '!he productioo 
of iodide (upper panel) and disappearance of 
3,3'-T2 (lcwer panel). expressed as prol/30 
min, were calculated fran the radioactivity 
in the respective fractions (left hand 
scale) • The decrease of iodide production 
and 3,3'-T2 clearance, induced by T4 , T3 and 
rT 3 , is expressed as percentage of =ntrol 
experiments on the right hand scale. 
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Fig. 7. Influence of varying cell nlllTlber on 
3,3' -T2 metaOOliffil by rat hepatocytes. Cell 
isolation was perfonred as describe.'! in Mi-
terials and Methods. Before plating separate 
cell suspensions were prepared containing 25, 
50, 100 or 200% of the usual 2 x 106 cells. 
The actual number of cells was verified by 
determination of the DNA content in the vari-
ous culture dishes. All other procedures 
were unaltered. Hereafter, culture medium (4 
ml) containing 10-6 M 3,3'-T2 , 3,[3' _125I]-T2 
and 10% NBCS was inOJ.bated for 60 min at 37C 
with the various cell concentrations in du-
plicate. Sequential 100 pl sarrples were 
drawn at the indicated times, extracted with 
ethanol and chromato:Jraphed on Sephadex 
LH-20. 3,3'-'1'2 decrease, expressed as per-
centage of original arrount, as well as iod.ide 
production (:pnoles) were calculated fran the 
radioactivity in the respective fractions. 
Effects of other iodothyronines on 3,3 '- T2 metabolism 
Tile effects of higher iod.othyronines on 3,3' -T2 rnetaOOlism were twofold. 
Both deiodination and overall clearance were affected but not to the same ex-
tent. Fig.6 demonstrates that the reduction of deiod.ination was much rrore pro-
nounced than the reduction of overall clearance of 10-S M 3,3'-T2 . Reverse T3 
proved to be the most powerful inhibitor of deiodination, affording 80% inhibi-
tion at 2 )M, whereas T3 only had a weak inhibitory potency, i.e. 15% inhibi-
tion at 2 pM· Inhibition of deiodination by rT3 and T4 was accompanied by an 
accumulation of T2s. The clearance of 3, 3' -T2 was decreased by 25% with 2 pM T4 
or rT3, and by 15% with 2 pM T3 . These differences were not caused by" changes 
in the non-protein-bound fraction of 3,3'-T2 since it was not affected by the 
other iOOothyronines. 
Effects of in vivo fasting on in vivo 3,3:. T2 metabolism 
Tile DNA corrected metabolic properties of hepatocytes of 72 h fasted rats 
and of control animals are given in Table 2. 'IWo observations can be rrade from 
these experiments. First, t..""le total arrount of 3,3' -T2 metaOOlized by the cells 
in 30 min did not significantly differ in OOth groups. Second, deiodination was 
reduced in cells fran fasted anima.ls resulting in the accumulation of T2s. This 
reduction varied from 20 to 40% over the range of concentrations tested. Judged 
from the deiodination rates at saturating sUbstrate levels, the total deiodina-
ti ve capacity of the fasted cells was reduced. Since overall clearance was not 
dbninished this suggested a decrease in the activity of the deiodinating enzyme. 
The lack of significance at 10-6 M 3,3'-T2 may be attributed to the small frac-
tion of substrate deiodinated at high concentrations, increasing the variation 
between experiments. Mean values, however, corresp:mded well with those found 
in the incubations containing 10-? M 3,3'-T2. 
Influence of cell number 
The dependence of 3,3'-T2 clearance and deiodination on the number of hepa-
tocytes in the culture dishes is given in Fig.?. Cell number amounted to 0.5, 
1, 2 and 4 x 106 cells per dish. The DNA content varied accordingly: 9 ~ 1, 19 
+ 2, 44 + 9 and 92 2:. 6 pg DNA. In this experiment a concentration of 10-6 M 
3,3'-T2 was used in order to study the maximal deiodinative capacity of the 
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Table 2. METABOLISM OF 3,3'-T2 BY RAT HEPATOCYTES. INFLUENCES OF 72 h IN VIVO FASTING 
BEFORE CELL ISOLATION ON 3,3'-T2 METABOLIC RATE ANO PRODUCTION OF IODIDE. 
3,Y-T2 3,3 1-T2 metabolized iodide produced decrease 
(M) control* fasted* p control fasted p of iodide production 
( pmol/1 00 ~g DNA ± SD) (pmol/100 V9 DNA ± SD) % 
10-11 0.056 ± 0.006 ( 2) 0.040 ± 0.011 (2) NS 0.056 ± 0.006 0.037 ± 0.008 <0.05 34 
10-10 0. 51 ± 0.05 ( 5) 0.43 ± 0.17 ( 3) NS 0. 51 ± 0.04 0. 41 ± 0.08 <0.05 20 
1 o- 9 5. 1 ± 0.4 ( 5) 4. 2 ± 0.9 ( 3) NS 5.0 ± 0.4 3. 8 ± 0.6 <0. OS 24 
1 o- 8 46 ± 15 ( 18) 43 ± 15 ( 8) NS 43 ± 13 27 ± 9 <0. OS 37 
10- 7 439 ± 96 ( S) 399 ± 91 ( 3) NS 254 ± 73 153 ± 41 <0. 05 40 
1 o- 6 3624 ± 1191 ( 6) 3614 ± 902 ( 3) NS 238 ± 146 183 ± 162 NS 24 
* Number of experiment in parentheses. Statistical analysis was performed using the Student t test. 
cells. Production of iodide appeared to be linear with the number of cells but 
the disappearance of 3,3'-T2 was not. 
Discussion 
Obviously, isolated hepatocytes provide a more physiological system to study 
iodothyronine metabolism than liver homogenates or subcellular fractions. 
Deicxlination of 3,3' -T2 by hepatocytes is much faster than deiodination by mi.-
crosorres (10,18). This has been explained by the initial sulfation of 3,3'-Tz 
in hepatocytes that facilitates subsequent deia:lination ( 9) . It was demonstrat-
ed that in rat liver cells both 3,3'-Tz and T3 have to be conjugated with sul-
fate before any substantial deiodination occurs (9). Both T2s and T3S appeared 
to be much better substrates for deiodination by rat liver microsomes than the 
non-sulfated compounds as indicated by the Vmaxl~ ratio's. This ratio amounted 
to 1038 for T2s and 21 for 3,3'-T2 (9), and 228 for T3s and 3 for T3 (11). 
It was demonstrated in the present study that the total capacity of 3,3'-Tz 
sulfation in hepatocytes is at least 20 times higher than their deia:linating po-
tential. On the other hand, there is litle acc1.m1ulation of T2s at lo,.,r ( < 10-7 
M) substrate concentrations, indicating that under these conditions sulfation is 
the rate-limiting step. This notion is supported by the fact that inhibition of 
sulfation reduces overall 3,3'-Tz clearance (9), Whereas inhibition of deicxlina-
tion by, for instance, thiouracil does not affect 3,3'-T2 clearance (Table 1). 
The observed rapid clearance of 3,3'-T2 by our hepatocytes agrees with studies 
using isolated, perfused rat livers (19,20). Inane of these, Flock et al {19) 
identified iodide as the principal product at a perfusate concentration of 8 x 
lO-B M 3,3'-T2. 
Sulfation is the crucial step in the hepatic metabolism of both 3,3'-Tz and 
The latter is not as good a sUbstrate for phenol sulfotransferases as 
3,3'-T2 (21), explaining at least in part the slower hepatic T3 clearance 
(9,19,20). 
Another factor influencing 3,3'-Tz metabolism appeared to be the 
non-protein-bound fraction of this corrpound in the rned.ium. Similar ;,observations 
have been made concerning the metal::olism of T3 by hepatocytes (22). Ho..vever, 
also in our case there is not a simple 1:1 relationship between the free 3,3'-Tz 
fraction and the extent of its degradation with increasing serum concentrations 
in the medium. Cellular storage, on the other hand, does not contribute signi-
ficantly to the 3,3'-Tz disappearance, since no more than 5% of added radioac-
tivity was at any time associated with the cells. A similar lo;...r percentage up-
Ill 
take of 3,3'-T2 was observed by Flock et al (19) in the perfused rat liver. 
Finally, the disappearance of medium 3,3'-T2 depended on the mnnber of 
cells. The clearance of 3,3'-T2 was not linearly related to the number of cells 
in contrast to ic:dide production. A likely explanation for this phenomenon may 
be found in the different capacities of the sulfating and deiodinating systems 
of the hepatocyte. At the high 3,3'-T2 concentrations used (10-6 M) deiodina-
tion is saturated, whereas sulfation, which determines the 3,3'-T2 clearance, is 
not (Fig.4). Interestingly, Faber et al (23) noted in euthyroid and hyperthyro-
id human subjects an identical 40% hepatic 3,3'-T2 clearance in spite of the 
greatly elevated levels in the latter group. This rray reflect the constant 
3,3'-T2 clearance over a wide range of concentrations observed by us. 
Oxidative deamination is a minor pathway for the elimination of iodothyron-
ines (24), Roche et al observed generation of diac fran 3,3'-T2 in rat kidneys 
( 25) . Especially at high substrate concentrations we found that the hepa.tocytes 
produced a coo-pound with chranatographic properties that are ccxrpatible with 
diac. However, definitive identification would require the demonstration of co-
elution in rrore refined chranatographic systems such as HPLC. It is of interest 
that tetrac is only detected in rat bile after administration of a high dose of 
T4 (16}. 
The occurence of inner ring deiodination of 3,3'-T2 or T2S in hepatocytes is 
unlikely since no formation of 3'-T1 or its sulfate was observed. This is not 
due to the subsequent metabolism of these c:orrpounds by rapid outer ring deiodi-
nation since both 3'-T1 and its sulfate proved to be poor substrates for micro-
sorral deiodination (Otten and Visser, unpublished observations) . 
It is important to realize that the conditions used in our experiments do 
not reflect the actual in vivo situation. The concentrations 3,3'-T2 are very 
high in comparison with those found in sera of rat and man (5), \'Jhile the pro-
tein content of the culture medium is considerably lo.ver. HONever, this experi-
mental design, by its simplicity, provides a suitable model for studying the 
rrn.J.ltiple processes involved in hepatic iodothyronine handling. We have investi-
gated apart from substrate concentrations, the influences of thiourea deriva-
tives, fasting and other iodothyronines on 3,3'-T2 metabolism in these cells. 
PTU and thiouracil proved to be potent inhibitors of T2S deiodination in cells 
as well as with rat liver microsames (9). A rapid cellular uptake and metabolic 
availability of these carnpounds is suggested py the immediate onset of inhibi-
tion without preincubation. With the highest concentration tested (lo-4 M PTU) 
no deiodination could be demonstrated. A similar inhibition was noted for outer 
ring deiodination of T4 in hepatocytes {8). Since this concentration is in the 
range of therapeutic serwn levels of PTU-treated patients (8,26) it is rerrark-
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able that peripheral T3 prcrluction from T4 still occurs in PTU-treated and 
T4-sUbstituted hypothyroid patients (27) or thyroidectomized rats (28). This is 
compatible with an extra-hepatic deiodination by a less PTU-sensitive deiodinase 
(28). 
The experiments with hepa.tocytes fran 72 h fasted rats are in agreement with 
observations by others, that in the fasted state the hepatic deiodinase activity 
is reduced. The reduction in our study {20-40%) was scmewhat lower than gener-
ally found in the literature (29-31). This may be explained by partial restora-
tion of the fasted state during the 4 h preincubation with fully supplemented 
culture medium. Clearance of 3,3'-T2 in these cells was not reduced. This ac-
cords with a recent report on uninhibited sulfation in starved rats (32). 
In contrast to fasting, other iodothyronines did interfere with 3,3'-T2 
clearance. Disappearance of 3,3'-T2 from the medium was affected to a lesser 
extent than deicdination. Whereas deicdination is probably inhibited by corrpet-
ition for deiodinase activity, the reduced clearance ~ght theoretically be 
caused by competition either for cellular uptake or for intracellular conjuga-
tion. At present, it is not possible to distinguish between these alternatives. 
It is also a matter of future interest Whether the iodothyronines themselves or 
their respecit•_re conjugates caused the inhibition of deiodination. The fact 
that the inhibition was enhanced by preincubation with the respective iodothy-
ronines does not answer this question. 
The demonstration of the importance of sulfation in the hepatic metabolism 
of iodothyronines {9,11, this paper) revives the interest in earlier work on 
this sUbject. Following the initial reports by Roche et al (33,34) on the in 
vivo generation of T3s in rats, conjugation of iodothyronines with sulfate has 
received little attention. This is intelligible in the light of the srrall quan-
tities of iodothyronine sulfates in human plasma (35), urine (36) and rat bile 
( 16), giving the impression that sulfation is a minor metabolic pathway. The 
lo.-.r levels of sulfated iodothyronines in bile can now be explained by the find-
ing that these conjugates are highly susceptible to deiodination before they are 
released. Significant secretion of sulfates is only expected when deiodination 
is inhibited. Indeed, increased arrounts of T2s have been observed in the bile 
of thiouracil-treated rats (37). The augmented biliary excretion of radioactiv-
ity after 'PTU administration to rats equilibrated with labeled T3 or T4 (38) may 
be based on the same phenomenon. 
In conclusion, the present study sho.ols that the clearance of 3, 3' -T 2 by rat 
hepatocytes is determined by the large sulfate-transferring capacity of the 
cells. This ensures a constant fractional clearance of 3,3'-T2 by the liver, 
independent of factors that affect deiodinase activity such as PTU or fasting. 
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The T2s generated normally undergoes rapid outer ring deiodination before it is 
released. This process is inhibited by thiouracil, PTU, fasting and other iodo-
thyronines, but not by methimazole. Only when deiodination is inhibited, 
mulation of T2s is observed. 
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PAPER 5 
RAPID DEIODINATION OF TRIIODOTHYRONINE SULFATE 
BY RAT LIVER MICROSOMAL FRACTION 
T.J. Visser, J.A. Mol, M.H. Otten 
Transmitted by Michael M. Kaplan on January 7, 1983 
ABSTRACT: Triiodothyronine sulfate (TJS) was synthetized chemically, and reacted at 37 C and pH 7.2 with rat 
liver microsomes and 5 m1~ dithiothreitol (OTT). The production of 3,3'-diiodothyronine sulfate (3,3'-TzS) from 
u11labeled T3S was measured after hydrolysis v1ith a specific 3,3'-T2 radioimmunoassay, and the production of 
radioactive r- from outer ri rtg-1 abel ed T3S by ion-exchange chromatography. Production of both 3, 3'-T 2S and I-
was OTT dependent, strongly inhibited by 6-propyl-2-thiouracil (PTU), and abolished after heat-inactivation of 
the microsomes. The time sequence and enzyme dependertce of product formatiort suggested that most if not all r-
was produced via 3,3'-TzS. I11ner ri11g deiodination of T3S was two orders of magnitude faster than that of T3 
as the result of a lower apparent Km (4.6 vs 10.7 )JM) and a markedly increased Vmax (1050 vs 33 pmol/mg protein· 
min). It is postulated that T3S is a key intermediate in the metabolism of T3. 
Deiodination and conjugation with sulfate or 
glucuronic acid are major pathways in the metabolism 
of ·iodothyronines. In rats equilibrated with outer 
rirtg radioiodine-labeled T3 or T4, roughly half of 
the radioactivity appears in the urine as r-. The 
other half, which is excreted with the feces, presu-
mably reflects biliary excretion of conjugates {1). 
If in these rats deiodinatio11 is blocked by PTU 
treatment, urinary excretion decreases and fecal ex-
cretion increases before plasma radioactivity chan-
ges (1). Similarly, during incubation of iodothyro-
nines with rat kidney slices {2) or isolated hepato-
cytes (3,4) conjugates accumulate if deiodination is 
inhibited (e.g. by PTU) or saturated. 
A possible explanation is that a large fraction 
of iodothyronines is conjugated first and deiodina-
ted subsequently, implying that the conjugates are 
more prone to deiodination than the parent compounds. 
We recently obtained evidence in support of this 
hypothesis, as it was observed that outer ring deio-
dination of 3,3'-Tz ill rat hepatocytes was strictly 
correlated with the sulfotransferase activity of 
these ce 11 s 1. This indicated that sulfate conjuga-
tion was the rate-limiting step preceding deiodina-
tior~. Consonantly, 3,3'-TzS was rapidly deiodinated 
by rat liver microsomesl. 
We now report that the inner ring deiodination of 
T3S by rat liver microsomes is extremely rapid com-
pared with that of T3. 
~~ATERIALS AND METHODS 
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T3 was obtained from Henning, and ~·- fl T3 
{> 1200 ,uCi/,ug) from Amersham. T3S was synthetized 
by a modification of a previous method (5). In 
short, mixtures of either 0.5 ,umol T3 and 0.1 fJCi 
125r-T3, or 5 nmol T3 and 10 jJCi 125r-T3 , were pre-
pared, the solvent was evaporated, and the res1dues 
were reacted for 1 h at -5 C with 100 ,ul concentra-
ted H2S04. After dilution with water of 0 C, the re-
action products I-, T3S and T3 were separated on 
Sephadex LH-20 by successive elution \'lith 0.1 N HCl, 
water and 0.1 1-1 NaOH-ethanol (1:1). The yield of 
1) M.H. Otten, J.A. Mol, and T.J. Visser, submitted 
for publication 
both labeled (2 mCi/,umol) and "unlabeled" (0.2 jJCi/ 
j.Jmol) T3S was 40%. The identity of T3S was demor~­
strated by acid and sulfatase hydrolysis, resulting 
in the quantitative liberation of T3 as analyzed by 
chromatography and radioimmonoassay. 
Rat liver microsomes were prepared as described 
(6). Deiodination was studied by measurement of A) 
the release of radioactive r- from outer ring-
labeled T3S, and B) the production of "unlabeled" 
3,3'-TzS from T3S of low specific radioactivity. 
Reaction mixtures contained microsomes artd T3S at 
the indicated concentrations in 0.1-0.2 ml 0.1 M 
sodium phosphate (pH 7.2), 2 mM EDTA and 5 mM OTT. 
Incubation was done at 37 C under air. In assay A the 
reaction was stopped by the addition of 50 j.Jl 5o;; 
human serum containing 5 mM PTU. After protein preci-
pitation with trichloroacetic acid, I- was measured 
in the supernatant by ion-exchange chromatography 
(7). To assay B was added l ml l N HCl followed by 
reactio11 for 1 hat 80 C to hydrolyze 3,3'-TzS. The 
pH was neutralized with 1 ml 1 N NaOH, and 3,3'-T2 
was measured in duplicate in 50 j.Jl aliquots by RIA 
(6 I. 
Each experimental point was determined in tripli-
cate and corrected for non-enzymatic deiodination as 
estimated in control incubations without microsomes. 
In the controls less than 1% of added radioactivity 
was recovered as r-, and 3,3'-TzS formation was less 
than 10:; of that in complete mixtures. After hydro-
lysis recovery of 3,3'-Tz from added 3,3'-TzS, pre-
pared similarly as T3S, was 93;;, 3,3'-Tz was un-
detectable if hydrolysis of assay mixtures with added 
T3S or 3,3'-TzS 1vas omitted. 
RESULTS AND DISCUSSION 
Fig. depicts the production of 3,3'-TzS and r-
from 0 5 fJM T3S as a function of reaction time and 
microsomal protein concentration. In both instances 
there is an initial increase in the .accumulation of 
3,3'-T2S with little production of r-. In a second 
phase the concentration of 3,3'-T2S formed reaches a 
plateau, while I- formation becomes more prominent 
and roughly linear with time and protein concentra-
tion. This suggests that T3S first undergoes inner 
ring deiodination, and that r- arises mainly from the 
subsequent outer ring deiodination of 3,3'-T2S· The 
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Fig. 1. Production of 3,3'~TzS (o) or radioactive 
r- 1'1 _.during incubations of 0.5 IJM "unl~beled" or IJ'- ;;5~ T3S, respectively, for 5-60 min with 42 pg 
m1crosomal protein per ml (left), or for 15 min w1th 
16.8-168 !-J9 protein per ml (right). The amounts of 
3,3'-TzS and r produced were estimated as described 
u11der "Materials and !~ethods", and expressed as per-
centage of added T3S. The results are the means of 
two closely agreeing experiments, each performed 
with two different preparations of labeled and un-
labeled TJS. 
high rate of 3,3'-TzS deiodination this implies was 
confirmed by the measurement of r- generation from 
added 3,3'-TzS 1 The intermediate formation of 
3'-TrS appears unlikely, as this compound is~ poor 
substrate for microsomal deiodinase activity 
Production of 3,3'-TzS and r- was not detectable 
1-1hen microsomes 1·1ere preheated for 30 min at 80 C, 
or when incubations were done in the absence of OTT. 
The effects of potential inhibitors on 3,3'-TzS pro-
duction were tested in incubations of 0.5 iJM T3S for 
5 min with 8.4 iJg microsomal protein per ml. r- for-
mation \'las assayed in 15 min incubations with 42 ,ug 
protein per ml. One p~~ T4, T3, i opanoi c acid and DIT 
inhibited 3,3'-TzS production by 58, 14, 25 and 0%, 
and r- production by 56, lO, 31 and Q);, respectively. 
As rTJ is rapidly converted to 3,3'-TZ, its effect 
on 3, '-TzS format1on could not be assessed, but 
l pM rT3 was found to decrease r- generation by 90L 
Tne order of potency of these compounds resembles 
their effects on the deiodination of nonconjugated 
iodothyronines (6,8) 1 This analogy also holds for 
PTU, which at 10 )JM lowered 3,3'-T2S production by 
sz·:, and I- production by 97%. 
The kinetics of TJS inner ring deiodination '.'lere 
l'leasured under conditions of ini ti a 1 reaction rates, 
i.e. short reaction time (5 min) and low protein con-
centration (8.4 ,ug/ml}. Parallel experiments with 
outer ring-labeled T3S demonstrated that I- produc-
tion was less than 10% of 3,3'-TZS production. This 
indicates not only that further deiodination of 
3,3'-TzS is negligible under these circumstances but 
also that direct outer ring deiodination of T3S is, 
if anything, a minor pathway. The results are shown 
in Fig. 2, and compared with the inner ring deiodi-
nation of T3. At low substrate concentrations 
({ 1 .u~·l} deiodination of T3S is two orders of magni-
tude faster than the deiodination of T3. Line\'/eaver-
Burk plots reveal for T3S an apparent Km of 4.6 + 1.3 
,uM and 'lmax of 1050 _! 190 pmol/mg protein· min (mean 
.:!:_ SO, n " 4), and for T3 10. 7 J.lr~ and 33 pmo 1 /mg 
protein·min, respectively. The latter values are very 
similar to those previously reported (6). The enhan-
cement of the inner ring deiodination of T3 by sulfa-
tion, therefore, appears to result primarily from an 
increase in Vmax rather than a decrease in Km. It is 
likely, however, that lower Km and Vmax values will 
be measured at reduced OTT levels (7). 
Recent studies have suggested that deiodination of 
both rings of iodothyronines is catalyzed by a single 
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Fig. 2. Linear and double-reciprocal (inset) plots 
of the production of 3,3'-T2S during incubation of 
varyina concentrations of "unlabeled" T3S for 5 min 
with 8~4 !Jg microsomal protein per ml (left), or the 
production of 3,3'-Tz during incubation of T3 for 
15 min with 84 !Jg protein per ml (right}. In both 
cases 3,3'-Tz immunoreactivity was measured after 
acid treatment, as described under "Materials and 
Methods''. 
deiodinase in rat liver microsomes (9,10). The simi-
lar effects of inhibitors on the inner ring deiodina-
tion of T3S and outer ring deiodination of 3,3'-TzS 1 
as on the deiodination of nonconjugated iodothyro-
nines (6,8) are compatible with this notion, and 
suggest that the sulfate conjugates are also sub-
strates for this enzyme. 
The facilitated deiodination o-:' sulfates is unex-
pected, considering that the deiodinase is in a lipid 
environment in the membrane, whereas such conjugates 
are less lipid soluble than the nonconjugated iodo-
thyronines. Neither would sulfation of the phenolic 
hydroxyl group be expected to affect the binding 
strength of the iodines to the inner ring. The mecha-
nism of this facilitated deiodination, therefore, re-
mains obscure but may be related to the deiodinase 
being a basic protein (11). 
The physiological relevance of our observations 
depends on the extent to which this mechanism oper-
ates in vivo. At least they indicc.te that T3S is not 
an end stage in the metabolism of T3. The demonstra-
tion of a rapid increase in the biliary excretion of 
T3 conjugates in rats treated with PTU (l) would tend 
to support the hypothesis that little T3 deiodination 
takes place without prior su 1 fate conjugation. Pre-
liminary experiments in our laboratory indicate that 
deiodination of T3 by rat hepatocytes depends on the 
sulfate concentration in the medium, but much further 
work is needed to test the above hypothesis. The 
question is equally i ntri gui ng whether de i odi nation 
of T4 is similarly facilitated by sulfation of glucu-
ronidation. 
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PAPER 6 
3,3',5-TRIIODOTHYRONINE METABOLISM IN RAT HEPATOCYTES 
The significance of sulfation for metabolic clearance and deiodination 
M.H. Otten, G. Hennemann, R. Docter, T.J. Visser 
It was recently demonstrated by us that deiodination of the biological ac-
tive thyroid hormone 3,3' ,5-triiodothyronine (T3 ) and of 3,3'-diiodothyronine 
(3,3'-T2 } in rat hepatocytes only occurs after conjugation with sulfate. 
Sulfation of these iodothyronines accelerates their deiodination by rat liver 
microsames. In the light of the increasing interest in tissue-specific iodothy-
ronine handling, we have investigated in detail the multiple processes involved 
in hepatic T3 metabolism with monolayers of freshly isolated rat hepatocytes. 
After incubation of the cells with 10-8 M T3 and [3'-125I]T3 for 3 hat 37C co-
lumn chrcmatography of the :rrediurn revealed besides unprocessed T 3 three labeled 
metabolites: 60% iodide (I), 30% T3 glucuronide (T3G) and 10% T3 sulfate (T3S). 
Propylthiouracil (PTU) inhibited deiodination effectively in a dose-dependent 
manner. This inhibition resulted in a reciprocal increase of the intermediate 
T3s. Glucuronidation was affected 
Interference with sulfotransferase 
only at high concentrations PTU. 
activity by medium so~- depletion lowered 
T3 clearance and iodide production but also T3S generation when deiodination was 
blocked by PTU. Inhibitors of sulfation, e.g. salicylamide, dichloronitrophe-
nol and pentachlorophenol, induced an inhibition of iodide formation which cor-
related strongly with the effect on T3S production in the presence of PTU. 
Under the conditions used, overall T3 metabolism showed no saturation at concen-
trations up to 10 ~ while the apparent ~ for glucuronidation appeared lower 
than for sulfation. 
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In conjunction with previous findings, it is concluded that hepatic deiodi-
nation of T3 involves 3 consecutive metabolic steps: sulfation, inner ring de-
iodination and finally outer ring deiodination of the 3,3'-T2 sulfate generated. 
PTU {10 pM) effectively blocks both deiodinating reactions leaving T3 disappear-
ance essentially intact. Hepatic T3 metabolism and clearance capacity is pre-
dominantly determined by sulfation and glucuronidation. Deio:::!.ination of T3 ap-
pears not to be enhanced by conjugation with glucuronic acid. 
Introduction 
In euthyroid subjects 3,3' ,5,5'-tetraiodothyronine {thyroxine, T4 ) is the 
predominant secretion product of the thyroid gland. To exert the required bio-
logical action T4 has to be converted to 3,3' ,5-triiodothyronine {T3). This 
process takes place by outer ring or 5'-deiodination of T4 in many extrathyroi-
dal tissues. However, the contribution of plasma T3 or local T3 generation to 
the nuclear T3 occupancy varies per tissue, indicating tissue specific L~yroid 
horm:me metabolism (1,2,3). The metabolic kinetics of multiple iodothyronines 
have been extensively studied in vivo in both man and rat (4,5). However, the 
use of these serum sarrpling teclmiques do not allo.v the es tinate of the actual 
contribution of the respective tissues to overall metal::xJlism. tvbreover the 
rapid succession of intracellular metabolic processes may remain undetected. 
Therefore, detailed studies of thyroid hormone metabolism in isolated tissues 
may contribute to a better integrated understanding. 
We have studied the metabolism of both 3,3'-diicdothyronine (3,3' -T2 ) and T3 
in monolayers of freshly isolated rat hepatocytes. By these experiments a hith-
erto unrecognized metal:olic pathway of iodothyronines was disclosed. Whereas 
fonnerly deiod.ination and conjugation with either glucuronic acid or sulfate 
were considered to have different metabolic functions it was demonstrated by us 
that sulfation of 3,3'-T2 and T3 considerably facilitates their rate of deiodi-
nation in hepatocytes (6). r-breover, sulfation with its large capacity, ap-
peared to be a wajor rate-determing factor in the overall hepatic clearance of 
these icXI.othyronines. In corrparison with 3,3'-T2, vvhich is mainly subjected to 
sulfation and subsequent outer ring deiodination {7), T3 metabolism is rrore com-
plex. Next to sulfation, this honrone is also conjugated with glucuronic acid. 
Furthermore, T3s is metabolized through primary deiodination in the inner ring 
(5-deiodination) with subsequent outer ring or 3'-deiodination of the 3,3'-T2 
sulfate (T2S) generated (8). In this paper we describe the quantitative contri-
butions of these pathways to overall T3 metabolism in rat hepatocytes as well as 
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the effects of several compounds that interfere with sulfation, glucuronidation 
and deiodination. 
Materials and methods 
3,3' ,5-Triioclo-L-thyronine was obtained from Henning Berlin GrribH, Berlin, 
FRG. [3'-125r]T3 with a specific activity of 1200 Ci/g was purchased from 
Amersham, UK. The following materials were from Sigma Chemical Co., st. Louis, 
MO.: 6-propyl-2-thiouracil, L-ascorbic acid, d-saccharic acid-1,4-lactone, bo-
vine pancreas insulin, collagenase type I, sulfatase type VIII, f3 -glucuronidase 
type IX, Hepes, piperazine-N,N'-bis (2-ethanesulfonic acid) (Pipes), N,N-bis 
(2-hydroxylethyl}-2-aminoethane sulfonic acid (Bes). Sephadex lH-20 carre from 
Pharrracia Fine Chemicals, Uppsala, Sweden. Salicylamide, 
2,6-didhloronitrophenol and pentachlorophenol were purChased from Riedel-de Haen 
A.G., Harmover, FRG. Fetal calf serum, penicillin and streptamycine sulfate 
were obtained from Flow Laboratories, Irvine, UK. Hams' F10 nutrient mixture 
'WaS provided by Gibco Europe, The Netherlands. Hanks balanced salt solution (9) 
and Dulbecco phosphate buffered saline (10) were prepared in our own laboratory. 
Hepatocyte monolayer preparation and incubation procedures 
Hepatocytes were isolated according to the method of Berry and Friend (11) 
with mQnor modifications as described earlier {12). Livers of male Wistar rats, 
weighing 300 g, were first perfused for 10 min with ea2+ free Hanks' salt solu-
tion and additionally for 20 min with the same medium containing 0.05% collage-
nase. The perfusion medium was kept at 37C and fH 7.4 under 5% co2 and 95% o2 . 
After mincing of the liver the cells were washed by repeated centrifugation and 
resuspending. Thereupon the cells were suspended in culture medium to yield 106 
cells per 2 ml. This suspension was slowly infused in plastic culture dishes 
(1.8 ¢, Greiner, Ntlrtingen, FRG} and placed for 4 h at 37C in a culture 
stove under atrrospheric cooditions. At this stage the culture medium was can-
posed of unm:xlified Ham's F10, 10.6 rrM Pipes, 11.2 rrM Bes, 8.9 rrM Hepes, 2 rrM 
cac12, 12 rrU/1 insulin, 10 U/1 penicillin, 10 pg/ml streptomycin sulfate and 10% 
fetal bovine serum at pH 7 .4. Cell viability as estimated by trypan blue exclu-
sion at the end of the 4 h incubation period as well as after the experiments, 
was over 85%. Subsequently, the incubations were initiated and performed at 37C 
under atmospheric conditions. For the incubations 2 ml Dulbecco balanced salt 
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medium with 1.0 mM MgS04 was used, containing 10-lO to 10-S M T3 and 0.2 pCi 
[3'-125r]T3. To test the influence of inhibited sulfation on T3 metabolism, es-
sentially two methods have been used: a) reduction of the sulfate availability 
in the culbJre medium (13} and b) addition of compounds knCM1!1 to interfere with 
sulfotransferase activity. To reduce the intracellular sulfate concentration 
hepatocytes were preincubated for one hour in so~- free Dulbecco medium, prior 
to incuba.tion with T3 and variable arrounts of M:JS04 . As inhibitors of sulfa-
transferase activity have been tested the competitive inhibitor salicylamide 
(14) and the selective inhibitors 2,6-dichloro-4-nitrophenol (DCNP) and penta-
chlorophenol (PCP) ( 15). In other experiments the influence of 
6-propyl-2-thiouracil (PTU), as inhibitor of deiodination, has been investigat-
ed. In all incubations 1 nM L-ascorbic acid was added to prevent non-specific 
deio:.:'lination. All experiments were perfonned in triplicate. The data presented 
in the figures are expressed as the triplicate mean and representative of at 
least three different experiments. 
Analysis of culture medium 
After incubation, o.s ml sarrples of the culture medium were prepared for 
chrorratcgraphic analysis by acidification with an equal volume of 1 N HCl. The 
mixure was applied to small (1 ml) sephadex LH-20 colurrms equilibrated in 0.1 N 
HCl. The columns were eluted subsequently with serial 1 ml fractions of 0.1 N 
HCl, 0.1 M scrlium acetate at f'H 4.0, H2o and ethanol. This nev.r chroma.tographic 
method provided a good separation of iodide; T3 glucuronide (T3G), T3S and unre-
acted T3 , respectively. 
T3 clearance and metabolite production were calculated from the radioactivi-
ty in the respective fractions. Due to the inconsistent adsorption of T3 to the 
culture dishes and uptake in the cellular compartment this amount was orrUtted 
from the calculations. Analysis of the nature of the conjugates was ac~ 
plished by hydrolysis with ~-glururonidase and sulfatase with or without sac-
charic acid lactone and subsequent chromatography on Sephadex LH-20 as described 
above. Furthermore, the composition of iodothyronine conjugates in the culture 
medium was verified by a newly developed high performance liquid Chromatography 
{HPLC) teclmique using a reversed phase Cl8 Bondapak column (Waters) and elution 
with a 1.5 ml/rnin flew of a 70% O.Ql M KH2Po4 and 30% acetonitrile (v/v) mixture 
at Iii 2.1. Good separation was obtained for respectively eluting iodide, T2s, 
T3S and T3G. 
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Analysis of radioactivity in the cellular compartment 
The am::mnt of total l25r radioactivity with the cellular corrpartrnent was es-
timated by the decrease of radioactivity in sequential 100 ul samples from the 
medium in the same culture dish with or without hep3.tocytes. These experiments 
were carried out in the presence of l0-10, 10-S or 10-6 M unlabeled T3 and 0.4 
pCi [3'-l25r]T3. The composition of the radioactivity in the cells was deter-
mined in ethanol extracts by chromatographic analysis on Sephadex lH-20 as des-
cribed ab:::>ve. 
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Fig.l. Chraratography of culture medium be-
fore and 3 h after incubation of 10-8 M T3 
and [3'-125I]T3 with isolated rat hepato-
cytes (upper panel) . Parallel incubates 
contained 1 or 100 )JM PI'U (low-er panel). 
Culture rrediun (500 pl) was acidifie:l by" ad-
dition of 500 ~1 1 N'HCl and directly ap-
plied to srmll (1 ml bed volume), 0.1 N HCl 
equilibrated Sephadex LH-20 columns. Serial 
elution was performed with 1 ml fractions of 
0.1 N HCl, 0.1 M sodium acetate at pi 4.0 
(NaAc), HzO and ethanol (E) as indicated by 
the horizontal bars. The respective frac-
tions contained: iodide (I), T3 glucuronide 
(G), T3 sulfate (S) and unreacted T3• 
Identification of the radioactive material G 
and S was obtained by hydrolysis 
and sulfatase. with ~ -gluooronidase 
Oirorratograpby of the hydrolysates yielded 
exclusively T3 as liberated compound. 
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Fig.2. Disappearance of T3 and simultaneous 
production of T3 metal::olites during 3 h in-
cUbation of 10-8 M T3 with (3'-125r]T3 . 
Isolated rat hepatocytes (2 x 106 cells) 
were incUbated for 3 h at 37C in larger than 
usual culture dishes (5 ern ¢), Costan, cam-
bridge, MA., USA) with 4 ml instead of 2 ml 
protein-free Dulbecco medium. This was done 
in order to reduce the influence of serial 
(100 pl) sampling on total T3 content of the 
culture rredium. By this fashion only 12.5% 
of the incUbation medium was rerroved. The 
samples were chromatographed as described in 
Fig .1 and the conversion rates calculated 
fran the radioactivity in the various frac-
tions. No other products but iodide (I), T3 
glucuronide (T3G) and T3 sulfate (T3S) were 
detected. 
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Results 
T3 mewbolism in rat hepatocytes 
Column chromatography of the culture medium on Sephadex ~20 before and 
after 3 h incubation of rat hepatocytes with 10-8 M T3 in the presence of 
[3'_l25r]T3 revealed 3 distinct radioactive products. The 125r- produced by 
out8r ring deiodination eluted in the HCl fractions. The sodium acetate and H2o 
fractions contained the respective T3 conjugates with glucuronic acid (T3G) and 
sulfate (T3s) (Fig.l). Identification of T3G and T3S was accomplished by hydro-
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CONCENTRATION T 3 
Fig.3. Influence of substrate concentration 
and PTU on T3 metaOOlisn by rat hepa.tocytes. 
Monolayers of isolated hepatocytes were in-
cubated for 3 h at 37C with protein-free 
Dulbecco medium containing 10-10 to 10-5 M 
T3 and [3' - 125 r)T3 with or without 10 pM 
PrU. Culture medium was analysed 1::¥ colurm 
chromatography on Sephadex ~20 as des-
cribed in Fig. 1 . T 3 metabolism, expressed 
as fractional clearance, is shewn on the 
right hand scale. The distribution of T3 
meta1::olites, i.e. icrlide {I), T3 glucuro-
nide {T3G) and T3 sulfate {T3s) expressed as 
percentage of total metal:::olite production, 
is depicted on the left hand scale. 
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CONCENTRATION PTU 
Fig.4. Influence of PI'U on hepatic T3 meta-
OOlism. Isolated rat hepa.tocytes were incu-
bated for 3 h at 37C with Dulbecco medium 
containing 10-9, 10-8 or 10-7 M T3 with 
[3•-125I]T3 and either no or 10-7 to 10-3 M 
Pru. The 
tribution 
left hand panels depict the 
of the T3 metabolites, 
dis-
e.g. 
icrlide (I), T3 glucuronide {T3G) and T3 sul-
fate (T3S) expressed as percentage of total 
metabolite production. The right hand pa-
nels shew the calculated arrounts in 
prol/dish of T3 metal:::olized in relation to 
the production of its metabolites. 
lysis of the radioactive material in the respective fractions with either 
-glucuronidase or sulfatase. T3G was completely hydrolysed by ~-glucuronidase, 
but not in the presence of its inhibitor, sacCharic acid lactone. T3s was hy-
drolysed by sulfatase, irrespective of the presence of 5 rrM saccharic acid lac-
tone. Chromatography of these incubates revealed no other liberated radioactive 
material but T3 . Fig.l also shows the chromatograms of T3 incubations in the 
presence of 1. 0 and 100 pM PTU. The decreased iodide production and increased 
fonration of T3s is presented. in greater detail belCM. Analysis of 50 pl unpro-
cessed culture rredium by HPI.C derronstrated an identical conposi.tion of icxlide, 
T3s and T3G as obtained by the Sephadex Chramatography. No T2S or T2G were de-
tected irrespective of the presence of PTU during the incubations. 
The disappearance of 10-8 M T3 , as well as the production of T3 metaOOlites 
over a 3 h pericd, are depicted in Fig.2. Iodide constituted. the principal me-
tabolite (60%), but T3G formation (30%) predominated over the appearance of T3S 
(10%) in the culture medium. 
The influence of increasing T3 concentrations with or without 10 pM PI'U is 
given in Fig.3. Over a concentration range from 10-10 to 10-5M the fraction of 
T3 cleared in 3 h remained fairly constant, i.e. 45 to 55 percent of medium T3 
(right hand scale). This was someWhat less in the presence of PTlJ (lcwer 
panel). Similarly, the relative T3G formation with 30-40% of total 1netabolite 
production (left hand scale) was little affected by either substrate concentra-
tion or PTU. However, with increasing T3 concentrations the proportion of iod-
ide formation decreased while T3S production showed a reciprocal rise. In the 
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Fig.S. Total 125 r radioactivity in culture medium during incul:etion of [3' _125I]T3 and unla-
beled T3 with (e----o) or without (o----o) hepatocytes. Dulbecco medium (4 ml) containing 0.5 
pCi [3•-125r]T3 with lo-10, 10-8 or 10-6M unlabeled T3 was incubated for 3 h at 37C in 1:-~e 
large culture dishes described in Fig.2, with or without 2x 106 isolated rat hepatocytes. 
Serial 100 pl sarrples were taken from the medium up to 3 h. The arrount of radioactivity (cpn 
per 100 pl) is given as mean:!::. SD of 6 parallel incuha.tes. 
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presence of 10 pM PTU little iodide was generated. Instead, T3s appeared as the 
ma.jor metaOOlite. 
The dose-response curves of PTU influence on T3 metaOOlism are given in 
Fig.4. The left hand panels Show the Qistribution of T3 metabolites, expressed 
as percentages of total 
i.e. 10-9 , 10-8 and 
metaOOlite p~uction for the 3 concentrations tested, 
10-7 M T3 . The right hand p3.nels depict the production 
rates of the three metabolites in relation to the arrount of T3 metabolized. 
Deiodination was maximally blocked by 10 pM PTU 'Whereas T 3 clearance was not yet 
affected to the extent that occured at higher P'IU concentrations. Therefore, 10 
pM PTU was used for inhibition of deiodination in other experiments. T3G fonna-
tion from 10-9 M T3 was slightly increased at moderate PTU concentrations. 
However, at the highest PTU concentrations tested T3G production invariably de-
clined in all experiments, thus contributing to the observed reduction of T3 
clearance. The generation of T3S was again inversly proportional to that of 
icdide, but tended to decline at higher PTU concentrations. During initial ex-
periments no complete inhibition of iodide production could be achieved by PTU. 
This PI'U-insensitive deiodination, which was not saturable at 10 pM T3, was as-
cribed to oxidizing corrponnds in the prot:ein-free culture medium, possibly li-
berated frcm lysoscmes of degraded cells. Non-specific deiodination was aJJrost 
corrpletely prevented 1:y addition of 1 rrM L-ascorbic acid which per se, did not 
affect hepatic T3 metabolism. 
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SULFATE CONCENTRATION (r>1M) 
Fig.6. Influence of medium SO~- concentration on hepatic T3 metabolisn. Rat hepatocytes were 
preincuba.ted at 37C for 1 h with so~- depleted Dulbecco medium to reduce the cellular so~­
content. SUbsequently 2 rnl Dulbecco containing 10-8 M T3' [3'-125IJT3 with or without 10 pM l?'IU 
and increasing arrounts upto 1.0 rrM M:JS04 was incubated for 3 hat 37C witl• 10
6 isolated cells. 
The calculated arrounts in prol/106 cells/3 h of T3 met.aOOlized are depicted on the right hand 
scale as a function of the medium SO~- concentration. Tne prOOuction of the T3 metal::olites 
e.g. iodide (I), T3 glucuronide (T3G) and T3 sulfate (T3S) is sho.m on the left hand scale. 
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T3 in the cellular compartment 
The amount of T3 associated with the cellular compartment and the surface of 
the plastic culture dish was approximated by measuring the decrease of radioac-
tivity in the culture medium with or without hepatocytes. Equilibrium between 
medium and the cells was reached within 30 to 60 min incubation. The mediun ra-
dioactivity in the dishes with hepatocytes showed a remarkably similar decrease 
of approximately 50% for the three concentrations tested e.g. lo-10 , 10-8 and 
10-6 M T3 (Fig.S). On the other hand, the decline in culture medium radioactiv-
ity without hepatocytes tended to diminish at higher T3 concentrations, suggest-
ing saturated adsorption to the culture dish. The radioactivity in the cellular 
compartment as determined by chromatography, consisted for over 85% of T3, the 
remaining being distributed over iodide, T3G and T3s. 
Influence of inhibited su(fation on T,1 metabolism 
The effects 
icted in Fig.6. 
of culture medium 
Without SO~- the 
so~- concentration on T3 metabolism are dep-
was low but 
presence of 
rate of deiodination as well 
increased rapidly when 
10 pM PTU deiodination 
small amounts of Mgso4 were 
remained low but instead a 
as T3 clearance 
added. In the 
progressive s~-
dependent accumulation of T3s v.Jas observed. The production curves of iodide in 
the absence and T3s in the presence of PTU, showed a distinct resemblance in 
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SALICYLAMIDE (f1M) 
Fig.?. Influence of salicylamide on T3 metabolism in isolated rat hepatocytes. MJnolayers (106 
cells per dish) were incubated for 3 h at 37C with 2 ml Dulbecco medium containing 10-8 M T3 , 
[3' _l25r]T3 with or without 10 )1M PIU and varioos arrounts, upto 100 pM. salicylamide. 
Production of T3 metabolites , iodide (I), T3 glucuronide (T3G) and T3 sulfate (T3S) is given in 
pmol/3 h as a function of the salicylamide concentration. 
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Fig. B. D::NP and PCP influence on hepatic T3 metaboli::m. Isolated rat hepatocytes were incubat-
ed for 3 hat 37C with 2 ml Dulbecco medium containing 10-B M T3 , [3•-125r]T3 with or without 10 
j.lM PI'U and variable amounts of 2,6-dichloro-4-nitrophenol (DCNP) or pentachloroPhenol (PCP). 
The production of T3 metabolites e.g. icdide (I), T3 glu=onide (T3G) and T3 sulfate (T3S) is 
expressed in pnol/3 h as a :functioo of the DCNP or PCP concentration. 
their sulfate dependence. The generation of T3G tended to decline at higher 
so~- concentrations. As depicted in Fig.?, the competitive inhibitor of sul-
fotransferase activity, salicylamide greatly reduced deiodination as well as the 
accumulation of T3S in the presence of 10 pM PTU. The inhibition of the former 
proved to be somewhat less pronounced than that of the latter i.e. 70 and 94% 
at 100 1M salicylamide {Table I). Hc::lW"ever, a strong correlation between the de-
grees of inhibition was found (r=0.99, p<O.Ol). The observed reduction of T3G 
production is in agreement with competitive inhibition of glucuronidation at 
high concentrations of salicylamide (16). The influences of DQW and PCP on T3 
metabolism are depicted in Fig .8. PCP proved to be the rrore pa.verful inhibitor 
of T3 sulfation, as judged ~ the respective percentages inhibition of deiodina-
tion and that of T3s production in the presence of 10 ~M PTU (Table I). Similar 
to salicylamide a strong correlation was found for the inhibition of deiodina-
tion and T3 sulfation by DCNP and PCP. T3 glucuronidation was only affected at 
high levels of these rorrpounds. 
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Table I. Reduction of T3 deiodination and T3S production in the presence 
of 10 )lM PTU in rat hepatocytes by salicylamide, DCNP and PCP.* 
Compound Concentration Production inhibition ( %) correlation 
)lM Iodide T3S coefficient 
Salicylamide 5 7 17 
10 25 36 
25 52 82 0. 99, p<O.Ol 
50 62 92 
100 70 94 
DCNP 0. 1 2 0.3 
1.0 15 40 0. 96, p<O. 01 10 68 79 
50 96 94 
PCP 0. 1 22 9 
1.0 51 49 0. 99, p<O. 01 10 81 94 
50 96 98 
* DCN P: 2, 6-dichloro-4-nitrophenol; PCP: pentachlorophenol 
Discussion 
Vfhen our rronolayers of isolated rat hepatocytes were incubated with 
serum-free medium, containing [ 125r]T3 and unlabeled T3 , we noted in 30 to 60 
min a 50% decrease of medium radioactivity. A similar percentage has been found 
for T3 after 60 min incuba.tion with cultured rronkey hepatocarcincma cells (17). 
The 50% decrease occured irrespective of a 10.000 fold difference in T3 concen-
trations, illustrating the large cytosolic and probably non-specific binding ca-
pacity for T3 of rat liver cells (18-21) . The radioactivity in the cellular 
ccrrpartment consisted for over 85% of unchanged T3 . As T3 metal:Dlism progressed 
with time, giving rise to hydrophylic metal:Dlites, the radioactivity gradually 
reappeared in the culture medium in a similar fashion for the 3 concentrations 
tested. 'This is in close agreement with earlier observations in monkey hepatoma 
cells (17) and T3-perfused rat liver (22). At the same time ho.vever, we noted 
an important non-specific but saturable T3 binding to cell-free culture dishes, 
underlining the complexities of metal:Dlic studies with this model (17,23). T3 
absorption by the cellular compartment and the culture dishes, varied per exper-
iment and in the time, and was further influenced by added compounds as PIU and 
salicyl~de. This sequestration of T3 reduced the actual T3 medium concentra-
tion by an inconsistent factor. Therefore, the various metabolic conversion 
rates calculated from the original T3 concentration, are someWhat overestimated. 
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This, ho.vever, does not affect the conclusion rrade fran this study. 
Indications for the crucial role of sulfation in hepatic iodothyronine meta-
bolisu have recently been obtained in this la1::oratory. Although 1::oth 3, 3' -T2 
and T3 are poor substrates for rat liver microsomal deiodinase activity (24), 
deiodination of these substrates occured with surprising rapidity in isolated 
hepa.tocytes. It appeared that OOth iodothyronines had to be conjugated first 
with sulfate before any substantial deiodination occure:l ( 6). This was expla-
ined by the observation that the sulfate esters of 3,3'-T2 and T3 (T2s and T3S) 
are very good substrates for rat liver microsorral deiodinase. For outer ring 
deio:lination of T2s the Km is 0.34 pM with a Vmax of 353 prol/rrg protein.min 
(U), Whereas the respective values for 3,3'-T2 are 8.9 pM and 188 u. For T3s 
the prima.ry step of degradation is inner ring deiodination ( 8) . Interestingly, 
this reaction is preda:ninantly accelerated by an increase in Vmax (30 vs 1050 
U) , whereas the ~ was only rroderatel y lON'ered ( 10. 7 vs 4. 6 pM) • 'Ihe production 
of iodide from T3 in our model therefore is a reflection of 3 successive meta-
bolic steps: sulfation, inner ring or 5--deiodination and finally the rerroval of 
l25r- from the 3'-position. 
According to this concept, hepatic T3 metabolism and clearance capacity is 
rrainly determined by the combined rate of sulfation and glucuronidation. This 
notion is further sup_fX)rted by the findings in the present study. Reduction of 
sulfation by either so~- depletion or sulfotransferase inhibitors invariably 
led to a decrease of T3 clearance from the medium. On the other hand, inhibi-
tion of deiodination by increasing PTU concentrations gradually decreased iodide 
formation but increased T3s accumulation. No T2s was detected. Therefore in 
accordance with microsomal incubations (8), PTU apparently also in cells effec-
tively inhibits inner ring deiodination of T3s. This contrasts with the less 
PTU-sensitive T3 and T4 5--deiodinase activity observed by Sato and Robbins in 
cultured rat hepatocytes (25). Furthenrore, lxJth overall T3 clearance and the 
formation of T3 glucuronide were reduced at high (lo-3 M) PTU concentrations. 
Since PTU is known to be a substrate for UDP-glucuronyltransferase (26), compet-
ition with T3 for glucuronidation may well contribute to the observed reduction 
of T3 metabolism. However, sulfation appears to be the major deterrnQnant of the 
T3 clearance rate. '!he experiments with decreasing arrounts of ~- in the 
medium show a rapid decline in T3 disappearance and iodide production below 0.5 
nM so~- The lack of ccrrplete inhibition of deiodination without added so~­
may reflect inccrrplete depletion of the cellular so~- content. Incomplete in-
hibition in the absence of SO~- has also been observed for sulfation of sali-
cylamide in isolated rat hepatocytes ( 14) • Since in these cells the 
cysteine-oxidizing pathway is well preserved (27,28) sulfate neogenesis from 
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sulfur-containing protein residues is also feasible (14~27). 
Glucuronidation, on the other hand, appears not to be of major significance 
for deiodination of iodothyronines. Whereas deiodination of T3 is clearly in-
versely proportional to the production of T3s with increasing PTU concentrations 
(Fig.4), no such relation was found for T3G. Also contrasting with T3S, no rise 
in T3G formation was observed with increasing and deiodination saturating T3 
concentrations (Fig. 3) . Furthennore, after preincubation of the cells for 30 
min with 25 nM galactosamine, a compound that inhibits glucuronidation by cell 
depletion of UDP--glucuronic acid ( 29) , iodide production rerrained unchanged 
while T3G generation was al.::olished (Otten and Visser, unpublished). 
In recent years multiple reports mentioned elevations of T3 serum levels in 
rats fed a diet deficient in protein or essential aminoacids (30-32). In these 
studies, quite opposite to the fasted state (33-37), a normal T4 5'-deiodinase 
activity and T3 production rate appeared to exist. Instead, a reduced metal.::olic 
clearance rate and distribution volume of T3 was found and tentatively explained 
by a decrease in cellular T3 uptake (31). The data on free T3 concentration in 
these studies are controversial: either low, normal {32) or high (31). In rats 
fed a comparable low protein diet (8% casein), serum so~- was lowered from 0.9 
to 0.15 roM, resulting in decreased sulfation of the xenobiotic compound harmol 
{38). Identical low sulfate concentrations resulted in a marked reduction of T3 
clearance and deiodination in our hepatocytes. Therefore, it is tempting to 
speculate that the reduced T3 clearance in the protein malnourished rats, at 
least in part, might be due to diminished hepatic sulfation of T3' In a similar 
way, the muCh better substrate properties of 3,3'-T2 for rat hepatic sulfotrans-
ferases in comparison with T3 (39) might, in part, explain the differences in 
their respective rneta'colic clearance rates ( 40-43) . 
The sequential metabolism of T3 with sulfation preceding deiodination, is 
further illustrated by the effects of IXNP, PCP and salicylamide. IXNP and PCP 
selectively irihibit sulfation with respect to glucuronidation (13,15,44). 
Moreover, a close correlation was found between the dose-dependent inhibition of 
deiodination and that of sulfation in the presence of PTU {Table I). 
Glucuronidation of T3, however, is also affected at very high concentrations of 
these conpounds. Which is some-ihat surprising since 100 pM OCNP did not influ-
ence in vitro glucuronidation of harmol (44). This may be due to the heterogen-
eity of glucuronyl transferases (45). However, DCNP and PCP are also inhibitors 
of mitochondrial oxydative phosphorylation {46). Thus, by reducing the cellular 
ATP content these corrpounds might well inhibit the energy-dependent generation 
of the respective co-substrates, i.e. activated sulfate (adenosine 
3' -phosphate 5' -sulfatophosphate, PAPS) and glucuronic acid (UDP-glucuronate) 
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(47). Furthermore, PCP was found to inhibit deiodination directly (6). 
Salicylamide, on the other hand, is known to interfere by substrate competition 
especially with sulfation but also with glucuronidation (14,15). This is in 
agreement with our observation that T3 sulfation was more rapidly reduced than 
glucuronidation. The lack of corrplete inhibition of deicdination at the highest 
concentration salicylamide is not ca:rpletely understood. Since T3 is processed 
by multiple sulfotransferases (39), it may be speculated that these enzymes are 
not inhibited to the same degree by salicylamide. At the same time PTU, as po-
tential inhibitor of sulfation (Fig. 4), might abolish the reiT~C~.ining sulfotrans-
ferase activity thus preventing the expected generation of T3s. Hcwever, this 
inconsistency leaves open the possibility of some sulfation-independent T3 de-
icxlination. 
Of further interest is the remarkable constant disappearance rate of T3 
(40-50%) in spite of a substrate concentration range from lo-10 to 10-5 M 
(Fig.3). Due to the long incubation time and absence of medium albumin in these 
experiments the contribution of the recently demonstrated active uptake system 
for T3 in rat hepatocytes (48) will remain undetected. In the presence of PTU 
the sulfation/glucuronidation ratio of T3 is constant upto 1 pM and increases at 
10 p.M, suggesting that the apparent I)u of T3 for sulfation is higher than for 
glucuronidation, the latter being in the pM range. A theoretical kinetic mc::xiel 
for this type of metabolisu has recently been presented (49). The lower I)u of 
T3 glucuronidation in comparison with sulfation seems controversial since for 
phenolic corrpounds usually the reverse is found ( 13, 15) . Ho.vever, this phenome-
non may be understcxx'l since icxline substitution of phenol in the para-p::>sition, 
(T3 has icxiine in the ortho-position), appears to lower the ~ for glucuronida-
tion 30-fold (13). 
Finally, we were intrigued by the differences in T3 metabolism found by Sato 
and Robbins (26) in 2 day-cultured rat hepatcx.:ytes in corrparison with our re-
sults using freshly isolated cells. Apart from the mentioned difference in PTU 
sensitivity of 5-deicxiination another aspect deserves ccmnent. A rruch higher 3 
h proportional clearance rate of T3 (85%) was observed by Sato and Robbins upto 
a concentration of 10-7 M declining to 35% at 10-S M. The higher clearance rate 
ma_y be explained by a larger cell ntmlber (2 vs 1 x 106 cells used by us) but the 
reduction of this fractional clearance suggests saturation of the metabolic ca-
pacity not occuring with the freshly isolated cells. Secondly, virtually no 
glucuronidation of T3 was found with the cultured hepatocytes, Whereas we noted 
30 to 40% T3 glucuronide. Expression of fetal phenotype has been reported to 
occur in cultured rat hepatocytes (SO). At the same time, hepatic 
UDP-glucuronyltransferase activity is known to be low at perinatal age whereas 
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sulfation is present early in fetal development (15) . Also a rapid 50% decline 
in glucuronidation of phenolsulfanphtalein in 2 days cultured hepatocytes 
been described (51). Therefore, the lack of T3 glucuronidation found by 
has 
Sa to 
and Robbins may be due to dedifferentation of the cultured cells. Since glucu-
ronidation is known to be an active metabolic pathway of T3 in vivo (52,53) 
freshly isolated hepatocytes would seem to be the preferred model for studying 
in vitro hepa_tic icxiothyronine metabolism. 
It is concluded from the present study that there are two primary metabolic 
pathways for T3 in freshly isolated rat hepatocytes: sulfation and glucuronida-
tion. Whereas T3G seems not to be subjected to important deiodination, sulfa-
tion of T3 gives rise to a substrate that is rapidly degraded by sUbsequent 
inner ring and outer ring deiodination. In spite of some indirect evidence, the 
physiologic significance of this metabolic property awaits further in vivo in-
vestigation of T3 kinetics in relation to body sulfotransferase activity. 
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I. INTRODUCTION 
In man and animal many endogenous and 
xenobiotic compounds are conjugated in the liver 
and other tissues with either glucuronic acid or 
sulfate. Conjugation. apart from other aspects, in-
creases the molecular polarity of the aglycon 
thereby facilitating its biliary excretion. However, 
when biliary conjugates reach the gut lumen they 
may be hydrolysed by bacterial ,8-glucuronidase or 
sulfatase. This deconjugation promotes intestinal 
reabsorption of the original compound. thus creat-
ing an enterohepatic circulation. Bacterial {3-
glucuronidase activity in the gut contents is known 
to be very active. Much less information exists 
about the hydrolytic activity of gut bacteria to-
wards sulfate esters. Thyroid hormones are secreted 
in the bile both as sulfates and glucuronides. They 
probably are subjected to an enterohepatic circula-
tion, of which the exact magnitude has never been 
documented [I]. 
We have investigated the sulfatase activity of 
rat gut bacteria for the sulfate ester of 3.3'-di-
iodothyronine (3,3'-T2 ). This is a direct metabolite 
of the biologically active hormone tri-
iodothyronine [T3 ]. Simultaneously a preliminary 
identification of the nature of two sulfatase con-
taining bacterial strains was obtained. 
2. MATERIALS AND METHODS 
1.1. Production of the sulfute ester of 3,3'-Tl (T",S) 
and determination of its deconjugation 
T2 S is not commercially available. It was pre-
pared by biosynthesis by incubating I ,uM 33'-T2 
plus 20 ,uCi 3,[3'- 125 I]T2 with primary cultures of 
isolated rat hepatocytes. After an incubation period 
of 2 h at 37°C in the presence of 100 ,uM pro-
pylthiouracil (to inhibit deiodination) over 80% of 
the original 3,3'-T2 was sulfated [2]. After extrac-
tion of the incubation medium with ethanol, the 
extract was evaporated and chromatographed on 
Sephadex LH-20 columns. By this method T2 S 
could be isolated with > 90% purity. The molar 
mass was calculated from the amount of radioac-
tivity present in the isolated material. 
To determine the amount of T2 S deconjugation 
by various bacterial strains the same chromato-
graphic procedure was used. After ethanol extrac-
tion and evaporation of the bacterial culture 
medium, the remaining material was chromate-
graphed on Sephadex LH-20 by elution with 0.1 M 
HCl and 0.1 M NaOH, respectively. A good sep-
aration was obtained for iodide, T2 S and 3,3'-T2 • 
Sulfatase hydrolysis of T2 S was estimated from 
the decrease of radioactivity in the T2 S fraction 
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and its reappearance in the 3.3'-T2 fraction. Cor-
rection was made for nonspecific deiodination. 
1.2. Incubation of T1 S with bacteria from rat inresti-
na/ flora 
Diluted caecal contents from rats were cultured 
on a nonselective medium (Schaedler Broth, Oxoid, 
Basingstoke, U.K.) solidified with 2% agar in 
anaerobic cultures flasks [3]. Isolated bacteria were 
subcultured on the same medium with 0.3% agar 
in tubes. Caecal contents, anaerobic bacteria or 
bacterial strains and 10 nM T2 S with tracer activ-
ity were incubated in 10 ml broth at 37°C covered 
with paraffin for anaerobic conditions. After inoc-
ulation 1-ml samples were taken from the incubate 
at 0. 6, 10. 14, 18, 24 and 34 h and analysed for 
desulfation of T2 S. Control incubates of T2 S in 
broth were performed without bacteria. At 30 h 
samples from the incubate with and without T2 S 
were subcultured and the number of colony-form-
ing units was determined. To evaluate a possible 
substrate induction of sulfatase activity, bacteria 
were preincubated with 10 nM unlabelled T2 S for 
30 h prior to the incubation with labelled T2 S. For 
the incubation of T2S with Escherichia coli and 
Streptococcus aerobic conditions were used. 
3. RESULTS 
Preliminary anaerobic incubations of rat caecal 
contents with T2 S resulted in its partial desulfation 
in 24 h. The subcultured anaerobic part of the 
intestinal flora also showed hydrolytic activity. 
Therefore, more detailed studies were performed 
using strictly anaerobic strains. Two anaerobic. 
Gram-positive strains from the intestinal flora of 
rats were found to actively desulfate T2 S. Both 
strains (A and B) hydrolysed within 18 h 80% of 
the 10 pmoljml T2 S originally present in the 
medium (Fig. 1). Bacterial growth was not 
markedly influenced by the presence of T2S. After 
30 h of incubation with or without T2 S the num-
bers of bacteria for strain A amounted to 1.8 and 
1.4 · 10 6 bacteriajml, respectively. For strain B 
these numbers were 4.6 and 4.1 10 8 bacteriajmL 
The deconjugating potential of strain A was higher 
since it performed the same rate of T2 S hydrolysis 
in spite of a hundred fold lower number of 
bacteriajml (Fig. 1). 
Examples of the chromatographic patterns of 
T2S containing incubates with the anaerobic strain 
A. the aerobic strain C (E. coli) and without 
bacteria, before and after incubation are given in 
Fig. 2. No desulfation was noted with strain C or 
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Fig. 1 Hydrolysis of !0 nM sulfate ester of 3.3'-T2 (T,S) by t""o 
anaerobic Gram-positive strains A and B, isolated- from rat 
inlestinal microflora. 
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Fig. 2. Chromatography of culture medium containing !0 nM 
of the sulfate ester of 3,[3'- 125 IJT1 before and after incubation 
with; anaerobic strain A. aerobic strain C (E. coli). both from 
rat intestinal microflora, and without bacteria. 
in control incubates. but 3.4% aspecific deiodina-
tion occurred. Other strains of bacteria isolated 
from the intestinal flora of rats ( Ba,ctermdes, 
Escherichia and Streptococcus species) had no 
deconjugating activity towards T2S. No substrate 
induction of sulfatase activity by preincubation 
with unlabelled T2 S was observed. 
4. DISCuSSION 
Sulfatase activity of anaerobic rat intestinal fl0ra 
has been documented in vitro for sulfate esters of 
bile acids [4] and steroids [5]. The actual presence 
of sulfatase activity of the intestinal microflora in 
vivo is suggested by the increased excretion of 
orally administered oestrone [ 35 S]sulfate in the 
faeces of rats after treatment with antibiotics [6]. 
The role of bacterial sulfatase activity in relation 
to a possible enterohepatic circulation has recently 
been reviewed [7]. We have isolated from rat in-
testinal microflora 2 strictly anaerobic. gram posi-
tive bacterial strains, which show sulfatase activity 
for the sulfate ester of 3,3'-T1 in vitro. Sulfatase 
activity in mixed cultures of rat faecal prepara-
tions has also been demonstrated for the sulfate 
ester of T3 [8]. However, these incubations were 
done under aerobic conditions and therefore are 
different from the actual in vivo situation. Com-
parison of hydrolytic activity with our study can 
not be made since the bacterial concentration in 
the incubates is not given. The 24 h needed for 
80% desulfation of T3 S corresponds well with our 
study. A similar time has been documented for 
complete hydrolysis of 35 S-labelled lithocholate 
sulfate by P. aeruginosa from human faeces [9]. No 
sulfatase activity was demonstrated for E. coli, 
Bacterioides species, Streprococcus species and bi-
fidobacteria. Contrary to other experiments, which 
showed a substrate induction of glycosulfatase ac-
tivity in mixed faecal cultures [7], we were unable 
to demonstrate such induction in our anaerobic 
strains with a low concentration of T2 S. Since 
anaerobic conditions prevail in the intestinal lu-
men and the two anaerobic strains isolated by us 
from rat intestinal contents are very active in 
hydrolysing T2 S it is reasonable to assume that 
desulfation of biliary secreted sulfated iodothy-
ronines does actually take place in the rat gut. As 
iodothyronines are much better absorbed from the 
gastro-intestinal tract when they are in the free, 
that is the unconjugated form [10], this bacterial 
sulfatase activity therefore may actually enhance 
the enterohepatic circulation of iodothyronines. 
Depending on the turnover rate of such an enter-
ohepatic circulation, disturbance of the normal 
bowel function (e.g., diarrhoea. intestinal opera-
tion or malabsorption) may alter thyroid hormone 
disposal and bioavailability. However, the actual 
contribution of the gut bacteria to this process 
awaits further studies. 
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SUMMARY 
Peripheral thyroid hormone metabolism is the denomination for the multitude 
of bioChemical reactions and feedbaCk mechanisms involved in maintaining the eu-
thyroid state of the 'body. The aim of the research presented in this thesis has 
been to contribute to a better understanding of some aspects of this broad field 
of investigation. The manuscript consists of two sections. Section I attempts 
to integrate the current knowledge of peripheral thyroid hormone metabolism with 
the most relevant observations from our research. In Section II the factual 
data of this 'WOrk are presented as separate papers, which have either been pub-
lished or are su~tted for publication. 
In essence, three different lines of investigation have been followed. The 
first line studied the influences of dietary composition on iodothyronine serum 
levels in four healthy, non-obese subjects. The results suggested an active 
role of dietary fat in the regulation of these serum levels. A diet composed of 
100% fat induced a similar decrease of 3,3' ,5-triiodothyronine (T3) and increase 
of 3,3' ,5'-triiodothyronine (reverse T3 ) as total starvation. Fat also antagon-
ized the T3-stabilizing action of carbohydrates in hypocaloric nutrition. For 
the influence of food on thyroid hormone metabolism the dietary composition ap-
pears to be more important than the total amount of calories. 
Kinetic studies with labeled iodothyronines in human beings and animals give 
information about the respective production and metabolic clearance rates. 
However, the individual contribution of the various tissues to overall metabol-
ism remains obscure, ~d rapid successive intracellular reactions cannot be de-
tected. Since the liver plays a central role in peripheral thyroid hormone me-
taboli::m, +-.he second line of research dealt with iodothyronine metaOOlism at the 
tissue-level with the use of isolated rat hepatocytes. Fbr this purpose hepato-
cyte rronolayers were incubated with thyroxine, T3 , reverse T3 and 
3,3'-diiodothyronine (3,3'-T2). 
Hepatic processing of reverse T3 appeared to be quite different from that of 
3,3'-T2 and T3 . Reverse T3 is rapidly degraded py liver cells through direct 
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deiodination in the outer ring yielding iodide and 3,3'-T2. Only little conju-
gation, presumably with glucuronic acid, occurs. This contrasts with 3,3'-T2 
and T3, for which conjugation appeared to be the first and principal metabolic 
process. 3,3'-T2 is exclusively sulfated, Whereas T3 can also be conjugated 
with glucuronic acid. Sulfation considerably enhanced the inner ring deiodina-
tion of T3 and the outer ring deiodination of 3,3'-T2 . Inhibition of sulfation 
virtually aOOlished deiodination. It was concluded that hepatic clearance and 
deiodination of 3,3'-T2 and T3 largely depends on the sulfate transferring capa-
city of the liver cells. 
Iodothyronines preferentially appear in bile as conjugates. Hydrolysis of 
these conjugates by the intestinal rnicroflora might enhance enteral reabsorption 
of the aglycons, thereby pronating an enterohepatic circulation. The third line 
of research has investigated the hydrolytic potential of rat gut bacteria to-
wards iodothyronine sulfates. From rat cecal contents 2 anaerobic bacterial 
strains were isolated that actively hydrolysed 3,3'-T2 sulfate. 
In Section I of this thesis special attention is given to the recent recog-
nition of two tissue-specific pathways for iodothyronine deiodination. By this 
distinction the body tissues can be subdivided in having deiodinase activity 
whiCh is either inhibited, or unaffected by propylthiouracil (PTU). Instigated 
by this notion and our own results a tentative model is proposed, postulating a 
close metabolic interaction of the two tissue types in the modulation of iodo-
thyronine serum levels. It is conceived that the serum levels of a number of 
iodothyronines are determined by production in the one type of tissue and by de-
gradation in the other. Support for this hypothesis was found in our prelimina-
ry observation that human brains (~insensitive) may be an important site of 
3,3'-T2 production, whereas the liver (PTU-sensitive) very efficiently extracts 
this compound from the blood. 
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SAMENV AT TIN G 
Een allesomvattende definitie van wat er onder het perifere metabolisme van 
schildklierhormoon verstaan wordt, is niet eenvoudig te geven. 
funktie van schildklierhormoon lijkt te zijn de regulatie van 
De belangrijkste 
een gelijkmatige 
basale stofwisseling in het lichaam. De basale stofwisseling draagt zorg voor 
een bepaalde grond-snelheid van veel intracellulaire processen en biochemische 
reacties. Hierdoor ontstaat er een zekere uitgangs-toestand, waarop alle 
specifieke funkties van het liChaam, ieder met zijn eigen behoefte en regulatie, 
uitgevoerd kunnen worden. In grate lijnen kan men stellen, dat hoe rreer 
(minder) schildJ::.:i.ierhorrnoon in het lichaarn aanwezig is, hoe hoger (lager) het 
basaal rnetabolisme zal zijn afgesteld. 
De totale hoeveelheid schildklierhormoon in het lichaam wordt bepaald door 
twee faktoren: de produktie en de afbraak ervan. Door Oeze individueel of 
gelijktijdig te veranderen heeft het lichaam de mogelijkheid het basaal 
rnetalx>lisrre te reguleren. De produktie van schildklierho:rmoon vindt plaats in 
de schildklier, terwijl de afbraak in buiten de schildklier gelegen of 
"perifere" weefsels geschiedt. 
Het voornaarnste produkt van de schildklier, het thyroxine, bestaat uit een 
moleculair skelet met 4 jodiurn atomen. Hiervan stamt de voor thyroxine veel 
gebruikte afkorting "T4 ". Deze stof heeft zelf geen biologische aktiviteit, 
maar moet om deze te verkrijgen een anzetting ondergaan. Bij deze crnzetting 
wordt een van de 4 jodium-atamen van het basis-skelet afgesplitst, waardoor een 
molecuul ontstaat met 3 jc.Xlium-atorren en grote biologische aktiviteit, het 
zogenaamde trijodothyronine of T3 . Dit crnzettingsproces (dejodering) v.:ordt 
uitgevoerd door verschillende enzymen in de "perifere" weefsels. Ook de overige 
3 jcxlium-atomen kunnen op hun beurt gedejocleerd w::>rden, waardoor een hele reeks 
metabolieten (stofwisselingsprodukten) ontstaat (zie Fig.l, pagina 18). Een van 
de rnetabolieten die de laatste jaren veel aandacht heeft gekregen is het reverse 
T3 (rT3 ). Dit jodothyronine heeft net als T3 3 jodium atomen :maar met een 
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andere verdeling op het basis-skelet waardoor het iedere biologische aktitiveit 
mist. 
Naast deze dejoderings-reakties kunnen de metabolieten of jodothyronines ook 
nog een koppeling ondergaan met glucuronzuur (glucuronidatie) of sulfaat 
(sulfatering). Hierdoor veranderen de biochemische eigenschappen van de 
jodothyronines en kunnen ze bijvoorbeeld gemakkelijker via gal of urine 
uitgescheiden w:Jrden. Van alle weefsels die bij deze processen betrokken zijn 
neemt de lever een centrale plaats in. 
Het is al geruime tijd bekend, dat ziekte, geneesmiddelen of verandering in 
dieet-samenstelling het perifere metabolisme van schildklierhormoon kunnen 
beinvloeden. De meest opvallende verandering is een verminderde omzetting, in 
onder andere de lever, van het inaktieve T4 naar het aktieve T3 . Hierbij daalt 
de bloedspiegel van 
speculeert dat dit 
T 3 en secundair hieraan het basaal metabolisme. Men 
een energie-besparende aanpassing van het lichaam is in 
stress-situaties of tijdens voedselschaarste. Een interessante waarneming onder 
deze omstandigheden is de vrijwel reciproke 
bloed. Terwijl de daling van T3 veroorzaakt 
stijging van reverse T3 in het 
wordt door een verminderde 
produktie, kamt de stijging van rr3 tot stand door een afname van de klaring. 
De in dit proefschrift beschreven experimenten hebben tot doel gehad meer 
inziCht te verkrijgen in deze stofwisselingsprocessen van jodothyronines. In 
totaal zijn drie onderzoekslijnen te ondersdheiden. 
1) De bestudering van de invloed van vet in het voedsel op het perifere 
metatolisme van schildk.lierhonnoon. Uit dieetproeven met gezonde vrijwilligers 
kon worden opgemaakt dat vet een aktieve rol speelt bij de samenstelling van de 
jodothyronines in het bleed. Opvallend was hierbij dat een dieet bestaande uit 
1500 KCal 100% vet, dezelfde veranderingen induceerde als volledig vasten. 
2) T4 en zijn metabolieten worden voornamelijk uitgescheiden in de gal als 
conjugaten van glucuronzuur of sulfaat. In de darm worden de conjugaten slecht 
geresorbeerd terwijl dit voor de ongeconjugeerde of vrije jodothyronines juist 
gemakkelijk geschiedt. Onderzocht werd in hoeverre dannba.cterie~n in staat 
zijn om de jOOothyronines los te maken van hun conjugaten. Door incubaties van 
uit rattefaeces geisoleerde bacterie~ met de conjugaten kon inderdaad 
aangetoond worden dat bepaalde bacterie-soorten tot deze ontkoppeling in staat 
zijn. Hiennee is de rrogelijkheid van het uit de darm terugwinnen van reeds 
uitgescheiden schildklierhormoon (de entero-hepatische circulatie) aannemelijker 
gev.orden. Dit rnechanisme zou vooral van betekenis kunnen 
hormoon-schaarste zeals voorkarnt bij een te langzaam werkende 
zijn in tijden van 
schildklier . 
3) De derde lijn bestond uit gedetailleerd onderzoek naar het metabolisme 
van jodothyronines in de lever. Als m::xlel werd daarbij gebruik gemaakt van 
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gekweekte rattelevercellen. Verschillende jodothyronines werden gedurende enige 
tijd met de celcultures geincu'beerd, waarna het kweekmediurn onderzocht werd op 
gevorm::le produkten. Hierbij bleek dat er voor 3,3 '-T2 , een direkte metaOOliet 
van het aktieve T3 (Fig.l, pagina 18), 2 stofwisselingsprocessen bestaan in de 
lever: 1) dejodering en 2) sulfatering. Het wekte verbazing dat de dejodering 
van 3,3'-T2 zo gemakkelijk verliep in gekweekte levercellen, omdat uit vroeger 
onderzoek bekend was, dat 3,3'-T2 zeer slecht gedejodeerd wordt door het uit 
rattelever geisoleerde enzyrn dejcxlase. Op grond hiervan werd gep:::>stuleerd dat 
3,3'-T2 eerst gesulfateerd en pas daarna gedejodeerd zou worden. 
Een belangrijk deel van het proefschrift wordt gevonnd door de experimenten 
die de juistheid van deze hypothese aannemelijk gemaakt hebben. De essentie van 
de bewijsvoering wordt gevormd door drie waarnemingen: a) selektieve remming 
van de sulfatering in rattelevercellen veroorzaakt ook remming van de 
dejodering b) daarentegen geeft rernming van de dejodering juist ophoping van 
het met sulfaat geconjugeerde 3,3'-T2 (T2S) c) T2s bleek, in tegenstelling tot 
het oorspronkelijke 3,3'-T2 heel geed gedejodeerd te worden door het 
lever-dejcdase. 
Op identieke wijze kon aangetoond worden, dat dejodering van het biologisch 
aktieve T3 e',;eneens slechts optreedt na voorafgaande sulfatering van het T3 
rrolecuul. Vooral deze laatste waameming trekt de aandacht crrdat hierrree 
sulfatering in de lever een essentiele en snelheids-bepalende stap blijkt te 
zijn in de afbraak van het enige biologisch aktieve schildklierhormoon. 
Hierdoor mrdt het begrijpelijk waarcm het lichaams-T3 (en dus het basaal 
metabolisme) tijdens ziekte of vasten kan dalen: de produktie van T3 uit T4 in 
de lever vermindert onder deze omstandigheden, terwijl de klaring (afbraak) van 
T3 via sulfatering gelijk blijft. 
Daarnaast hebben incubatie experimenten van de levercellen met reverse T3 
aangetoand dat de klaring van deze inaktieve metaboliet wel door rechtstreekse 
dejodering tot stand kamt, d.w.z. zonder dat voorafgaande sulfatering hoeft 
plaats te vinden. Dit lijkt dan ook de verklaring waarom onder omstandigheden 
van verminderde dejodase-aktiviteit in de lever (ziekte, vasten) er een 
verminderde klaring en stijging van het serum rr3 optreedt. 
Terw:ijl door deze experimenten een beter inzicht verkregen werd in de 
mechanisrnen van het jodothyronine metabolisme kan de betekenis van deze 
waamemingen voor ziekteprocessen, vermagering of geneesmiddelen-gebrui.k nog 
niet exakt gedefinieerd worden. Hiervoor is nader onderzoek vereist. 
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NAWOORD 
De mogelijkheid om aan een promotieonderzoek te werken heb ik als een 
voorrecht beschouwd. Het is een leerzame periode die naast de incidentele 
voldoening van wetenschappelijk onderzoek, de gelegenheid geeft om als arts 
vertrouwd te raken met andere dan rnedische denk- en onderzoekswijzen. De 
onontbeerlijke ontwikkeling van een kritische instelling ten opzichte van met 
name eigen waarne~ngen als oOk die van anderen, komt de besluitvorming en het 
klinisch inzicht van de medicus ten goede. 
Het totstandkomen van een dissertatie is van veel mensen en een aantal 
onvoorspelbare faktoren afhankelijk. Op deze plaats wil ik graag mijn dank 
betuigen aan diegenen die voor mij de onzekere faktoren tot een minimum hebben 
weten te beperken en mij geinspireerd, gestimuleerd en geholpen hebben om dit 
proefschrift te voltooien. 
Dat betreft in de eerste plaats mijn prcm:::>tor, Jorg Hennemann, die mij op 
geheel eigen wijze wist te wllh~en voor een onbekend onderzoeksgebied en rnijn 
research-belangstelling gewekt heeft. Met veel genoegen derik ik terug aan de 
altijd stimulerende discussies over ons werk, zijn grote hulpvaardigheid bij 
moeilijKheden en het inzicht en de ervaring waarvan zijn adviezen getuigden. 
Het is Theo Visser geweest die vanaf mijn eerste anwennige begin in het 
laboratorium steeds op bijzonder plezierige wijze leiding heeft gegeven aan mijn 
onderzoek. Zijn kennis van zaken, heldere rranier van denk.en en goede idee~n 
zijn voor mij een bron van inspiratie gew-eest. Ook van de vrijheid die hij mij 
liet bij de experimentele uitvoering heb ik veel geleerd. 
Roel D::Jcter was als hcx::>fd van het laboratorium altijd behulpzaarn met 
praktische adviezen. Zijn computerprogramma's waren van onschatbare waarde bij 
het uitwerken van de talloze chromatografie~n. 
Jannet BlorrrLeenheer en Marla van Loon hebben op buitengewoon co5peratieve 
wijze de vaak gecompliceerde experimenten en massale chromatografie~ verzorgd. 
Hun vrolijkheid en persoonlijke inzet zijn mij zeer tot steun geweest. 
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Bert Bernard verrichtte de eerste experimenten en ontwikkelde de techniek van de 
leverperfusie. 
De gezamenlijke experimenten en plezierige discussies met Maarten Hazenberg 
(Medische Microbiologie) en Wouter de Herder hebben een wezenlijke bijdrage aan 
dit proefschrift geleverd. 
Aan de sarnenwerking met Hans van der Heyden en Eric Krenning, evenals aan de 
vele onderhoudende en leerzame uurtjes met rnijn kamergenoten Jan Mol en 
Huib Pols, bewaar ik de beste herinneringen. 
De grote bereidwilligheid en inzet van Yvonne van Dodewaard bij het accuraat 
tikken en verzorgen van het manuscript, rraakten ook dit onderdeel van het 
pramoveren tot een genoegen. 
De medewerkers van het laboratorium bedarik ik vcxor de goede en 
vriendschappe.lijke sfeer tijdens de jarenlange samenwerking. 
De Audiovisuele Dienst verzorgde op uitstekende wijze de figuren en 
Henk van Beek van de afdeling Automatische Signaal Verwerking (Centrale Research 
Werkplaatsen) was zeer behulpzaarn bij het gebruik van de tekstverwerker. 
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